,words,labels,sentence_id,full sentence
113,Selenium,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
114,content,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
115,in,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
116,the,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
117,tested,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
118,products,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
119,ranged,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
120,from,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
121,0.9,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
122,to,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
123,24.5,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
124,μg/100,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
125,g.,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
126,The,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
127,average,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
128,content,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
129,of,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
130,selenium,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
131,in,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
132,products,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
133,based,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
134,on,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
135,popular,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
136,gluten,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
137,-,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
138,free,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
139,cereals,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
140,was,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
141,2.8,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
142,μg/100,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
143,g,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
144,and,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
145,in,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
146,products,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
147,based,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
148,on,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
149,oat,B-http://purl.bioontology.org/ontology/SNOMEDCT/418504009,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
150,",",O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
151,amaranth,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
152,",",O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
153,teff,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
154,",",O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
155,and,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
156,quinoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/227515004,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
157,was,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
158,10.8,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
159,μg/100,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
160,g.,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
161,It,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
162,indicates,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
163,that,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
164,products,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
165,based,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
166,on,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
167,less,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
168,popular,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
169,grains,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
170,",",O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
171,especially,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
172,on,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
173,oat,B-http://purl.bioontology.org/ontology/SNOMEDCT/418504009,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
174,",",O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
175,should,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
176,be,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
177,more,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
178,frequently,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
179,chosen,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
180,as,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
181,a,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
182,source,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
183,of,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
184,selenium,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
185,by,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
186,people,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
187,on,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
188,gluten,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
189,-,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
190,free,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
191,diet,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
192,than,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
193,traditionally,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
194,consumed,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
195,gluten,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
196,-,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
197,free,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
198,grains,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
199,.,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
200,Dairy,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
201,sheep,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
202,have,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
203,been,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
204,farmed,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
205,traditionally,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
206,in,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
207,the,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
208,Mediterranean,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
209,basin,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
210,in,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
211,southern,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
212,Europe,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
213,",",O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
214,central,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
215,Europe,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
216,",",O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
217,eastern,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
218,Europe,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
219,",",O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
220,and,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
221,in,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
222,Near,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
223,East,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
224,countries,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
225,.,O,4.0,"Dairy sheep have been farmed traditionally in the Mediterranean basin in southern Europe , central Europe , eastern Europe , and in Near East countries ."
430,In,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
431,many,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
432,cases,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
433,",",O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
434,further,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
435,selection,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
436,goals,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
437,such,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
438,as,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
439,milk,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
440,composition,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
441,",",O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
442,udder,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
443,morphology,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
444,",",O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
445,somatic,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
446,cell,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
447,count,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
448,",",O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
449,and,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
450,scrapie,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
451,resistance,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
452,have,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
453,been,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
454,implemented,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
455,.,O,13.0,"In many cases , further selection goals such as milk composition , udder morphology , somatic cell count , and scrapie resistance have been implemented ."
1044,There,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1045,is,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1046,now,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1047,sufficient,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1048,level,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1049,of,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1050,evidence,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1051,for,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1052,the,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1053,association,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1054,between,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1055,overweight,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1056,and,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1057,11,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1058,types,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1059,of,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1060,cancer,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1061,",",O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1062,among,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1063,which,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1064,are,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1065,two,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1066,of,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1067,the,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1068,most,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1069,common,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1070,cancers,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1071,worldwide,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1072,",",O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1073,those,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1074,of,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1075,the,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1076,colorectum,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1077,and,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1078,postmenopausal,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1079,breast,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1080,.,O,33.0,"There is now sufficient level of evidence for the association between overweight and 11 types of cancer , among which are two of the most common cancers worldwide , those of the colorectum and postmenopausal breast ."
1901,When,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1902,further,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1903,subclassified,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1904,into,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1905,botanical,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1906,groups,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1907,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1908,those,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1909,in,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1910,the,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1911,highest,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1912,tertile,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1913,of,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1914,leguminosae,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1915,(,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1916,dried,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1917,beans,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1918,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1919,string,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1920,beans,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1921,and,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1922,peas,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1923,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1924,0.80,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1925,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1926,0.67,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1927,-,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1928,0.96,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1929,),O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1930,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1931,rosaceae,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1932,(,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1933,apples,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1934,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1935,peach,B-http://purl.bioontology.org/ontology/SNOMEDCT/735049002,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1936,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1937,nectarines,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1938,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1939,plums,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1940,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1941,pears,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1942,and,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1943,strawberries,B-http://purl.bioontology.org/ontology/SNOMEDCT/102261002,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1944,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1945,0.60,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1946,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1947,0.49,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1948,-,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1949,0.73,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1950,),O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1951,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1952,solanaceae,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1953,(,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1954,peppers,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1955,and,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1956,tomatoes,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1957,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1958,0.82,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1959,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1960,0.69,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1961,-,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1962,0.98,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1963,),O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1964,and,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1965,umbelliferae,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1966,(,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1967,carrots,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1968,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1969,0.73,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1970,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1971,0.60,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1972,-,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1973,0.89,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1974,),O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1975,had,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1976,decreased,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1977,risk,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1978,of,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1979,head,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1980,and,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1981,neck,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1982,cancer,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1983,",",O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1984,but,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1985,no,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1986,significant,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1987,associations,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1988,were,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1989,seen,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1990,for,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1991,9,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1992,other,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1993,botanical,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1994,groups,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
1995,.,O,59.0,"When further subclassified into botanical groups , those in the highest tertile of leguminosae ( dried beans , string beans and peas , 0.80 , 0.67 - 0.96 ) , rosaceae ( apples , peach , nectarines , plums , pears and strawberries , 0.60 , 0.49 - 0.73 ) , solanaceae ( peppers and tomatoes , 0.82 , 0.69 - 0.98 ) and umbelliferae ( carrots , 0.73 , 0.60 - 0.89 ) had decreased risk of head and neck cancer , but no significant associations were seen for 9 other botanical groups ."
2095,This,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2096,review,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2097,explores,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2098,the,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2099,constituents,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2100,of,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2101,cocoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2102,and,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2103,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2104,and,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2105,summarizes,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2106,evidence,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2107,about,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2108,the,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2109,role,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2110,of,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2111,cocoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2112,and,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2113,chocolate,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2114,components,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2115,on,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2116,human,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2117,health,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2118,and,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2119,particularly,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2120,on,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2121,reproduction,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2122,.,O,65.0,This review explores the constituents of cocoa and chocolate and summarizes evidence about the role of cocoa and chocolate components on human health and particularly on reproduction .
2153,Women,O,67.0,"Women seem to be particularly favored by consuming of cocoa products , and chocolate with specific features can also be a good supplementary source of energy for pregnant woman ."
2154,seem,O,67.0,"Women seem to be particularly favored by consuming of cocoa products , and chocolate with specific features can also be a good supplementary source of energy for pregnant woman ."
2155,to,O,67.0,"Women seem to be particularly favored by consuming of cocoa products , and chocolate with specific features can also be a good supplementary source of energy for pregnant woman ."
2156,be,O,67.0,"Women seem to be particularly favored by consuming of cocoa products , and chocolate with specific features can also be a good supplementary source of energy for pregnant woman ."
2157,particularly,O,67.0,"Women seem to be particularly favored by consuming of cocoa products , and chocolate with specific features can also be a good supplementary source of energy for pregnant woman ."
2158,favored,O,67.0,"Women seem to be particularly favored by consuming of cocoa products , and chocolate with specific features can also be a good supplementary source of energy for pregnant woman ."
2159,by,O,67.0,"Women seem to be particularly favored by consuming of cocoa products , and chocolate with specific features can also be a good supplementary source of energy for pregnant woman ."
2160,consuming,O,67.0,"Women seem to be particularly favored by consuming of cocoa products , and chocolate with specific features can also be a good supplementary source of energy for pregnant woman ."
2161,of,O,67.0,"Women seem to be particularly favored by consuming of cocoa products , and chocolate with specific features can also be a good supplementary source of energy for pregnant woman ."
2162,cocoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,67.0,"Women seem to be particularly favored by consuming of cocoa products , and chocolate with specific features can also be a good supplementary source of energy for pregnant woman ."
2163,products,I-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,67.0,"Women seem to be particularly favored by consuming of cocoa products , and chocolate with specific features can also be a good supplementary source of energy for pregnant woman ."
2164,",",O,67.0,"Women seem to be particularly favored by consuming of cocoa products , and chocolate with specific features can also be a good supplementary source of energy for pregnant woman ."
2165,and,O,67.0,"Women seem to be particularly favored by consuming of cocoa products , and chocolate with specific features can also be a good supplementary source of energy for pregnant woman ."
2166,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,67.0,"Women seem to be particularly favored by consuming of cocoa products , and chocolate with specific features can also be a good supplementary source of energy for pregnant woman ."
2167,with,O,67.0,"Women seem to be particularly favored by consuming of cocoa products , and chocolate with specific features can also be a good supplementary source of energy for pregnant woman ."
2168,specific,O,67.0,"Women seem to be particularly favored by consuming of cocoa products , and chocolate with specific features can also be a good supplementary source of energy for pregnant woman ."
2169,features,O,67.0,"Women seem to be particularly favored by consuming of cocoa products , and chocolate with specific features can also be a good supplementary source of energy for pregnant woman ."
2170,can,O,67.0,"Women seem to be particularly favored by consuming of cocoa products , and chocolate with specific features can also be a good supplementary source of energy for pregnant woman ."
2171,also,O,67.0,"Women seem to be particularly favored by consuming of cocoa products , and chocolate with specific features can also be a good supplementary source of energy for pregnant woman ."
2172,be,O,67.0,"Women seem to be particularly favored by consuming of cocoa products , and chocolate with specific features can also be a good supplementary source of energy for pregnant woman ."
2173,a,O,67.0,"Women seem to be particularly favored by consuming of cocoa products , and chocolate with specific features can also be a good supplementary source of energy for pregnant woman ."
2174,good,O,67.0,"Women seem to be particularly favored by consuming of cocoa products , and chocolate with specific features can also be a good supplementary source of energy for pregnant woman ."
2175,supplementary,O,67.0,"Women seem to be particularly favored by consuming of cocoa products , and chocolate with specific features can also be a good supplementary source of energy for pregnant woman ."
2176,source,O,67.0,"Women seem to be particularly favored by consuming of cocoa products , and chocolate with specific features can also be a good supplementary source of energy for pregnant woman ."
2177,of,O,67.0,"Women seem to be particularly favored by consuming of cocoa products , and chocolate with specific features can also be a good supplementary source of energy for pregnant woman ."
2178,energy,O,67.0,"Women seem to be particularly favored by consuming of cocoa products , and chocolate with specific features can also be a good supplementary source of energy for pregnant woman ."
2179,for,O,67.0,"Women seem to be particularly favored by consuming of cocoa products , and chocolate with specific features can also be a good supplementary source of energy for pregnant woman ."
2180,pregnant,O,67.0,"Women seem to be particularly favored by consuming of cocoa products , and chocolate with specific features can also be a good supplementary source of energy for pregnant woman ."
2181,woman,O,67.0,"Women seem to be particularly favored by consuming of cocoa products , and chocolate with specific features can also be a good supplementary source of energy for pregnant woman ."
2182,.,O,67.0,"Women seem to be particularly favored by consuming of cocoa products , and chocolate with specific features can also be a good supplementary source of energy for pregnant woman ."
2355,Furthermore,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2356,",",O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2357,ginger,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2358,administration,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2359,corrected,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2360,the,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2361,HFD,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2362,-,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2363,induced,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2364,changes,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2365,in,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2366,concentrations,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2367,of,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2368,intermediates,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2369,in,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2370,glycolysis,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2371,and,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2372,the,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2373,TCA,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2374,cycle,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2375,.,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2475,Thus,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2476,",",O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2477,ginger,B-http://purl.bioontology.org/ontology/SNOMEDCT/227400003,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2478,is,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2479,an,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2480,edible,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2481,plant,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2482,that,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2483,plays,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2484,a,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2485,role,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2486,in,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2487,the,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2488,therapeutic,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2489,treatment,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2490,of,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2491,obesity,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2492,and,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2493,related,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2494,disorders,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2495,.,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2948,Last,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2949,",",O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2950,speakers,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2951,described,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2952,the,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2953,role,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2954,of,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2955,dairy,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2956,products,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2957,in,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2958,global,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2959,public,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2960,health,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2961,and,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2962,nutrition,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2963,",",O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2964,the,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2965,scientific,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2966,basis,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2967,for,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2968,current,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2969,dairy,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2970,recommendations,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2971,",",O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2972,and,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2973,future,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2974,scientific,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2975,and,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2976,policy,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2977,needs,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2978,related,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2979,to,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2980,dairy,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2981,and,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2982,yogurt,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2983,recommendations,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
2984,.,O,92.0,"Last , speakers described the role of dairy products in global public health and nutrition , the scientific basis for current dairy recommendations , and future scientific and policy needs related to dairy and yogurt recommendations ."
3499,In,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3500,conclusion,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3501,",",O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3502,our,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3503,study,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3504,suggests,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3505,that,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3506,the,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3507,risk,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3508,of,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3509,GC,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3510,decreased,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3511,with,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3512,high,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3513,consumption,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3514,of,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3515,fresh,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3516,vegetables,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3517,and,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3518,fruits,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3519,",",O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3520,whereas,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3521,high,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3522,consumption,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3523,of,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3524,foods,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3525,rich,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3526,in,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3527,nitrate,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3528,and,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3529,carcinogenic,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3530,substances,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3531,produced,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3532,during,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3533,the,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3534,cooking,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3535,process,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3536,increased,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3537,the,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3538,risk,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3539,of,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3540,GC,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3541,.,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3632,During,O,115.0,"During mastitis , losses in milk production and compositional changes were most pronounced in infected glands and in severe responders ."
3633,mastitis,O,115.0,"During mastitis , losses in milk production and compositional changes were most pronounced in infected glands and in severe responders ."
3634,",",O,115.0,"During mastitis , losses in milk production and compositional changes were most pronounced in infected glands and in severe responders ."
3635,losses,O,115.0,"During mastitis , losses in milk production and compositional changes were most pronounced in infected glands and in severe responders ."
3636,in,O,115.0,"During mastitis , losses in milk production and compositional changes were most pronounced in infected glands and in severe responders ."
3637,milk,O,115.0,"During mastitis , losses in milk production and compositional changes were most pronounced in infected glands and in severe responders ."
3638,production,O,115.0,"During mastitis , losses in milk production and compositional changes were most pronounced in infected glands and in severe responders ."
3639,and,O,115.0,"During mastitis , losses in milk production and compositional changes were most pronounced in infected glands and in severe responders ."
3640,compositional,O,115.0,"During mastitis , losses in milk production and compositional changes were most pronounced in infected glands and in severe responders ."
3641,changes,O,115.0,"During mastitis , losses in milk production and compositional changes were most pronounced in infected glands and in severe responders ."
3642,were,O,115.0,"During mastitis , losses in milk production and compositional changes were most pronounced in infected glands and in severe responders ."
3643,most,O,115.0,"During mastitis , losses in milk production and compositional changes were most pronounced in infected glands and in severe responders ."
3644,pronounced,O,115.0,"During mastitis , losses in milk production and compositional changes were most pronounced in infected glands and in severe responders ."
3645,in,O,115.0,"During mastitis , losses in milk production and compositional changes were most pronounced in infected glands and in severe responders ."
3646,infected,O,115.0,"During mastitis , losses in milk production and compositional changes were most pronounced in infected glands and in severe responders ."
3647,glands,O,115.0,"During mastitis , losses in milk production and compositional changes were most pronounced in infected glands and in severe responders ."
3648,and,O,115.0,"During mastitis , losses in milk production and compositional changes were most pronounced in infected glands and in severe responders ."
3649,in,O,115.0,"During mastitis , losses in milk production and compositional changes were most pronounced in infected glands and in severe responders ."
3650,severe,O,115.0,"During mastitis , losses in milk production and compositional changes were most pronounced in infected glands and in severe responders ."
3651,responders,O,115.0,"During mastitis , losses in milk production and compositional changes were most pronounced in infected glands and in severe responders ."
3652,.,O,115.0,"During mastitis , losses in milk production and compositional changes were most pronounced in infected glands and in severe responders ."
3775,Dietary,O,121.0,"Dietary fatty acids alter HDL cholesterol concentrations , presumably through mechanisms related to reverse cholesterol transport ."
3776,fatty,O,121.0,"Dietary fatty acids alter HDL cholesterol concentrations , presumably through mechanisms related to reverse cholesterol transport ."
3777,acids,O,121.0,"Dietary fatty acids alter HDL cholesterol concentrations , presumably through mechanisms related to reverse cholesterol transport ."
3778,alter,O,121.0,"Dietary fatty acids alter HDL cholesterol concentrations , presumably through mechanisms related to reverse cholesterol transport ."
3779,HDL,O,121.0,"Dietary fatty acids alter HDL cholesterol concentrations , presumably through mechanisms related to reverse cholesterol transport ."
3780,cholesterol,O,121.0,"Dietary fatty acids alter HDL cholesterol concentrations , presumably through mechanisms related to reverse cholesterol transport ."
3781,concentrations,O,121.0,"Dietary fatty acids alter HDL cholesterol concentrations , presumably through mechanisms related to reverse cholesterol transport ."
3782,",",O,121.0,"Dietary fatty acids alter HDL cholesterol concentrations , presumably through mechanisms related to reverse cholesterol transport ."
3783,presumably,O,121.0,"Dietary fatty acids alter HDL cholesterol concentrations , presumably through mechanisms related to reverse cholesterol transport ."
3784,through,O,121.0,"Dietary fatty acids alter HDL cholesterol concentrations , presumably through mechanisms related to reverse cholesterol transport ."
3785,mechanisms,O,121.0,"Dietary fatty acids alter HDL cholesterol concentrations , presumably through mechanisms related to reverse cholesterol transport ."
3786,related,O,121.0,"Dietary fatty acids alter HDL cholesterol concentrations , presumably through mechanisms related to reverse cholesterol transport ."
3787,to,O,121.0,"Dietary fatty acids alter HDL cholesterol concentrations , presumably through mechanisms related to reverse cholesterol transport ."
3788,reverse,O,121.0,"Dietary fatty acids alter HDL cholesterol concentrations , presumably through mechanisms related to reverse cholesterol transport ."
3789,cholesterol,O,121.0,"Dietary fatty acids alter HDL cholesterol concentrations , presumably through mechanisms related to reverse cholesterol transport ."
3790,transport,O,121.0,"Dietary fatty acids alter HDL cholesterol concentrations , presumably through mechanisms related to reverse cholesterol transport ."
3791,.,O,121.0,"Dietary fatty acids alter HDL cholesterol concentrations , presumably through mechanisms related to reverse cholesterol transport ."
4929,Compared,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4930,to,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4931,mice,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4932,that,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4933,consumed,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4934,the,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4935,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4936,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4937,containing,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4938,diet,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4939,",",O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4940,the,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4941,mice,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4942,that,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4943,consumed,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4944,the,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4945,canola,B-http://purl.bioontology.org/ontology/SNOMEDCT/713648000;http://purl.bioontology.org/ontology/SNOMEDCT/226908006,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4946,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/713648000;http://purl.bioontology.org/ontology/SNOMEDCT/226908006,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4947,containing,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4948,diet,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4949,had,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4950,significantly,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4951,more,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4952,EPA,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4953,and,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4954,DHA,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4955,in,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4956,both,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4957,tumors,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4958,and,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4959,livers,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4960,",",O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4961,and,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4962,the,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4963,mean,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4964,tumor,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4965,growth,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4966,rate,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4967,and,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4968,cell,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4969,proliferation,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4970,in,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4971,the,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4972,tumor,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4973,were,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4974,significantly,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4975,slower,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4976,(,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4977,P<0.05,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4978,),O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
4979,.,O,157.0,"Compared to mice that consumed the corn oil containing diet , the mice that consumed the canola oil containing diet had significantly more EPA and DHA in both tumors and livers , and the mean tumor growth rate and cell proliferation in the tumor were significantly slower ( P<0.05 ) ."
5049,Epigenetic,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5050,therapy,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5051,induced,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5052,by,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5053,dietary,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5054,components,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5055,has,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5056,become,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5057,a,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5058,strong,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5059,interest,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5060,in,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5061,the,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5062,field,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5063,of,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5064,cancer,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5065,prevention,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5066,.,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5067,Olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5068,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5069,",",O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5070,a,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5071,potent,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5072,dietary,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5073,chemopreventive,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5074,agent,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5075,",",O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5076,control,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5077,colon,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5078,cancer,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5079,",",O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5080,however,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5081,",",O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5082,its,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5083,role,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5084,in,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5085,epigenetic,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5086,therapy,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5087,remains,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5088,unclear,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5089,.,O,161.0,"Olive oil , a potent dietary chemopreventive agent , control colon cancer , however , its role in epigenetic therapy remains unclear ."
5140,Tumor,O,164.0,Tumor burden and incidence in DMH and DMH + olive oil - treated rats was observed by macroscopic examination and histoarchitectural studies .
5141,burden,O,164.0,Tumor burden and incidence in DMH and DMH + olive oil - treated rats was observed by macroscopic examination and histoarchitectural studies .
5142,and,O,164.0,Tumor burden and incidence in DMH and DMH + olive oil - treated rats was observed by macroscopic examination and histoarchitectural studies .
5143,incidence,O,164.0,Tumor burden and incidence in DMH and DMH + olive oil - treated rats was observed by macroscopic examination and histoarchitectural studies .
5144,in,O,164.0,Tumor burden and incidence in DMH and DMH + olive oil - treated rats was observed by macroscopic examination and histoarchitectural studies .
5145,DMH,O,164.0,Tumor burden and incidence in DMH and DMH + olive oil - treated rats was observed by macroscopic examination and histoarchitectural studies .
5146,and,O,164.0,Tumor burden and incidence in DMH and DMH + olive oil - treated rats was observed by macroscopic examination and histoarchitectural studies .
5147,DMH,O,164.0,Tumor burden and incidence in DMH and DMH + olive oil - treated rats was observed by macroscopic examination and histoarchitectural studies .
5148,+,O,164.0,Tumor burden and incidence in DMH and DMH + olive oil - treated rats was observed by macroscopic examination and histoarchitectural studies .
5149,olive,O,164.0,Tumor burden and incidence in DMH and DMH + olive oil - treated rats was observed by macroscopic examination and histoarchitectural studies .
5150,oil,O,164.0,Tumor burden and incidence in DMH and DMH + olive oil - treated rats was observed by macroscopic examination and histoarchitectural studies .
5151,-,O,164.0,Tumor burden and incidence in DMH and DMH + olive oil - treated rats was observed by macroscopic examination and histoarchitectural studies .
5152,treated,O,164.0,Tumor burden and incidence in DMH and DMH + olive oil - treated rats was observed by macroscopic examination and histoarchitectural studies .
5153,rats,O,164.0,Tumor burden and incidence in DMH and DMH + olive oil - treated rats was observed by macroscopic examination and histoarchitectural studies .
5154,was,O,164.0,Tumor burden and incidence in DMH and DMH + olive oil - treated rats was observed by macroscopic examination and histoarchitectural studies .
5155,observed,O,164.0,Tumor burden and incidence in DMH and DMH + olive oil - treated rats was observed by macroscopic examination and histoarchitectural studies .
5156,by,O,164.0,Tumor burden and incidence in DMH and DMH + olive oil - treated rats was observed by macroscopic examination and histoarchitectural studies .
5157,macroscopic,O,164.0,Tumor burden and incidence in DMH and DMH + olive oil - treated rats was observed by macroscopic examination and histoarchitectural studies .
5158,examination,O,164.0,Tumor burden and incidence in DMH and DMH + olive oil - treated rats was observed by macroscopic examination and histoarchitectural studies .
5159,and,O,164.0,Tumor burden and incidence in DMH and DMH + olive oil - treated rats was observed by macroscopic examination and histoarchitectural studies .
5160,histoarchitectural,O,164.0,Tumor burden and incidence in DMH and DMH + olive oil - treated rats was observed by macroscopic examination and histoarchitectural studies .
5161,studies,O,164.0,Tumor burden and incidence in DMH and DMH + olive oil - treated rats was observed by macroscopic examination and histoarchitectural studies .
5162,.,O,164.0,Tumor burden and incidence in DMH and DMH + olive oil - treated rats was observed by macroscopic examination and histoarchitectural studies .
5215,We,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5216,observed,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5217,that,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5218,olive,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5219,oil,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5220,administration,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5221,lowered,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5222,tumor,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5223,incidence,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5224,and,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5225,inhibited,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5226,the,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5227,development,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5228,of,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5229,tumors,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5230,in,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5231,DMH,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5232,-,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5233,treated,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5234,rats,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5235,.,O,167.0,We observed that olive oil administration lowered tumor incidence and inhibited the development of tumors in DMH - treated rats .
5262,Furthermore,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5263,",",O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5264,the,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5265,inverse,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5266,relationship,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5267,between,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5268,gene,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5269,expression,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5270,and,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5271,DNA,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5272,methylation,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5273,",",O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5274,deviant,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5275,miRNA,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5276,pattern,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5277,and,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5278,miRNA,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5279,silencing,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5280,mediated,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5281,by,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5282,aberrant,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5283,DNA,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5284,methylation,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5285,was,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5286,also,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5287,seen,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5288,in,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5289,DMH,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5290,-,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5291,treated,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5292,rats,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5293,",",O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5294,which,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5295,was,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5296,potentially,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5297,reversible,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5298,upon,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5299,olive,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5300,oil,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5301,treatment,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5302,.,O,169.0,"Furthermore , the inverse relationship between gene expression and DNA methylation , deviant miRNA pattern and miRNA silencing mediated by aberrant DNA methylation was also seen in DMH - treated rats , which was potentially reversible upon olive oil treatment ."
5764,Similarly,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5765,",",O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5766,the,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5767,protection,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5768,from,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5769,water,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5770,intake,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5771,was,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5772,confined,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5773,to,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5774,women,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5775,who,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5776,did,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5777,not,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5778,experience,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5779,nocturia,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5780,and,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5781,to,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5782,men,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5783,who,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5784,did,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
5785,.,O,186.0,"Similarly , the protection from water intake was confined to women who did not experience nocturia and to men who did ."
6977,As,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6978,a,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6979,general,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6980,conclusion,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6981,",",O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6982,calcium,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6983,is,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6984,essential,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6985,for,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6986,bone,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6987,health,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6988,",",O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6989,although,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6990,it,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6991,will,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6992,not,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6993,prevent,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6994,bone,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6995,loss,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6996,due,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6997,to,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6998,other,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6999,factors,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7000,;,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7001,in,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7002,this,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7003,context,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7004,",",O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7005,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7006,and,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7007,dairy,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7008,foods,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7009,are,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7010,bioavailable,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7011,",",O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7012,relatively,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7013,inexpensive,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7014,sources,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7015,of,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7016,calcium,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7017,for,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7018,the,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7019,human,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7020,diet,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7021,.,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7220,The,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7221,cellular,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7222,damaging,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7223,effect,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7224,of,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7225,MG,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7226,was,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7227,shown,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7228,as,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7229,there,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7230,were,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7231,decreased,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7232,numbers,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7233,of,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7234,cultured,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7235,HEK-293,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7236,cells,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7237,after,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7238,24,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7239,h,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7240,of,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7241,MG,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7242,treatment,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7243,(,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7244,100,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7245,and,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7246,300,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7247,microM,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7248,),O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7249,",",O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7250,which,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7251,is,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7252,consistent,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7253,with,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7254,an,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7255,increased,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7256,cell,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7257,apoptosis,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7258,induced,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7259,by,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7260,MG,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7261,treatment,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7262,(,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7263,100,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7264,and,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7265,300,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7266,microM,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7267,),O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7268,.,O,239.0,"The cellular damaging effect of MG was shown as there were decreased numbers of cultured HEK-293 cells after 24 h of MG treatment ( 100 and 300 microM ) , which is consistent with an increased cell apoptosis induced by MG treatment ( 100 and 300 microM ) ."
7399,Cross,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7400,-,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7401,reacting,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7402,IgE,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7403,antibodies,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7404,recognizing,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7405,latex,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7406,and,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7407,fruit,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7408,allergens,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7409,(,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7410,papaya,B-http://purl.bioontology.org/ontology/SNOMEDCT/735212003,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7411,",",O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7412,avocado,B-http://purl.bioontology.org/ontology/SNOMEDCT/735249009,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7413,",",O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7414,banana,B-http://purl.bioontology.org/ontology/SNOMEDCT/256307007,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7415,",",O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7416,chestnut,B-http://purl.bioontology.org/ontology/SNOMEDCT/260188004,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7417,",",O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7418,passion,B-http://purl.bioontology.org/ontology/SNOMEDCT/227438004;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7419,fruit,I-http://purl.bioontology.org/ontology/SNOMEDCT/227438004;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7420,",",O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7421,fig,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7422,",",O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7423,melon,B-http://purl.bioontology.org/ontology/SNOMEDCT/260177005,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7424,",",O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7425,mango,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7426,",",O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7427,kiwi,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7428,",",O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7429,pineapple,B-http://purl.bioontology.org/ontology/SNOMEDCT/256313003,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7430,",",O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7431,peach,B-http://purl.bioontology.org/ontology/SNOMEDCT/735049002,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7432,",",O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7433,and,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7434,tomato,B-http://purl.bioontology.org/ontology/SNOMEDCT/734881000,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7435,),O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7436,were,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7437,demonstrated,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7438,by,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7439,RAST,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7440,-,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7441,inhibition,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7442,tests,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7443,.,O,246.0,"Cross - reacting IgE antibodies recognizing latex and fruit allergens ( papaya , avocado , banana , chestnut , passion fruit , fig , melon , mango , kiwi , pineapple , peach , and tomato ) were demonstrated by RAST - inhibition tests ."
7847,We,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7848,developed,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7849,a,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7850,comprehensive,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7851,composition,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7852,database,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7853,of,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7854,629,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7855,cereal,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7856,-,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7857,based,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7858,gluten,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7859,free,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7860,(,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7861,GF,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7862,),O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7863,products,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7864,available,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7865,in,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7866,Spain,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7867,.,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
8201,Under,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8202,the,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8203,maximum,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8204,scenario,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8205,",",O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8206,the,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8207,median,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8208,Estimated,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8209,Average,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8210,Requirements,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8211,(,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8212,EARs,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8213,),O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8214,met,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8215,ranged,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8216,from,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8217,22,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8218,-,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8219,75,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8220,%,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8221,for,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8222,14,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8223,nutrients,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8224,(,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8225,vitamins,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8226,A,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8227,",",O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8228,B1,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8229,",",O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8230,B2,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8231,",",O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8232,B3,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8233,",",O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8234,B6,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8235,",",O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8236,B12,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8237,",",O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8238,D,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8239,",",O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8240,E,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8241,",",O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8242,folic,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8243,acid,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8244,and,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8245,calcium,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8246,",",O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8247,fluoride,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8248,",",O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8249,iron,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8250,",",O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8251,selenium,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8252,and,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8253,zinc,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8254,),O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8255,",",O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8256,and,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8257,338,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8258,%,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8259,for,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8260,iodine,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8261,.,O,273.0,"Under the maximum scenario , the median Estimated Average Requirements ( EARs ) met ranged from 22 - 75 % for 14 nutrients ( vitamins A , B1 , B2 , B3 , B6 , B12 , D , E , folic acid and calcium , fluoride , iron , selenium and zinc ) , and 338 % for iodine ."
8285,In,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8286,both,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8287,scenarios,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8288,",",O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8289,the,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8290,median,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8291,Tolerable,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8292,Upper,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8293,Intake,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8294,Levels,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8295,(,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8296,ULs,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8297,),O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8298,met,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8299,were,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8300,<,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8301,55,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8302,%,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8303,for,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8304,all,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8305,nutrients,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8306,.,O,275.0,"In both scenarios , the median Tolerable Upper Intake Levels ( ULs ) met were < 55 % for all nutrients ."
8574,Poultry,B-http://purl.bioontology.org/ontology/SNOMEDCT/28230009,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8575,(,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8576,OR,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8577,=,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8578,0.74,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8579,),O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8580,",",O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8581,processed,B-http://purl.bioontology.org/ontology/SNOMEDCT/227031001;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8582,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/227031001;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8583,(,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8584,OR,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8585,=,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8586,0.64,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8587,),O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8588,and,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8589,vegetables,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8590,(,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8591,OR,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8592,=,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8593,0.65,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8594,),O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8595,were,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8596,inversely,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8597,associated,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8598,with,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8599,RCC,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8600,risk,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8601,.,O,283.0,"Poultry ( OR = 0.74 ) , processed meat ( OR = 0.64 ) and vegetables ( OR = 0.65 ) were inversely associated with RCC risk ."
8632,The,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8633,results,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8634,of,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8635,this,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8636,study,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8637,provide,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8638,further,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8639,indications,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8640,on,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8641,dietary,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8642,correlates,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8643,of,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8644,RCC,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8645,",",O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8646,and,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8647,in,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8648,particular,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8649,indicate,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8650,that,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8651,a,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8652,diet,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8653,rich,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8654,in,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8655,refined,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8656,cereals,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8657,and,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8658,poor,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8659,in,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8660,vegetables,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8661,may,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8662,have,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8663,an,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8664,unfavorable,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8665,role,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8666,on,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8667,RCC,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8668,.,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8930,We,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8931,compared,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8932,the,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8933,effects,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8934,of,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8935,normal,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8936,protein,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8937,(,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8938,control,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8939,),O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8940,diet,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8941,with,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8942,high,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8943,protein,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8944,diets,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8945,containing,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8946,whey,B-http://purl.bioontology.org/ontology/SNOMEDCT/226770007,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8947,",",O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8948,or,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8949,its,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8950,fractions,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8951,lactalbumin,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8952,and,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8953,lactoferrin,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8954,",",O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8955,on,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8956,energy,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8957,balance,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8958,and,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8959,metabolism,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
8960,.,O,292.0,"We compared the effects of normal protein ( control ) diet with high protein diets containing whey , or its fractions lactalbumin and lactoferrin , on energy balance and metabolism ."
9038,Lactalbumin,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9039,and,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9040,lactoferrin,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9041,decreased,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9042,plasma,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9043,leptin,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9044,and,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9045,insulin,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9046,",",O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9047,and,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9048,lactalbumin,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9049,increased,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9050,peptide,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9051,YY,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9052,.,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9449,(,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9450,c,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9451,),O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9452,2007,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9453,Wiley,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9454,-,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9455,Liss,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9456,",",O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9457,Inc.,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9458,Soybean,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9459,(,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9460,Glycine,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9461,max,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9462,),O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9463,is,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9464,a,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9465,vital,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9466,oilseed,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9467,legume,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9468,crop,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9469,that,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9470,provides,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9471,protein,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9472,and,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9473,oil,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9474,for,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9475,humans,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9476,and,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9477,feedstock,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9478,for,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9479,animals,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9480,.,O,312.0,"( c ) 2007 Wiley - Liss , Inc. Soybean ( Glycine max ) is a vital oilseed legume crop that provides protein and oil for humans and feedstock for animals ."
9515,In,O,315.0,"In Arabidopsis , Flowering Locus T ( FT ) protein is shown to be a mobile signal that moves from leaf to shoot apical meristem to induce flowering ."
9516,Arabidopsis,O,315.0,"In Arabidopsis , Flowering Locus T ( FT ) protein is shown to be a mobile signal that moves from leaf to shoot apical meristem to induce flowering ."
9517,",",O,315.0,"In Arabidopsis , Flowering Locus T ( FT ) protein is shown to be a mobile signal that moves from leaf to shoot apical meristem to induce flowering ."
9518,Flowering,O,315.0,"In Arabidopsis , Flowering Locus T ( FT ) protein is shown to be a mobile signal that moves from leaf to shoot apical meristem to induce flowering ."
9519,Locus,O,315.0,"In Arabidopsis , Flowering Locus T ( FT ) protein is shown to be a mobile signal that moves from leaf to shoot apical meristem to induce flowering ."
9520,T,O,315.0,"In Arabidopsis , Flowering Locus T ( FT ) protein is shown to be a mobile signal that moves from leaf to shoot apical meristem to induce flowering ."
9521,(,O,315.0,"In Arabidopsis , Flowering Locus T ( FT ) protein is shown to be a mobile signal that moves from leaf to shoot apical meristem to induce flowering ."
9522,FT,O,315.0,"In Arabidopsis , Flowering Locus T ( FT ) protein is shown to be a mobile signal that moves from leaf to shoot apical meristem to induce flowering ."
9523,),O,315.0,"In Arabidopsis , Flowering Locus T ( FT ) protein is shown to be a mobile signal that moves from leaf to shoot apical meristem to induce flowering ."
9524,protein,O,315.0,"In Arabidopsis , Flowering Locus T ( FT ) protein is shown to be a mobile signal that moves from leaf to shoot apical meristem to induce flowering ."
9525,is,O,315.0,"In Arabidopsis , Flowering Locus T ( FT ) protein is shown to be a mobile signal that moves from leaf to shoot apical meristem to induce flowering ."
9526,shown,O,315.0,"In Arabidopsis , Flowering Locus T ( FT ) protein is shown to be a mobile signal that moves from leaf to shoot apical meristem to induce flowering ."
9527,to,O,315.0,"In Arabidopsis , Flowering Locus T ( FT ) protein is shown to be a mobile signal that moves from leaf to shoot apical meristem to induce flowering ."
9528,be,O,315.0,"In Arabidopsis , Flowering Locus T ( FT ) protein is shown to be a mobile signal that moves from leaf to shoot apical meristem to induce flowering ."
9529,a,O,315.0,"In Arabidopsis , Flowering Locus T ( FT ) protein is shown to be a mobile signal that moves from leaf to shoot apical meristem to induce flowering ."
9530,mobile,O,315.0,"In Arabidopsis , Flowering Locus T ( FT ) protein is shown to be a mobile signal that moves from leaf to shoot apical meristem to induce flowering ."
9531,signal,O,315.0,"In Arabidopsis , Flowering Locus T ( FT ) protein is shown to be a mobile signal that moves from leaf to shoot apical meristem to induce flowering ."
9532,that,O,315.0,"In Arabidopsis , Flowering Locus T ( FT ) protein is shown to be a mobile signal that moves from leaf to shoot apical meristem to induce flowering ."
9533,moves,O,315.0,"In Arabidopsis , Flowering Locus T ( FT ) protein is shown to be a mobile signal that moves from leaf to shoot apical meristem to induce flowering ."
9534,from,O,315.0,"In Arabidopsis , Flowering Locus T ( FT ) protein is shown to be a mobile signal that moves from leaf to shoot apical meristem to induce flowering ."
9535,leaf,O,315.0,"In Arabidopsis , Flowering Locus T ( FT ) protein is shown to be a mobile signal that moves from leaf to shoot apical meristem to induce flowering ."
9536,to,O,315.0,"In Arabidopsis , Flowering Locus T ( FT ) protein is shown to be a mobile signal that moves from leaf to shoot apical meristem to induce flowering ."
9537,shoot,O,315.0,"In Arabidopsis , Flowering Locus T ( FT ) protein is shown to be a mobile signal that moves from leaf to shoot apical meristem to induce flowering ."
9538,apical,O,315.0,"In Arabidopsis , Flowering Locus T ( FT ) protein is shown to be a mobile signal that moves from leaf to shoot apical meristem to induce flowering ."
9539,meristem,O,315.0,"In Arabidopsis , Flowering Locus T ( FT ) protein is shown to be a mobile signal that moves from leaf to shoot apical meristem to induce flowering ."
9540,to,O,315.0,"In Arabidopsis , Flowering Locus T ( FT ) protein is shown to be a mobile signal that moves from leaf to shoot apical meristem to induce flowering ."
9541,induce,O,315.0,"In Arabidopsis , Flowering Locus T ( FT ) protein is shown to be a mobile signal that moves from leaf to shoot apical meristem to induce flowering ."
9542,flowering,O,315.0,"In Arabidopsis , Flowering Locus T ( FT ) protein is shown to be a mobile signal that moves from leaf to shoot apical meristem to induce flowering ."
9543,.,O,315.0,"In Arabidopsis , Flowering Locus T ( FT ) protein is shown to be a mobile signal that moves from leaf to shoot apical meristem to induce flowering ."
9964,Both,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9965,epidemiological,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9966,and,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9967,laboratory,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9968,evidence,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9969,suggests,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9970,that,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9971,a,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9972,high,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9973,intake,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9974,of,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9975,total,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9976,fat,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9977,increases,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9978,susceptibility,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9979,to,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9980,cancer,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9981,of,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9982,different,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9983,sites,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9984,",",O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9985,particularly,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9986,the,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9987,breast,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9988,and,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9989,colon,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
9990,.,O,335.0,"Both epidemiological and laboratory evidence suggests that a high intake of total fat increases susceptibility to cancer of different sites , particularly the breast and colon ."
10112,No,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10113,definitive,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10114,conclusions,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10115,were,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10116,reached,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10117,for,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10118,other,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10119,dietary,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10120,factors,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10121,",",O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10122,including,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10123,total,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10124,calories,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10125,",",O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10126,cholesterol,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10127,",",O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10128,fiber,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10129,",",O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10130,and,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10131,selenium,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10132,",",O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10133,nor,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10134,could,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10135,the,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10136,quantitative,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10137,contribution,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10138,of,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10139,diet,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10140,to,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10141,overall,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10142,cancer,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10143,risk,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10144,be,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10145,estimated,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10146,.,O,340.0,"No definitive conclusions were reached for other dietary factors , including total calories , cholesterol , fiber , and selenium , nor could the quantitative contribution of diet to overall cancer risk be estimated ."
10147,The,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10148,European,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10149,Commission,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10150,asked,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10151,EFSA,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10152,for,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10153,a,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10154,scientific,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10155,opinion,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10156,on,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10157,the,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10158,risks,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10159,for,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10160,animal,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10161,and,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10162,human,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10163,health,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10164,related,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10165,to,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10166,the,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10167,presence,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10168,of,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10169,glycoalkaloids,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10170,(,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10171,GAs,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10172,),O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10173,in,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10174,feed,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10175,and,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10176,food,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10177,.,O,341.0,The European Commission asked EFSA for a scientific opinion on the risks for animal and human health related to the presence of glycoalkaloids ( GAs ) in feed and food .
10230,For,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10231,these,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10232,effects,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10233,",",O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10234,the,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10235,CONTAM,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10236,Panel,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10237, ,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10238,identified,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10239,a,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10240,lowest,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10241,-,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10242,observed,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10243,-,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10244,adverse,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10245,-,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10246,effect,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10247,level,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10248,of,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10249,1,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10250,mg,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10251,total,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10252,potato,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10253,GAs,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10254,/,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10255,kg,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10256,body,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10257,weight,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10258,(,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10259,bw,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10260,),O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10261,per,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10262,day,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10263,as,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10264,a,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10265,reference,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10266,point,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10267,for,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10268,the,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10269,risk,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10270,characterisation,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10271,following,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10272,acute,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10273,exposure,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10274,.,O,344.0,"For these effects , the CONTAM Panel   identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10352,Due,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10353,to,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10354,the,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10355,limited,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10356,data,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10357,available,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10358,",",O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10359,a,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10360,margin,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10361,of,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10362,exposure,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10363,(,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10364,MOE,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10365,),O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10366,approach,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10367,was,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10368,applied,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10369,.,O,349.0,"Due to the limited data available , a margin of exposure ( MOE ) approach was applied ."
10514,It,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10515,can,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10516,also,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10517,be,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10518,considered,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10519,as,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10520,a,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10521,substitute,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10522,for,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10523,animal,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10524,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10525,due,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10526,to,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10527,various,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10528,allergy,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10529,concerns,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10530,associated,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10531,with,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10532,dairy,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10533,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10534,.,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10576,Further,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10577,",",O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10578,associations,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10579,between,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10580,nutritional,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10581,contents,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10582,(,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10583,vitamins,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10584,",",O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10585,minerals,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10586,and,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10587,low,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10588,fat,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10589,),O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10590,and,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10591,pharmacological,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10592,properties,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10593,of,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10594,plant,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10595,-,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10596,based,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10597,protein,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10598,may,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10599,have,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10600,extra,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10601,beneficial,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10602,effects,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10603,.,O,357.0,"Further , associations between nutritional contents ( vitamins , minerals and low fat ) and pharmacological properties of plant - based protein may have extra beneficial effects ."
10604,The,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10605,review,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10606,aims,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10607,to,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10608,summarize,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10609,the,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10610,four,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10611,different,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10612,groups,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10613,of,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10614,plant,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10615,sources,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10616,(,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10617,nuts,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10618,",",O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10619,cereals,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10620,",",O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10621,seeds,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10622,and,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10623,legumes,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10624,),O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10625,used,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10626,for,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10627,the,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10628,preparation,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10629,of,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10630,plant,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10631,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10632,based,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10633,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10634,beverages,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10635,.,O,358.0,"The review aims to summarize the four different groups of plant sources ( nuts , cereals , seeds and legumes ) used for the preparation of plant - based milk beverages ."
10715,We,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10716,examined,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10717,whether,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10718,the,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10719,adherence,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10720,to,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10721,major,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10722,dietary,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10723,patterns,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10724,at,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10725,baseline,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10726,of,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10727,5824,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10728,nondiabetic,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10729,Danes,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10730,(,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10731,30,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10732,-,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10733,60,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10734,y,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10735,),O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10736,enrolled,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10737,in,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10738,the,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10739,nonpharmacological,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10740,Inter99,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10741,intervention,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10742,predicted,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10743,changes,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10744,in,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10745,fasting,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10746,plasma,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10747,glucose,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10748,(,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10749,FPG,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10750,),O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10751,and,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10752,postchallenge,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10753,2,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10754,-,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10755,h,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10756,plasma,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10757,glucose,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10758,(,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10759,2h,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10760,-,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10761,PG,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10762,),O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10763,concentrations,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10764,during,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10765,a,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10766,5,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10767,y,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10768,period,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10769,and,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10770,whether,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10771,a,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10772,potential,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10773,association,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10774,was,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10775,dependent,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10776,on,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10777,baseline,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10778,glucose,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10779,tolerance,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10780,status,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10781,.,O,363.0,We examined whether the adherence to major dietary patterns at baseline of 5824 nondiabetic Danes ( 30 - 60 y ) enrolled in the nonpharmacological Inter99 intervention predicted changes in fasting plasma glucose ( FPG ) and postchallenge 2 - h plasma glucose ( 2h - PG ) concentrations during a 5 y period and whether a potential association was dependent on baseline glucose tolerance status .
10889,A,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10890,higher,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10891,modern,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10892,score,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10893,(,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10894,of,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10895,1,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10896,SD,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10897,),O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10898,predicted,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10899,an,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10900,annual,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10901,decrease,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10902,in,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10903,2h,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10904,-,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10905,PG,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10906,of,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10907,0.015,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10908,mmol,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10909,/,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10910,L,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10911,(,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10912,P,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10913,<,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10914,0.01,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10915,),O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10916,regardless,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10917,of,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10918,glucose,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10919,tolerance,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10920,status,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10921,.,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10958,In,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10959,conclusion,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10960,",",O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10961,glucose,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10962,tolerance,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10963,status,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10964,did,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10965,not,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10966,",",O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10967,in,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10968,general,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10969,",",O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10970,affect,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10971,the,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10972,predictive,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10973,effect,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10974,of,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10975,the,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10976,dietary,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10977,patterns,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
10978,.,O,368.0,"In conclusion , glucose tolerance status did not , in general , affect the predictive effect of the dietary patterns ."
11323,Thus,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11324,",",O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11325,this,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11326,study,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11327,found,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11328,that,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11329,replacing,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11330,one,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11331,sugar,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11332,-,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11333,sweetened,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11334,soda,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11335,beverage,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11336,or,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11337,beer,B-http://purl.bioontology.org/ontology/SNOMEDCT/53410008,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11338,with,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11339,one,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11340,serving,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11341,of,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11342,water,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11343,per,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11344,day,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11345,at,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11346,baseline,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11347,was,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11348,related,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11349,to,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11350,a,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11351,lower,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11352,incidence,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11353,of,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11354,obesity,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11355,and,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11356,to,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11357,a,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11358,higher,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11359,weight,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11360,loss,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11361,over,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11362,a,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11363,four,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11364,-,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11365,year,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11366,period,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11367,time,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11368,in,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11369,the,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11370,case,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11371,of,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11372,beer,B-http://purl.bioontology.org/ontology/SNOMEDCT/53410008,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11373,",",O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11374,based,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11375,on,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11376,mathematical,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11377,models,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11378,.,O,379.0,"Thus , this study found that replacing one sugar - sweetened soda beverage or beer with one serving of water per day at baseline was related to a lower incidence of obesity and to a higher weight loss over a four - year period time in the case of beer , based on mathematical models ."
11379,The,O,380.0,The Mediterranean dietary pattern has been linked with reduced cardiovascular disease incidence and mortality .
11380,Mediterranean,O,380.0,The Mediterranean dietary pattern has been linked with reduced cardiovascular disease incidence and mortality .
11381,dietary,O,380.0,The Mediterranean dietary pattern has been linked with reduced cardiovascular disease incidence and mortality .
11382,pattern,O,380.0,The Mediterranean dietary pattern has been linked with reduced cardiovascular disease incidence and mortality .
11383,has,O,380.0,The Mediterranean dietary pattern has been linked with reduced cardiovascular disease incidence and mortality .
11384,been,O,380.0,The Mediterranean dietary pattern has been linked with reduced cardiovascular disease incidence and mortality .
11385,linked,O,380.0,The Mediterranean dietary pattern has been linked with reduced cardiovascular disease incidence and mortality .
11386,with,O,380.0,The Mediterranean dietary pattern has been linked with reduced cardiovascular disease incidence and mortality .
11387,reduced,O,380.0,The Mediterranean dietary pattern has been linked with reduced cardiovascular disease incidence and mortality .
11388,cardiovascular,O,380.0,The Mediterranean dietary pattern has been linked with reduced cardiovascular disease incidence and mortality .
11389,disease,O,380.0,The Mediterranean dietary pattern has been linked with reduced cardiovascular disease incidence and mortality .
11390,incidence,O,380.0,The Mediterranean dietary pattern has been linked with reduced cardiovascular disease incidence and mortality .
11391,and,O,380.0,The Mediterranean dietary pattern has been linked with reduced cardiovascular disease incidence and mortality .
11392,mortality,O,380.0,The Mediterranean dietary pattern has been linked with reduced cardiovascular disease incidence and mortality .
11393,.,O,380.0,The Mediterranean dietary pattern has been linked with reduced cardiovascular disease incidence and mortality .
11506,Moreover,O,384.0,"Moreover , strong evidence links this dietary pattern with reduced cardiovascular disease incidence , reoccurrence , and mortality ."
11507,",",O,384.0,"Moreover , strong evidence links this dietary pattern with reduced cardiovascular disease incidence , reoccurrence , and mortality ."
11508,strong,O,384.0,"Moreover , strong evidence links this dietary pattern with reduced cardiovascular disease incidence , reoccurrence , and mortality ."
11509,evidence,O,384.0,"Moreover , strong evidence links this dietary pattern with reduced cardiovascular disease incidence , reoccurrence , and mortality ."
11510,links,O,384.0,"Moreover , strong evidence links this dietary pattern with reduced cardiovascular disease incidence , reoccurrence , and mortality ."
11511,this,O,384.0,"Moreover , strong evidence links this dietary pattern with reduced cardiovascular disease incidence , reoccurrence , and mortality ."
11512,dietary,O,384.0,"Moreover , strong evidence links this dietary pattern with reduced cardiovascular disease incidence , reoccurrence , and mortality ."
11513,pattern,O,384.0,"Moreover , strong evidence links this dietary pattern with reduced cardiovascular disease incidence , reoccurrence , and mortality ."
11514,with,O,384.0,"Moreover , strong evidence links this dietary pattern with reduced cardiovascular disease incidence , reoccurrence , and mortality ."
11515,reduced,O,384.0,"Moreover , strong evidence links this dietary pattern with reduced cardiovascular disease incidence , reoccurrence , and mortality ."
11516,cardiovascular,O,384.0,"Moreover , strong evidence links this dietary pattern with reduced cardiovascular disease incidence , reoccurrence , and mortality ."
11517,disease,O,384.0,"Moreover , strong evidence links this dietary pattern with reduced cardiovascular disease incidence , reoccurrence , and mortality ."
11518,incidence,O,384.0,"Moreover , strong evidence links this dietary pattern with reduced cardiovascular disease incidence , reoccurrence , and mortality ."
11519,",",O,384.0,"Moreover , strong evidence links this dietary pattern with reduced cardiovascular disease incidence , reoccurrence , and mortality ."
11520,reoccurrence,O,384.0,"Moreover , strong evidence links this dietary pattern with reduced cardiovascular disease incidence , reoccurrence , and mortality ."
11521,",",O,384.0,"Moreover , strong evidence links this dietary pattern with reduced cardiovascular disease incidence , reoccurrence , and mortality ."
11522,and,O,384.0,"Moreover , strong evidence links this dietary pattern with reduced cardiovascular disease incidence , reoccurrence , and mortality ."
11523,mortality,O,384.0,"Moreover , strong evidence links this dietary pattern with reduced cardiovascular disease incidence , reoccurrence , and mortality ."
11524,.,O,384.0,"Moreover , strong evidence links this dietary pattern with reduced cardiovascular disease incidence , reoccurrence , and mortality ."
11675,There,O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11676,was,O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11677,",",O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11678,however,O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11679,",",O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11680,no,O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11681,consistent,O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11682,correlation,O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11683,between,O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11684,skin,O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11685,reactivity,O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11686,and,O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11687,chronic,O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11688,respiratory,O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11689,symptoms,O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11690,.,O,391.0,"There was , however , no consistent correlation between skin reactivity and chronic respiratory symptoms ."
11691,There,O,392.0,There was a high prevalence of acute symptoms during the work shift .
11692,was,O,392.0,There was a high prevalence of acute symptoms during the work shift .
11693,a,O,392.0,There was a high prevalence of acute symptoms during the work shift .
11694,high,O,392.0,There was a high prevalence of acute symptoms during the work shift .
11695,prevalence,O,392.0,There was a high prevalence of acute symptoms during the work shift .
11696,of,O,392.0,There was a high prevalence of acute symptoms during the work shift .
11697,acute,O,392.0,There was a high prevalence of acute symptoms during the work shift .
11698,symptoms,O,392.0,There was a high prevalence of acute symptoms during the work shift .
11699,during,O,392.0,There was a high prevalence of acute symptoms during the work shift .
11700,the,O,392.0,There was a high prevalence of acute symptoms during the work shift .
11701,work,O,392.0,There was a high prevalence of acute symptoms during the work shift .
11702,shift,O,392.0,There was a high prevalence of acute symptoms during the work shift .
11703,.,O,392.0,There was a high prevalence of acute symptoms during the work shift .
11960,The,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11961,objective,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11962,of,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11963,this,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11964,study,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11965,was,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11966,to,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11967,determine,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11968,the,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11969,effect,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11970,of,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11971,substitution,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11972,of,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11973,20,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11974,%,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11975,split,B-http://purl.bioontology.org/ontology/SNOMEDCT/260184002,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11976,yellow,I-http://purl.bioontology.org/ontology/SNOMEDCT/260184002,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11977,pea,I-http://purl.bioontology.org/ontology/SNOMEDCT/260184002,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11978,(,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11979,SYP,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11980,),O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11981,flour,B-http://purl.bioontology.org/ontology/SNOMEDCT/63766005,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11982,treated,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11983,by,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11984,Revtech,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11985,thermal,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11986,processing,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11987,at,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11988,140,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11989, ,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11990,°,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11991,C,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11992,with,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11993,10,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11994,%,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11995,steam,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11996,(,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11997,RT10,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11998,%,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
11999,),O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12000,and,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12001,without,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12002,steam,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12003,(,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12004,RT0,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12005,%,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12006,),O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12007,for,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12008,wheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/229944000;http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12009,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/229944000;http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12010,in,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12011,bread,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12012,on,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12013,the,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12014,sensory,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12015,attributes,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12016,",",O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12017,acceptability,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12018,",",O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12019,nutrient,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12020,composition,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12021,",",O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12022,firmness,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12023,",",O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12024,color,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12025,",",O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12026,and,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12027,pH.,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12028,RT10,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12029,%,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12030,was,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12031,more,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12032,acceptable,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12033,overall,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12034,than,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12035,bread,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002;http://purl.bioontology.org/ontology/SNOMEDCT/260184002;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12036,with,I-http://purl.bioontology.org/ontology/SNOMEDCT/226559002;http://purl.bioontology.org/ontology/SNOMEDCT/260184002;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12037,untreated,I-http://purl.bioontology.org/ontology/SNOMEDCT/226559002;http://purl.bioontology.org/ontology/SNOMEDCT/260184002;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12038,pea,I-http://purl.bioontology.org/ontology/SNOMEDCT/226559002;http://purl.bioontology.org/ontology/SNOMEDCT/260184002;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12039,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/226559002;http://purl.bioontology.org/ontology/SNOMEDCT/260184002;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12040,(,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12041,USYP,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12042,),O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12043,or,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12044,RT0,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12045,%,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12046,as,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12047,assessed,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12048,by,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12049,110,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12050,consumers,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12051,.,O,403.0,"The objective of this study was to determine the effect of substitution of 20 % split yellow pea ( SYP ) flour treated by Revtech thermal processing at 140   ° C with 10 % steam ( RT10 % ) and without steam ( RT0 % ) for wheat flour in bread on the sensory attributes , acceptability , nutrient composition , firmness , color , and pH. RT10 % was more acceptable overall than bread with untreated pea flour ( USYP ) or RT0 % as assessed by 110 consumers ."
12524,When,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12525,consumers,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12526,were,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12527,informed,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12528,of,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12529,sodium,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12530,reduction,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12531,and,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12532,its,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12533,health,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12534,benefits,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12535,before,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12536,tasting,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12537,cottage,B-http://purl.bioontology.org/ontology/SNOMEDCT/226814003;http://purl.bioontology.org/ontology/SNOMEDCT/102264005,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12538,cheese,I-http://purl.bioontology.org/ontology/SNOMEDCT/226814003;http://purl.bioontology.org/ontology/SNOMEDCT/102264005,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12539,with,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12540,lower,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12541,sodium,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12542,(,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12543,4,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12544,-,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12545,12,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12546,%,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12547,),O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12548,",",O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12549,overall,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12550,liking,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12551,scores,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12552,for,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12553,the,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12554,lower,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12555,sodium,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12556,cottage,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12557,cheeses,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12558,were,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12559,not,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12560,different,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12561,from,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12562,higher,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12563,sodium,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12564,cottage,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12565,cheeses,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12566,.,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12688,A,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12689,qualitative,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12690,reading,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12691,and,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12692,evaluation,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12693,of,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12694,relevant,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12695,articles,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12696,on,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12697,the,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12698,cancer,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12699,-,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12700,preventive,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12701,effect,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12702,of,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12703,the,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12704,consumption,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12705,of,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12706,fruits,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12707,and,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12708,vegetables,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12709,was,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12710,made,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12711,followed,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12712,by,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12713,the,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12714,calculation,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12715,of,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12716,the,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12717,mean,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12718,relative,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12719,risk,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12720,and,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12721,range,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12722,for,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12723,cohort,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12724,and,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12725,case,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12726,-,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12727,control,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12728,studies,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12729,separately,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12730,.,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12961,Extrapolating,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12962,to,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12963,a,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12964,random,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12965,community,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12966,population,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12967,showed,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12968,that,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12969,at,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12970,the,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12971,age,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12972,of,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12973,two,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12974,",",O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12975,egg,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12976,appears,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12977,the,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12978,most,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12979,frequent,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12980,food,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12981,allergen,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12982,(,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12983,3.2,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12984,%,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12985,),O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12986,",",O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12987,while,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12988,cow,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12989,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12990,(,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12991,2.0,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12992,%,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12993,),O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12994,",",O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12995,and,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12996,peanut,B-http://purl.bioontology.org/ontology/SNOMEDCT/762952008,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12997,are,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12998,of,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12999,similar,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
13000,frequency,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
13001,(,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
13002,1.9,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
13003,%,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
13004,),O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
13005,.,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
13357,These,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13358,data,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13359,show,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13360,that,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13361,while,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13362,ingestion,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13363,of,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13364,CA,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13365,alone,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13366,or,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13367,combined,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13368,with,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13369,POT,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13370,acutely,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13371,increases,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13372,circulating,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13373,insulin,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13374,concentrations,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13375,",",O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13376,it,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13377,does,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13378,not,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13379,appreciably,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13380,alter,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13381,the,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13382,postprandial,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13383,increase,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13384,in,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13385,plasma,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13386,IL-6,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13387,concentrations,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13388,in,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13389,obese,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13390,women,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13391,.,O,443.0,"These data show that while ingestion of CA alone or combined with POT acutely increases circulating insulin concentrations , it does not appreciably alter the postprandial increase in plasma IL-6 concentrations in obese women ."
13418,In,O,446.0,"In particular , variation in gluten intake during the complementary feeding period may be an independent risk factor in CD pathogenesis ."
13419,particular,O,446.0,"In particular , variation in gluten intake during the complementary feeding period may be an independent risk factor in CD pathogenesis ."
13420,",",O,446.0,"In particular , variation in gluten intake during the complementary feeding period may be an independent risk factor in CD pathogenesis ."
13421,variation,O,446.0,"In particular , variation in gluten intake during the complementary feeding period may be an independent risk factor in CD pathogenesis ."
13422,in,O,446.0,"In particular , variation in gluten intake during the complementary feeding period may be an independent risk factor in CD pathogenesis ."
13423,gluten,O,446.0,"In particular , variation in gluten intake during the complementary feeding period may be an independent risk factor in CD pathogenesis ."
13424,intake,O,446.0,"In particular , variation in gluten intake during the complementary feeding period may be an independent risk factor in CD pathogenesis ."
13425,during,O,446.0,"In particular , variation in gluten intake during the complementary feeding period may be an independent risk factor in CD pathogenesis ."
13426,the,O,446.0,"In particular , variation in gluten intake during the complementary feeding period may be an independent risk factor in CD pathogenesis ."
13427,complementary,O,446.0,"In particular , variation in gluten intake during the complementary feeding period may be an independent risk factor in CD pathogenesis ."
13428,feeding,O,446.0,"In particular , variation in gluten intake during the complementary feeding period may be an independent risk factor in CD pathogenesis ."
13429,period,O,446.0,"In particular , variation in gluten intake during the complementary feeding period may be an independent risk factor in CD pathogenesis ."
13430,may,O,446.0,"In particular , variation in gluten intake during the complementary feeding period may be an independent risk factor in CD pathogenesis ."
13431,be,O,446.0,"In particular , variation in gluten intake during the complementary feeding period may be an independent risk factor in CD pathogenesis ."
13432,an,O,446.0,"In particular , variation in gluten intake during the complementary feeding period may be an independent risk factor in CD pathogenesis ."
13433,independent,O,446.0,"In particular , variation in gluten intake during the complementary feeding period may be an independent risk factor in CD pathogenesis ."
13434,risk,O,446.0,"In particular , variation in gluten intake during the complementary feeding period may be an independent risk factor in CD pathogenesis ."
13435,factor,O,446.0,"In particular , variation in gluten intake during the complementary feeding period may be an independent risk factor in CD pathogenesis ."
13436,in,O,446.0,"In particular , variation in gluten intake during the complementary feeding period may be an independent risk factor in CD pathogenesis ."
13437,CD,O,446.0,"In particular , variation in gluten intake during the complementary feeding period may be an independent risk factor in CD pathogenesis ."
13438,pathogenesis,O,446.0,"In particular , variation in gluten intake during the complementary feeding period may be an independent risk factor in CD pathogenesis ."
13439,.,O,446.0,"In particular , variation in gluten intake during the complementary feeding period may be an independent risk factor in CD pathogenesis ."
13476,The,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13477,study,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13478,population,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13479,comprised,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13480,a,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13481,random,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13482,sample,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13483,of,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13484,1743,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13485,children,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13486,aged,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13487,6,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13488,-,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13489,36,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13490,months,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13491,",",O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13492,recruited,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13493,from,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13494,the,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13495,National,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13496,Danish,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13497,Civil,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13498,Registry,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13499,.,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13943,Per,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13944,capita,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13945,consumer,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13946,exposure,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13947,to,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13948,most,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13949,of,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13950,these,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13951,food,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13952,ingredients,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13953,is,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13954,rather,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13955,low,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13956,with,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13957,a,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13958,few,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13959,notable,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13960,exceptions,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13961,such,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13962,as,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13963,sugar,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13964,and,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13965,starch,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
13966,.,O,465.0,Per capita consumer exposure to most of these food ingredients is rather low with a few notable exceptions such as sugar and starch .
14287,The,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14288,prospective,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14289,part,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14290,of,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14291,the,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14292,study,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14293,was,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14294,performed,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14295,on,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14296,103,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14297,birch,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14298,pollen,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14299,-,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14300,hypersensitive,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14301,patients,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14302,who,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14303,were,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14304,OAS,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14305,-,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14306,free,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14307,at,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14308,the,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14309,time,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14310,of,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14311,the,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14312,first,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14313,visit,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14314,and,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14315,were,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14316,periodically,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14317,followed,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14318,-,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14319,up,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14320,for,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14321,OAS,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
14322,.,O,477.0,The prospective part of the study was performed on 103 birch pollen - hypersensitive patients who were OAS - free at the time of the first visit and were periodically followed - up for OAS .
15140,The,O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15141,low,O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15142,glycaemic,O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15143,response,O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15144,to,O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15145,orange,O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15146,and,O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15147,apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15148,may,O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15149,be,O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15150,ascribed,O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15151,to,O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15152,the,O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15153,high,O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15154,content,O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15155,of,O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15156,fructose,O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15157,which,O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15158,is,O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15159,rapidly,O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15160,cleared,O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15161,and,O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15162,metabolized,O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15163,by,O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15164,the,O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15165,liver,O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15166,",",O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15167,without,O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15168,elevating,O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15169,the,O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15170,blood,O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15171,glucose,O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15172,.,O,503.0,"The low glycaemic response to orange and apple may be ascribed to the high content of fructose which is rapidly cleared and metabolized by the liver , without elevating the blood glucose ."
15319,An,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15320,understanding,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15321,of,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15322,food,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15323,cravings,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15324,and,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15325,aversions,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15326,may,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15327,lead,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15328,to,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15329,improved,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15330,methods,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15331,for,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15332,the,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15333,prevention,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15334,and,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15335,treatment,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15336,of,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15337,obesity,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15338,and,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15339,eating,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15340,disorders,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15341,.,O,511.0,An understanding of food cravings and aversions may lead to improved methods for the prevention and treatment of obesity and eating disorders .
15739,These,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15740,findings,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15741,support,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15742,the,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15743,hypothesis,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15744,that,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15745,high,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15746,intake,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15747,of,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15748,vegetables,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15749,",",O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15750,fruits,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15751,",",O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15752,or,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15753,grains,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15754,decreases,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15755,the,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15756,risk,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15757,of,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15758,polyps,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15759,and,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15760,suggest,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15761,that,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15762,any,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15763,protective,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15764,effects,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15765,might,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15766,reflect,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15767,unmeasured,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15768,constituents,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15769,in,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15770,these,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15771,foods,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
15772,.,O,527.0,"These findings support the hypothesis that high intake of vegetables , fruits , or grains decreases the risk of polyps and suggest that any protective effects might reflect unmeasured constituents in these foods ."
16099,The,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16100,RS,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16101,pattern,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16102,had,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16103,the,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16104,highest,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16105,contribution,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16106,of,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16107,alcohol,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16108,(,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16109,9.4,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16110,%,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16111,),O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16112,",",O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16113,soft,B-http://purl.bioontology.org/ontology/SNOMEDCT/226465004,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16114,drinks,I-http://purl.bioontology.org/ontology/SNOMEDCT/226465004,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16115,(,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16116,9.4,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16117,%,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16118,),O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16119,",",O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16120,white,B-http://purl.bioontology.org/ontology/SNOMEDCT/226590000;http://purl.bioontology.org/ontology/SNOMEDCT/226559002,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16121,bread,I-http://purl.bioontology.org/ontology/SNOMEDCT/226590000;http://purl.bioontology.org/ontology/SNOMEDCT/226559002,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16122,(,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16123,7.7,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16124,%,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16125,),O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16126,",",O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16127,fast,B-http://purl.bioontology.org/ontology/SNOMEDCT/255620007,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16128,food,I-http://purl.bioontology.org/ontology/SNOMEDCT/255620007,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16129,",",O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16130,sweets,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16131,",",O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16132,and,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16133,snacks,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16134,.,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16135,The,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16136,D,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16137,pattern,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16138,had,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16139,the,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16140,lowest,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16141,contribution,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16142,of,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16143,maize,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16144,(,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16145,15.5,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16146,%,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16147,),O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16148,and,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16149,the,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16150,highest,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16151,contribution,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16152,of,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16153,whole,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16154,-,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16155,fat,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16156,dairy,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16157,(,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16158,8.0,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16159,%,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16160,),O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16161,",",O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16162,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16163,and,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16164,pasta,B-http://purl.bioontology.org/ontology/SNOMEDCT/226740002,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16165,",",O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16166,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16167,",",O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16168,poultry,B-http://purl.bioontology.org/ontology/SNOMEDCT/28230009,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16169,",",O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16170,eggs,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16171,",",O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16172,saturated,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16173,fat,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16174,",",O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16175,fruits,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16176,",",O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16177,and,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16178,vegetables,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16179,.,O,539.0,"The D pattern had the lowest contribution of maize ( 15.5 % ) and the highest contribution of whole - fat dairy ( 8.0 % ) , rice and pasta , meat , poultry , eggs , saturated fat , fruits , and vegetables ."
16423,Liver,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16424,biopsies,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16425,were,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16426,collected,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16427,at,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16428,2,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16429,d,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16430,postpartum,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16431,",",O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16432,and,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16433,protein,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16434,content,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16435,was,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16436,analyzed,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16437,by,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16438,label,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16439,-,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16440,free,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16441,quantitative,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16442,shotgun,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16443,proteomics,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16444,(,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16445,nanoscale,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16446,liquid,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16447,chromatography,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16448,coupled,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16449,to,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16450,tandem,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16451,mass,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16452,spectrometry,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16453,),O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16454,.,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16990,Apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
16991,",",O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
16992,carrot,B-http://purl.bioontology.org/ontology/SNOMEDCT/256319004,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
16993,",",O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
16994,potato,B-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
16995,",",O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
16996,hazelnut,B-http://purl.bioontology.org/ontology/SNOMEDCT/256353000,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
16997,and,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
16998,birch,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
16999,reactivity,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17000,was,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17001,transferable,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17002,in,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17003,Prausnitz,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17004,-,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17005,Küstner,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17006,test,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17007,like,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17008,IgE,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17009,antibodies,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17010,.,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17453,Control,O,581.0,Control animals received 250 microliters vehicle only .
17454,animals,O,581.0,Control animals received 250 microliters vehicle only .
17455,received,O,581.0,Control animals received 250 microliters vehicle only .
17456,250,O,581.0,Control animals received 250 microliters vehicle only .
17457,microliters,O,581.0,Control animals received 250 microliters vehicle only .
17458,vehicle,O,581.0,Control animals received 250 microliters vehicle only .
17459,only,O,581.0,Control animals received 250 microliters vehicle only .
17460,.,O,581.0,Control animals received 250 microliters vehicle only .
17552,In,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17553,either,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17554,study,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17555,",",O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17556,total,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17557,serum,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17558,cholesterol,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17559,levels,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17560,of,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17561,the,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17562,three,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17563,coffee,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17564,lipid,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17565,groups,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17566,were,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17567,not,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17568,significantly,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17569,different,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17570,from,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17571,each,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17572,other,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
17573,.,O,585.0,"In either study , total serum cholesterol levels of the three coffee lipid groups were not significantly different from each other ."
18298,Future,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18299,research,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18300,should,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18301,consider,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18302,cooking,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18303,methods,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18304,in,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18305,the,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18306,study,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18307,design,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18308,in,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18309,order,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18310,to,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18311,reduce,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18312,confounding,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18313,factors,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18314,and,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18315,further,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18316,explore,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18317,the,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18318,health,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18319,impact,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18320,of,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18321,this,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18322,food,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18323,.,O,613.0,Future research should consider cooking methods in the study design in order to reduce confounding factors and further explore the health impact of this food .
18565,Present,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18566,data,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18567,evidence,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18568,the,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18569,relevance,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18570,of,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18571,the,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18572,timing,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18573,of,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18574,a,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18575,highly,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18576,caloric,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18577,and,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18578,palatable,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18579,meal,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18580,for,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18581,circadian,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18582,synchrony,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18583,and,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18584,metabolic,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18585,function,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
18586,.,O,621.0,Present data evidence the relevance of the timing of a highly caloric and palatable meal for circadian synchrony and metabolic function .
19242,Frequent,O,641.0,"Frequent consumption of mung bean pancake , tofu , cabbage , spinach and sesame oil decreased the risk ."
19243,consumption,O,641.0,"Frequent consumption of mung bean pancake , tofu , cabbage , spinach and sesame oil decreased the risk ."
19244,of,O,641.0,"Frequent consumption of mung bean pancake , tofu , cabbage , spinach and sesame oil decreased the risk ."
19245,mung,B-http://purl.bioontology.org/ontology/SNOMEDCT/256354006;http://purl.bioontology.org/ontology/SNOMEDCT/443981000124106,641.0,"Frequent consumption of mung bean pancake , tofu , cabbage , spinach and sesame oil decreased the risk ."
19246,bean,I-http://purl.bioontology.org/ontology/SNOMEDCT/256354006;http://purl.bioontology.org/ontology/SNOMEDCT/443981000124106,641.0,"Frequent consumption of mung bean pancake , tofu , cabbage , spinach and sesame oil decreased the risk ."
19247,pancake,I-http://purl.bioontology.org/ontology/SNOMEDCT/256354006;http://purl.bioontology.org/ontology/SNOMEDCT/443981000124106,641.0,"Frequent consumption of mung bean pancake , tofu , cabbage , spinach and sesame oil decreased the risk ."
19248,",",O,641.0,"Frequent consumption of mung bean pancake , tofu , cabbage , spinach and sesame oil decreased the risk ."
19249,tofu,B-http://purl.bioontology.org/ontology/SNOMEDCT/227365007,641.0,"Frequent consumption of mung bean pancake , tofu , cabbage , spinach and sesame oil decreased the risk ."
19250,",",O,641.0,"Frequent consumption of mung bean pancake , tofu , cabbage , spinach and sesame oil decreased the risk ."
19251,cabbage,B-http://purl.bioontology.org/ontology/SNOMEDCT/735108004,641.0,"Frequent consumption of mung bean pancake , tofu , cabbage , spinach and sesame oil decreased the risk ."
19252,",",O,641.0,"Frequent consumption of mung bean pancake , tofu , cabbage , spinach and sesame oil decreased the risk ."
19253,spinach,B-http://purl.bioontology.org/ontology/SNOMEDCT/256329006,641.0,"Frequent consumption of mung bean pancake , tofu , cabbage , spinach and sesame oil decreased the risk ."
19254,and,O,641.0,"Frequent consumption of mung bean pancake , tofu , cabbage , spinach and sesame oil decreased the risk ."
19255,sesame,B-http://purl.bioontology.org/ontology/SNOMEDCT/89707004,641.0,"Frequent consumption of mung bean pancake , tofu , cabbage , spinach and sesame oil decreased the risk ."
19256,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/89707004,641.0,"Frequent consumption of mung bean pancake , tofu , cabbage , spinach and sesame oil decreased the risk ."
19257,decreased,O,641.0,"Frequent consumption of mung bean pancake , tofu , cabbage , spinach and sesame oil decreased the risk ."
19258,the,O,641.0,"Frequent consumption of mung bean pancake , tofu , cabbage , spinach and sesame oil decreased the risk ."
19259,risk,O,641.0,"Frequent consumption of mung bean pancake , tofu , cabbage , spinach and sesame oil decreased the risk ."
19260,.,O,641.0,"Frequent consumption of mung bean pancake , tofu , cabbage , spinach and sesame oil decreased the risk ."
19279,For,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19280,meat,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19281,and,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19282,fish,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19283,",",O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19284,pan,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19285,frying,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19286,was,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19287,associated,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19288,with,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19289,decreased,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19290,risk,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19291,",",O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19292,whereas,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19293,stewing,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19294,or,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19295,broiling,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19296,was,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19297,associated,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19298,with,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19299,increased,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19300,risk,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19301,.,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19355,Although,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19356,several,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19357,studies,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19358,have,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19359,assessed,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19360,the,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19361,association,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19362,between,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19363,total,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19364,fluid,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19365,intake,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19366,",",O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19367,specific,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19368,drinks,B-http://purl.bioontology.org/ontology/SNOMEDCT/226465004,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19369,and,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19370,bladder,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19371,cancer,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19372,",",O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19373,no,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19374,firm,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19375,conclusions,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19376,can,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19377,yet,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19378,be,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19379,drawn,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19380,.,O,647.0,"Although several studies have assessed the association between total fluid intake , specific drinks and bladder cancer , no firm conclusions can yet be drawn ."
19461,For,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19462,381,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19463,cases,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19464,(,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19465,81.9,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19466,%,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19467,men,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19468,),O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19469,and,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19470,371,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19471,controls,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19472,(,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19473,76.3,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19474,%,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19475,men,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19476,),O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19477,",",O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19478,total,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19479,fluid,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19480,intake,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19481,could,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19482,be,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19483,calculated,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19484,.,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19798,Their,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19799,main,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19800,bioactive,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19801,constituents,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19802,include,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19803,angiotensin,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19804,I,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19805,-,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19806,converting,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19807,enzyme,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19808,(,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19809,ACE,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19810,),O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19811,inhibitory,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19812,peptides,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19813,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19814,vitamins,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19815,C,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19816,and,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19817,E,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19818,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19819,flavonoids,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19820,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19821,flavanols,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19822,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19823,cathecins,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19824,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19825,anthocyanins,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19826,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19827,phenolic,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19828,acids,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19829,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19830,polyphenols,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19831,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19832,tannins,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19833,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19834,resveratrol,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19835,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19836,polysaccharides,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19837,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19838,fiber,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19839,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19840,saponin,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19841,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19842,sterols,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19843,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19844,as,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19845,well,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19846,as,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19847,K,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19848,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19849,Ca,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19850,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19851,and,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19852,P.,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19853,They,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19854,may,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19855,reduce,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19856,blood,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19857,pressure,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19858,by,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19859,different,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19860,mechanisms,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19861,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19862,such,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19863,as,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19864,ACE,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19865,inhibition,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19866,effect,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19867,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19868,antioxidant,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19869,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19870,vasodilatory,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19871,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19872,opiate,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19873,-,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19874,like,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19875,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19876,Ca(2,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19877,+,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19878,),O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19879,channel,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19880,blocking,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19881,",",O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19882,and,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19883,chymase,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19884,inhibitory,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19885,activities,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19886,.,O,662.0,"Their main bioactive constituents include angiotensin I - converting enzyme ( ACE ) inhibitory peptides , vitamins C and E , flavonoids , flavanols , cathecins , anthocyanins , phenolic acids , polyphenols , tannins , resveratrol , polysaccharides , fiber , saponin , sterols , as well as K , Ca , and P. They may reduce blood pressure by different mechanisms , such as ACE inhibition effect , antioxidant , vasodilatory , opiate - like , Ca(2 + ) channel blocking , and chymase inhibitory activities ."
19887,These,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19888,functional,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19889,foods,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19890,may,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19891,provide,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19892,new,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19893,therapeutic,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19894,applications,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19895,for,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19896,hypertension,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19897,prevention,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19898,and,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19899,treatment,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19900,",",O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19901,and,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19902,contribute,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19903,to,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19904,a,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19905,healthy,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19906,cardiovascular,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19907,population,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19908,.,O,663.0,"These functional foods may provide new therapeutic applications for hypertension prevention and treatment , and contribute to a healthy cardiovascular population ."
19966,Moreover,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19967,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19968,substantial,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19969,experimental,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19970,studies,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19971,have,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19972,supported,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19973,the,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19974,protective,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19975,role,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19976,of,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19977,fruits,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19978,against,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19979,CVDs,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19980,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19981,and,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19982,several,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19983,fruits,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19984,(,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19985,grape,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19986,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19987,blueberry,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19988,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19989,pomegranate,B-http://purl.bioontology.org/ontology/SNOMEDCT/227441008,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19990,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19991,apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19992,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19993,hawthorn,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19994,",",O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19995,and,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19996,avocado,B-http://purl.bioontology.org/ontology/SNOMEDCT/735249009,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19997,),O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19998,have,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
19999,been,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20000,widely,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20001,studied,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20002,and,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20003,have,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20004,shown,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20005,potent,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20006,cardiovascular,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20007,protective,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20008,action,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20009,.,O,667.0,"Moreover , substantial experimental studies have supported the protective role of fruits against CVDs , and several fruits ( grape , blueberry , pomegranate , apple , hawthorn , and avocado ) have been widely studied and have shown potent cardiovascular protective action ."
20415,The,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20416,subjects,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20417,were,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20418,asked,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20419,for,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20420,dietary,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20421,data,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20422,referring,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20423,to,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20424,the,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20425,year,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20426,preceding,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20427,the,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20428,diagnosis,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20429,of,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20430,NPC,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20431,and,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20432,",",O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20433,with,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20434,help,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20435,of,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20436,their,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20437,families,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20438,",",O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20439,during,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20440,childhood,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20441,and,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20442,after,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20443,weaning,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20444,.,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
21139,The,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21140,cumulative,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21141,months,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21142,with,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21143,SCC,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21144,above,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21145,a,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21146,threshold,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21147,was,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21148,included,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21149,as,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21150,a,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21151,proxy,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21152,for,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21153,chronic,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21154,mastitis,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21155,.,O,701.0,The cumulative months with SCC above a threshold was included as a proxy for chronic mastitis .
21327,Oral,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21328,and,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21329,external,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21330,dosing,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21331,methods,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21332,replicating,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21333,field,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21334,exposure,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21335,were,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21336,developed,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21337,using,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21338,the,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21339,double,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21340,crested,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21341,cormorant,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21342,(,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21343,DCCO,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21344,),O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21345,to,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21346,test,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21347,the,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21348,toxicity,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21349,of,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21350,artificially,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21351,weathered,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21352,Deepwater,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21353,Horizon,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21354,Mississippi,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21355,Canyon,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21356,252,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21357,oil,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21358,.,O,708.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
21752,The,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21753,most,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21754,frequent,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21755,adverse,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21756,events,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21757,were,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21758,gastrointestinal,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21759,disorders,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21760,and,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21761,allergic,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21762,reactions,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21763,which,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21764,were,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21765,self,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21766,-,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21767,limiting,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21768,in,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21769,the,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21770,majority,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21771,of,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21772,cases,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21773,.,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21774,The,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21775,available,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21776,data,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21777,suggests,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21778,that,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21779,despite,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21780,the,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21781,safety,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21782,of,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21783,cinnamon,B-http://purl.bioontology.org/ontology/SNOMEDCT/227388008,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21784,use,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21785,as,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21786,a,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21787,spice,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21788,and/or,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21789,flavoring,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21790,agent,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21791,",",O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21792,its,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21793,use,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21794,may,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21795,be,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21796,associated,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21797,with,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21798,significant,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21799,adverse,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21800,effects,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21801,in,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21802,medicinal,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21803,uses,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21804,with,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21805,larger,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21806,doses,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21807,or,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21808,longer,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21809,duration,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21810,of,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21811,use,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21812,and,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21813,should,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21814,be,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21815,clinically,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21816,monitored,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21817,.,O,725.0,"The available data suggests that despite the safety of cinnamon use as a spice and/or flavoring agent , its use may be associated with significant adverse effects in medicinal uses with larger doses or longer duration of use and should be clinically monitored ."
21981,Therefore,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21982,",",O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21983,secondary,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21984,control,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21985,measures,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21986,to,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21987,prevent,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21988,biogenic,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21989,amine,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21990,formation,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21991,in,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21992,foods,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21993,or,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21994,to,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21995,reduce,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21996,their,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21997,levels,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21998,once,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
21999,formed,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
22000,need,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
22001,to,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
22002,be,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
22003,considered,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
22004,as,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
22005,alternatives,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
22006,.,O,733.0,"Therefore , secondary control measures to prevent biogenic amine formation in foods or to reduce their levels once formed need to be considered as alternatives ."
22064,Mangos,O,737.0,Mangos are a source of bioactive compounds with potential health promoting activity .
22065,are,O,737.0,Mangos are a source of bioactive compounds with potential health promoting activity .
22066,a,O,737.0,Mangos are a source of bioactive compounds with potential health promoting activity .
22067,source,O,737.0,Mangos are a source of bioactive compounds with potential health promoting activity .
22068,of,O,737.0,Mangos are a source of bioactive compounds with potential health promoting activity .
22069,bioactive,O,737.0,Mangos are a source of bioactive compounds with potential health promoting activity .
22070,compounds,O,737.0,Mangos are a source of bioactive compounds with potential health promoting activity .
22071,with,O,737.0,Mangos are a source of bioactive compounds with potential health promoting activity .
22072,potential,O,737.0,Mangos are a source of bioactive compounds with potential health promoting activity .
22073,health,O,737.0,Mangos are a source of bioactive compounds with potential health promoting activity .
22074,promoting,O,737.0,Mangos are a source of bioactive compounds with potential health promoting activity .
22075,activity,O,737.0,Mangos are a source of bioactive compounds with potential health promoting activity .
22076,.,O,737.0,Mangos are a source of bioactive compounds with potential health promoting activity .
22349,The,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22350,nuclear,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22351,peroxisome,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22352,proliferator,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22353,-,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22354,activated,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22355,receptors,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22356,(,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22357,PPAR,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22358,),O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22359,have,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22360,been,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22361,shown,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22362,to,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22363,play,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22364,crucial,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22365,roles,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22366,in,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22367,regulating,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22368,energy,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22369,homeostasis,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22370,including,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22371,lipid,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22372,and,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22373,carbohydrate,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22374,metabolism,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22375,",",O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22376,inflammatory,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22377,responses,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22378,",",O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22379,and,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22380,cell,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22381,proliferation,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22382,",",O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22383,differentiation,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22384,",",O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22385,and,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22386,survival,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22387,.,O,747.0,"The nuclear peroxisome proliferator - activated receptors ( PPAR ) have been shown to play crucial roles in regulating energy homeostasis including lipid and carbohydrate metabolism , inflammatory responses , and cell proliferation , differentiation , and survival ."
22489,However,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22490,",",O,752.0,"However , it only slightly affected human PPARgamma activity ."
22491,it,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22492,only,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22493,slightly,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22494,affected,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22495,human,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22496,PPARgamma,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22497,activity,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22498,.,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22526,Skim,B-http://purl.bioontology.org/ontology/SNOMEDCT/25743006;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,754.0,Skim milk enhanced the activity of PPAR to a lesser degree than regular milk .
22527,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/25743006;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,754.0,Skim milk enhanced the activity of PPAR to a lesser degree than regular milk .
22528,enhanced,O,754.0,Skim milk enhanced the activity of PPAR to a lesser degree than regular milk .
22529,the,O,754.0,Skim milk enhanced the activity of PPAR to a lesser degree than regular milk .
22530,activity,O,754.0,Skim milk enhanced the activity of PPAR to a lesser degree than regular milk .
22531,of,O,754.0,Skim milk enhanced the activity of PPAR to a lesser degree than regular milk .
22532,PPAR,O,754.0,Skim milk enhanced the activity of PPAR to a lesser degree than regular milk .
22533,to,O,754.0,Skim milk enhanced the activity of PPAR to a lesser degree than regular milk .
22534,a,O,754.0,Skim milk enhanced the activity of PPAR to a lesser degree than regular milk .
22535,lesser,O,754.0,Skim milk enhanced the activity of PPAR to a lesser degree than regular milk .
22536,degree,O,754.0,Skim milk enhanced the activity of PPAR to a lesser degree than regular milk .
22537,than,O,754.0,Skim milk enhanced the activity of PPAR to a lesser degree than regular milk .
22538,regular,O,754.0,Skim milk enhanced the activity of PPAR to a lesser degree than regular milk .
22539,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,754.0,Skim milk enhanced the activity of PPAR to a lesser degree than regular milk .
22540,.,O,754.0,Skim milk enhanced the activity of PPAR to a lesser degree than regular milk .
22641,This,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22642,study,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22643,unambiguously,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22644,clarified,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22645,at,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22646,the,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22647,cellular,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22648,level,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22649,that,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22650,cow,B-http://purl.bioontology.org/ontology/SNOMEDCT/3718001;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22651,'s,I-http://purl.bioontology.org/ontology/SNOMEDCT/3718001;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22652,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/3718001;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22653,increased,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22654,the,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22655,activities,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22656,of,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22657,human,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22658,PPARalpha,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22659,",",O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22660,PPARdelta,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22661,",",O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22662,and,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22663,RXRalpha,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22664,.,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22942,Enrichment,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22943,of,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22944,lipoproteins,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22945,with,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22946,fatty,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22947,acids,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22948,derived,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22949,from,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22950,animal,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22951,and/or,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22952,plant,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22953,fats,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22954,may,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22955,modify,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22956,the,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22957,oxidizability,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22958,of,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22959,lipoproteins,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22960,and,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22961,their,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22962,effects,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22963,on,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22964,endothelial,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22965,barrier,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22966,function,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
22967,.,O,768.0,Enrichment of lipoproteins with fatty acids derived from animal and/or plant fats may modify the oxidizability of lipoproteins and their effects on endothelial barrier function .
23165,Dietary,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23166,cholesterol,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23167,supplementation,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23168,to,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23169,the,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23170,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23171,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23172,diet,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23173,decreased,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23174,oxidizability,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23175,of,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23176,LDL,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23177,and,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23178,partially,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23179,protected,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23180,the,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23181,oxidized,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23182,LDL,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23183,-,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23184,mediated,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23185,endothelial,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23186,cell,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23187,dysfunction,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23188,as,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23189,compared,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23190,with,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23191,the,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23192,corn,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23193,oil,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23194,diet,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23195,group,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
23196,.,O,776.0,Dietary cholesterol supplementation to the corn oil diet decreased oxidizability of LDL and partially protected the oxidized LDL - mediated endothelial cell dysfunction as compared with the corn oil diet group .
24016,Due,O,804.0,"Due to allergenicity and consumer perceptions of genetically modified organisms , consumer demand for soy alternatives is increasing ."
24017,to,O,804.0,"Due to allergenicity and consumer perceptions of genetically modified organisms , consumer demand for soy alternatives is increasing ."
24018,allergenicity,O,804.0,"Due to allergenicity and consumer perceptions of genetically modified organisms , consumer demand for soy alternatives is increasing ."
24019,and,O,804.0,"Due to allergenicity and consumer perceptions of genetically modified organisms , consumer demand for soy alternatives is increasing ."
24020,consumer,O,804.0,"Due to allergenicity and consumer perceptions of genetically modified organisms , consumer demand for soy alternatives is increasing ."
24021,perceptions,O,804.0,"Due to allergenicity and consumer perceptions of genetically modified organisms , consumer demand for soy alternatives is increasing ."
24022,of,O,804.0,"Due to allergenicity and consumer perceptions of genetically modified organisms , consumer demand for soy alternatives is increasing ."
24023,genetically,O,804.0,"Due to allergenicity and consumer perceptions of genetically modified organisms , consumer demand for soy alternatives is increasing ."
24024,modified,O,804.0,"Due to allergenicity and consumer perceptions of genetically modified organisms , consumer demand for soy alternatives is increasing ."
24025,organisms,O,804.0,"Due to allergenicity and consumer perceptions of genetically modified organisms , consumer demand for soy alternatives is increasing ."
24026,",",O,804.0,"Due to allergenicity and consumer perceptions of genetically modified organisms , consumer demand for soy alternatives is increasing ."
24027,consumer,O,804.0,"Due to allergenicity and consumer perceptions of genetically modified organisms , consumer demand for soy alternatives is increasing ."
24028,demand,O,804.0,"Due to allergenicity and consumer perceptions of genetically modified organisms , consumer demand for soy alternatives is increasing ."
24029,for,O,804.0,"Due to allergenicity and consumer perceptions of genetically modified organisms , consumer demand for soy alternatives is increasing ."
24030,soy,O,804.0,"Due to allergenicity and consumer perceptions of genetically modified organisms , consumer demand for soy alternatives is increasing ."
24031,alternatives,O,804.0,"Due to allergenicity and consumer perceptions of genetically modified organisms , consumer demand for soy alternatives is increasing ."
24032,is,O,804.0,"Due to allergenicity and consumer perceptions of genetically modified organisms , consumer demand for soy alternatives is increasing ."
24033,increasing,O,804.0,"Due to allergenicity and consumer perceptions of genetically modified organisms , consumer demand for soy alternatives is increasing ."
24034,.,O,804.0,"Due to allergenicity and consumer perceptions of genetically modified organisms , consumer demand for soy alternatives is increasing ."
24051,Effects,O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24052,of,O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24053,pasteurization,O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24054,",",O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24055,fat,O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24056,addition,O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24057,",",O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24058,and,O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24059,curd,O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24060,disruption,O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24061,followed,O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24062,by,O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24063,repressing,O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24064,were,O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24065,studied,O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24066,.,O,806.0,"Effects of pasteurization , fat addition , and curd disruption followed by repressing were studied ."
24084,Pasteurization,O,808.0,Pasteurization alone led to increased uptake of water and nonviable tofus .
24085,alone,O,808.0,Pasteurization alone led to increased uptake of water and nonviable tofus .
24086,led,O,808.0,Pasteurization alone led to increased uptake of water and nonviable tofus .
24087,to,O,808.0,Pasteurization alone led to increased uptake of water and nonviable tofus .
24088,increased,O,808.0,Pasteurization alone led to increased uptake of water and nonviable tofus .
24089,uptake,O,808.0,Pasteurization alone led to increased uptake of water and nonviable tofus .
24090,of,O,808.0,Pasteurization alone led to increased uptake of water and nonviable tofus .
24091,water,O,808.0,Pasteurization alone led to increased uptake of water and nonviable tofus .
24092,and,O,808.0,Pasteurization alone led to increased uptake of water and nonviable tofus .
24093,nonviable,O,808.0,Pasteurization alone led to increased uptake of water and nonviable tofus .
24094,tofus,O,808.0,Pasteurization alone led to increased uptake of water and nonviable tofus .
24095,.,O,808.0,Pasteurization alone led to increased uptake of water and nonviable tofus .
24166,Fourier,O,812.0,Fourier - transform infrared spectroscopy of the amide I region showed that an increase of β - sheet structures led to increased hardness .
24167,-,O,812.0,Fourier - transform infrared spectroscopy of the amide I region showed that an increase of β - sheet structures led to increased hardness .
24168,transform,O,812.0,Fourier - transform infrared spectroscopy of the amide I region showed that an increase of β - sheet structures led to increased hardness .
24169,infrared,O,812.0,Fourier - transform infrared spectroscopy of the amide I region showed that an increase of β - sheet structures led to increased hardness .
24170,spectroscopy,O,812.0,Fourier - transform infrared spectroscopy of the amide I region showed that an increase of β - sheet structures led to increased hardness .
24171,of,O,812.0,Fourier - transform infrared spectroscopy of the amide I region showed that an increase of β - sheet structures led to increased hardness .
24172,the,O,812.0,Fourier - transform infrared spectroscopy of the amide I region showed that an increase of β - sheet structures led to increased hardness .
24173,amide,O,812.0,Fourier - transform infrared spectroscopy of the amide I region showed that an increase of β - sheet structures led to increased hardness .
24174,I,O,812.0,Fourier - transform infrared spectroscopy of the amide I region showed that an increase of β - sheet structures led to increased hardness .
24175,region,O,812.0,Fourier - transform infrared spectroscopy of the amide I region showed that an increase of β - sheet structures led to increased hardness .
24176,showed,O,812.0,Fourier - transform infrared spectroscopy of the amide I region showed that an increase of β - sheet structures led to increased hardness .
24177,that,O,812.0,Fourier - transform infrared spectroscopy of the amide I region showed that an increase of β - sheet structures led to increased hardness .
24178,an,O,812.0,Fourier - transform infrared spectroscopy of the amide I region showed that an increase of β - sheet structures led to increased hardness .
24179,increase,O,812.0,Fourier - transform infrared spectroscopy of the amide I region showed that an increase of β - sheet structures led to increased hardness .
24180,of,O,812.0,Fourier - transform infrared spectroscopy of the amide I region showed that an increase of β - sheet structures led to increased hardness .
24181,β,O,812.0,Fourier - transform infrared spectroscopy of the amide I region showed that an increase of β - sheet structures led to increased hardness .
24182,-,O,812.0,Fourier - transform infrared spectroscopy of the amide I region showed that an increase of β - sheet structures led to increased hardness .
24183,sheet,O,812.0,Fourier - transform infrared spectroscopy of the amide I region showed that an increase of β - sheet structures led to increased hardness .
24184,structures,O,812.0,Fourier - transform infrared spectroscopy of the amide I region showed that an increase of β - sheet structures led to increased hardness .
24185,led,O,812.0,Fourier - transform infrared spectroscopy of the amide I region showed that an increase of β - sheet structures led to increased hardness .
24186,to,O,812.0,Fourier - transform infrared spectroscopy of the amide I region showed that an increase of β - sheet structures led to increased hardness .
24187,increased,O,812.0,Fourier - transform infrared spectroscopy of the amide I region showed that an increase of β - sheet structures led to increased hardness .
24188,hardness,O,812.0,Fourier - transform infrared spectroscopy of the amide I region showed that an increase of β - sheet structures led to increased hardness .
24189,.,O,812.0,Fourier - transform infrared spectroscopy of the amide I region showed that an increase of β - sheet structures led to increased hardness .
24556,Novel,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24557,data,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24558,suggesting,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24559,differences,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24560,in,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24561,diversity,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24562,of,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24563,the,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24564,microbiota,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24565,between,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24566,healthy,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24567,and,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24568,osteoporotic,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24569,women,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24570,are,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24571,provided,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
24572,.,O,828.0,Novel data suggesting differences in diversity of the microbiota between healthy and osteoporotic women are provided .
25161,The,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25162,protective,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25163,effect,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25164,does,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25165,not,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25166,seem,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25167,to,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25168,be,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25169,due,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25170,to,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25171,cholesterol,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25172,-,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25173,lowering,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25174,.,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25461,Asthma,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25462,induced,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25463,by,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25464,cereal,B-http://purl.bioontology.org/ontology/SNOMEDCT/23182003;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,857.0,Asthma induced by cereal flour is a long recognized entity .
25465,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/23182003;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,857.0,Asthma induced by cereal flour is a long recognized entity .
25466,is,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25467,a,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25468,long,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25469,recognized,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25470,entity,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25471,.,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25525,Specific,O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25526,anti,O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25527,-,O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25528,wheat,O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25529,",",O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25530,rye,O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25531,and,O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25532,barley,O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25533,flour,O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25534,IgE,O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25535,antibodies,O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25536,were,O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25537,found,O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25538,by,O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25539,RAST,O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25540,.,O,860.0,"Specific anti - wheat , rye and barley flour IgE antibodies were found by RAST ."
25954,They,O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
25955,down,O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
25956,regulate,O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
25957,the,O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
25958,expression,O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
25959,of,O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
25960,BCL-2,O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
25961,and,O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
25962,COX-2,O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
25963,proteins,O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
25964,",",O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
25965,and,O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
25966,reduced,O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
25967,DNA,O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
25968,damage,O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
25969,.,O,879.0,"They down regulate the expression of BCL-2 and COX-2 proteins , and reduced DNA damage ."
26095,On,O,885.0,"On the contrary , at the moment , several epidemiological studies have suggested that moderate consumption of alcohol reduces overall mortality , mainly from coronary diseases ."
26096,the,O,885.0,"On the contrary , at the moment , several epidemiological studies have suggested that moderate consumption of alcohol reduces overall mortality , mainly from coronary diseases ."
26097,contrary,O,885.0,"On the contrary , at the moment , several epidemiological studies have suggested that moderate consumption of alcohol reduces overall mortality , mainly from coronary diseases ."
26098,",",O,885.0,"On the contrary , at the moment , several epidemiological studies have suggested that moderate consumption of alcohol reduces overall mortality , mainly from coronary diseases ."
26099,at,O,885.0,"On the contrary , at the moment , several epidemiological studies have suggested that moderate consumption of alcohol reduces overall mortality , mainly from coronary diseases ."
26100,the,O,885.0,"On the contrary , at the moment , several epidemiological studies have suggested that moderate consumption of alcohol reduces overall mortality , mainly from coronary diseases ."
26101,moment,O,885.0,"On the contrary , at the moment , several epidemiological studies have suggested that moderate consumption of alcohol reduces overall mortality , mainly from coronary diseases ."
26102,",",O,885.0,"On the contrary , at the moment , several epidemiological studies have suggested that moderate consumption of alcohol reduces overall mortality , mainly from coronary diseases ."
26103,several,O,885.0,"On the contrary , at the moment , several epidemiological studies have suggested that moderate consumption of alcohol reduces overall mortality , mainly from coronary diseases ."
26104,epidemiological,O,885.0,"On the contrary , at the moment , several epidemiological studies have suggested that moderate consumption of alcohol reduces overall mortality , mainly from coronary diseases ."
26105,studies,O,885.0,"On the contrary , at the moment , several epidemiological studies have suggested that moderate consumption of alcohol reduces overall mortality , mainly from coronary diseases ."
26106,have,O,885.0,"On the contrary , at the moment , several epidemiological studies have suggested that moderate consumption of alcohol reduces overall mortality , mainly from coronary diseases ."
26107,suggested,O,885.0,"On the contrary , at the moment , several epidemiological studies have suggested that moderate consumption of alcohol reduces overall mortality , mainly from coronary diseases ."
26108,that,O,885.0,"On the contrary , at the moment , several epidemiological studies have suggested that moderate consumption of alcohol reduces overall mortality , mainly from coronary diseases ."
26109,moderate,O,885.0,"On the contrary , at the moment , several epidemiological studies have suggested that moderate consumption of alcohol reduces overall mortality , mainly from coronary diseases ."
26110,consumption,O,885.0,"On the contrary , at the moment , several epidemiological studies have suggested that moderate consumption of alcohol reduces overall mortality , mainly from coronary diseases ."
26111,of,O,885.0,"On the contrary , at the moment , several epidemiological studies have suggested that moderate consumption of alcohol reduces overall mortality , mainly from coronary diseases ."
26112,alcohol,O,885.0,"On the contrary , at the moment , several epidemiological studies have suggested that moderate consumption of alcohol reduces overall mortality , mainly from coronary diseases ."
26113,reduces,O,885.0,"On the contrary , at the moment , several epidemiological studies have suggested that moderate consumption of alcohol reduces overall mortality , mainly from coronary diseases ."
26114,overall,O,885.0,"On the contrary , at the moment , several epidemiological studies have suggested that moderate consumption of alcohol reduces overall mortality , mainly from coronary diseases ."
26115,mortality,O,885.0,"On the contrary , at the moment , several epidemiological studies have suggested that moderate consumption of alcohol reduces overall mortality , mainly from coronary diseases ."
26116,",",O,885.0,"On the contrary , at the moment , several epidemiological studies have suggested that moderate consumption of alcohol reduces overall mortality , mainly from coronary diseases ."
26117,mainly,O,885.0,"On the contrary , at the moment , several epidemiological studies have suggested that moderate consumption of alcohol reduces overall mortality , mainly from coronary diseases ."
26118,from,O,885.0,"On the contrary , at the moment , several epidemiological studies have suggested that moderate consumption of alcohol reduces overall mortality , mainly from coronary diseases ."
26119,coronary,O,885.0,"On the contrary , at the moment , several epidemiological studies have suggested that moderate consumption of alcohol reduces overall mortality , mainly from coronary diseases ."
26120,diseases,O,885.0,"On the contrary , at the moment , several epidemiological studies have suggested that moderate consumption of alcohol reduces overall mortality , mainly from coronary diseases ."
26121,.,O,885.0,"On the contrary , at the moment , several epidemiological studies have suggested that moderate consumption of alcohol reduces overall mortality , mainly from coronary diseases ."
26468,The,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26469,literature,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26470,reviews,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26471,revealed,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26472,similar,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26473,aspects,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26474,of,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26475,the,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26476,challenges,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26477,of,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26478,smallholder,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26479,crop,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26480,-,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26481,livestock,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26482,mixed,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26483,farming,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26484,systems,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26485,in,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26486,both,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26487,countries,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26488,.,O,896.0,The literature reviews revealed similar aspects of the challenges of smallholder crop - livestock mixed farming systems in both countries .
26784,The,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26785,experiment,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26786,was,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26787,conducted,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26788,in,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26789,the,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26790,summer,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26791,of,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26792,2006,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26793,and,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26794,involved,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26795,24,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26796,Friesian,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26797,cows,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26798,that,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26799,were,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26800,divided,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26801,into,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26802,3,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26803,groups,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26804,of,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26805,8,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26806,animals,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26807,according,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26808,to,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26809,different,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26810,type,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26811,of,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26812,fat,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26813,supplementation,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26814,:,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26815,a,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26816,traditional,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26817,diet,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26818,with,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26819,no,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26820,fat,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26821,supplementation,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26822,",",O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26823,a,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26824,diet,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26825,supplemented,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26826,with,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26827,whole,B-http://purl.bioontology.org/ontology/SNOMEDCT/710178007,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26828,flaxseed,I-http://purl.bioontology.org/ontology/SNOMEDCT/710178007,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26829,",",O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26830,and,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26831,a,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26832,diet,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26833,supplemented,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26834,with,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26835,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26836,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
26837,.,O,909.0,"The experiment was conducted in the summer of 2006 and involved 24 Friesian cows that were divided into 3 groups of 8 animals according to different type of fat supplementation : a traditional diet with no fat supplementation , a diet supplemented with whole flaxseed , and a diet supplemented with fish oil ."
27203,Sunflower,O,924.0,Sunflower oil avoided gene expression changes related to age .
27204,oil,O,924.0,Sunflower oil avoided gene expression changes related to age .
27205,avoided,O,924.0,Sunflower oil avoided gene expression changes related to age .
27206,gene,O,924.0,Sunflower oil avoided gene expression changes related to age .
27207,expression,O,924.0,Sunflower oil avoided gene expression changes related to age .
27208,changes,O,924.0,Sunflower oil avoided gene expression changes related to age .
27209,related,O,924.0,Sunflower oil avoided gene expression changes related to age .
27210,to,O,924.0,Sunflower oil avoided gene expression changes related to age .
27211,age,O,924.0,Sunflower oil avoided gene expression changes related to age .
27212,.,O,924.0,Sunflower oil avoided gene expression changes related to age .
27252,These,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27253,pesticides,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27254,after,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27255,consumption,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27256,have,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27257,a,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27258,detrimental,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27259,effect,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27260,on,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27261,human,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27262,health,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27263,and,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27264,their,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27265,intake,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27266,can,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27267,lead,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27268,to,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27269,various,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27270,diseases,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27271,such,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27272,as,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27273,kidney,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27274,damage,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27275,",",O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27276,neurological,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27277,disorders,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27278,",",O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27279,cardiovascular,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27280,diseases,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27281,",",O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27282,circulatory,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27283,and,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27284,reproductive,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27285,problems,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27286,.,O,927.0,"These pesticides after consumption have a detrimental effect on human health and their intake can lead to various diseases such as kidney damage , neurological disorders , cardiovascular diseases , circulatory and reproductive problems ."
27457,The,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27458,average,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27459,reduction,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27460,in,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27461,various,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27462,washing,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27463,solutions,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27464,ranged,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27465,from,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27466,10.21,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27467,to,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27468,79.68,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27469,%,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27470,",",O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27471,22.60,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27472,to,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27473,89.48,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27474,%,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27475,",",O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27476,22.95,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27477,to,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27478,94,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27479,-,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27480,21,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27481,%,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27482,and,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27483,11.24,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27484,-,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27485,70.32,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27486,%,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27487,for,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27488,the,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27489,removal,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27490,of,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27491,deltamethrin,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27492,",",O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27493,cypermethrin,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27494,",",O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27495,chlorpyrifos,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27496,",",O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27497,and,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27498,endosulfan,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27499,",",O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27500,respectively,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27501,.,O,932.0,"The average reduction in various washing solutions ranged from 10.21 to 79.68 % , 22.60 to 89.48 % , 22.95 to 94 - 21 % and 11.24 - 70.32 % for the removal of deltamethrin , cypermethrin , chlorpyrifos , and endosulfan , respectively ."
27617,Findings,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27618,were,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27619,categorized,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27620,as,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27621,strong,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27622,or,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27623,weak,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27624,evidence,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27625,",",O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27626,inconsistent,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27627,effects,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27628,",",O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27629,too,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27630,little,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27631,evidence,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27632,or,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27633,effect,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27634,unlikely,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27635,for,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27636,experimental,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27637,and,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27638,observational,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27639,data,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27640,separately,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27641,.,O,936.0,"Findings were categorized as strong or weak evidence , inconsistent effects , too little evidence or effect unlikely for experimental and observational data separately ."
27957,Except,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27958,the,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27959,residue,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27960,forms,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27961,",",O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27962,the,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27963,main,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27964,forms,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27965,of,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27966,metals,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27967,in,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27968,the,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27969,edible,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27970,parts,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27971,of,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27972,three,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27973,selected,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27974,vegetables,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27975,were,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27976,ethanol-,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27977,",",O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27978,NaCl-,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27979,",",O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27980,and,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27981,HAc,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27982,-,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27983,extractable,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27984,fractions,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27985,for,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27986,As,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27987,",",O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27988,Pb,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27989,",",O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27990,and,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27991,Cd,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27992,",",O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27993,respectively,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27994,;,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27995,however,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27996,",",O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27997,Cu,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27998,was,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
27999,mainly,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28000,presented,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28001,as,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28002,NaCl,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28003,-,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28004,extractable,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28005,and,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28006,Zn,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28007,as,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28008,HAc,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28009,-,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28010,extractable,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28011,fractions,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28012,.,O,950.0,"Except the residue forms , the main forms of metals in the edible parts of three selected vegetables were ethanol- , NaCl- , and HAc - extractable fractions for As , Pb , and Cd , respectively ; however , Cu was mainly presented as NaCl - extractable and Zn as HAc - extractable fractions ."
28742,Child,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28743,preferences,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28744,and,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28745,attitudes,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28746,for,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28747,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28748,may,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28749,differ,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28750,from,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28751,those,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28752,of,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28753,adults,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28754,",",O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28755,and,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28756,as,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28757,such,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28758,",",O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28759,understanding,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28760,and,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28761,fulfilling,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28762,the,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28763,needs,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28764,of,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28765,children,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28766,is,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28767,crucial,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28768,to,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28769,reverse,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28770,the,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28771,decline,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28772,in,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28773,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28774,consumption,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
28775,.,O,975.0,"Child preferences and attitudes for milk may differ from those of adults , and as such , understanding and fulfilling the needs of children is crucial to reverse the decline in milk consumption ."
29054,For,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29055,certain,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29056,individual,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29057,cancer,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29058,sites,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29059,:,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29060,endometrial,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29061,",",O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29062,lung,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29063,",",O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29064,oral,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29065,and,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29066,ovarian,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29067,cancer,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29068,",",O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29069,and,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29070,non,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29071,-,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29072,Hodgkins,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29073,lymphoma,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29074,the,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29075,majority,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29076,of,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29077,meta,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29078,-,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29079,analyses,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29080,observed,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29081,an,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29082,inverse,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29083,association,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29084,with,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29085,green,B-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29086,tea,I-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29087,.,O,984.0,"For certain individual cancer sites : endometrial , lung , oral and ovarian cancer , and non - Hodgkins lymphoma the majority of meta - analyses observed an inverse association with green tea ."
29174,The,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29175,evidence,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29176,for,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29177,diabetes,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29178,-,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29179,related,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29180,health,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29181,outcomes,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29182,is,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29183,less,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29184,convincing,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29185,",",O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29186,while,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29187,the,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29188,included,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29189,meta,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29190,-,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29191,analyses,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29192,generally,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29193,suggested,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29194,an,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29195,inverse,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29196,association,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29197,between,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29198,green,B-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29199,tea,I-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29200,and,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29201,BMI,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29202,-,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29203,related,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29204,and,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29205,blood,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29206,pressure,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29207,outcomes,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29208,.,O,988.0,"The evidence for diabetes - related health outcomes is less convincing , while the included meta - analyses generally suggested an inverse association between green tea and BMI - related and blood pressure outcomes ."
29760,Male,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29761,Sprague,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29762,Dawley,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29763,rats,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29764,(,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29765,8,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29766,weeks,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29767,-,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29768,old,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29769,),O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29770,were,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29771,grouped,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29772,(,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29773,6,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29774,rats,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29775,/,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29776,group,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29777,),O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29778,in,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29779,four,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29780,experimental,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29781,groups,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29782,:,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29783,nan,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29784,(,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29785,normal,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29786,diet,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29787,and,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29788,water,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29789,),O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29790,",",O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29791,NL,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29792,(,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29793,normal,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29794,diet,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29795,and,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29796,tomato,B-http://purl.bioontology.org/ontology/SNOMEDCT/226498009;http://purl.bioontology.org/ontology/SNOMEDCT/734881000;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29797,juice,I-http://purl.bioontology.org/ontology/SNOMEDCT/226498009;http://purl.bioontology.org/ontology/SNOMEDCT/734881000;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29798,),O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29799,",",O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29800,HA,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29801,(,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29802,high,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29803,-,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29804,fat,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29805,diet,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29806,and,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29807,water,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29808,),O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29809,",",O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29810,and,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29811,HL,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29812,(,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29813,high,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29814,-,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29815,fat,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29816,diet,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29817,and,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29818,tomato,B-http://purl.bioontology.org/ontology/SNOMEDCT/226498009;http://purl.bioontology.org/ontology/SNOMEDCT/734881000;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29819,juice,I-http://purl.bioontology.org/ontology/SNOMEDCT/226498009;http://purl.bioontology.org/ontology/SNOMEDCT/734881000;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29820,),O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29821,.,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
30063,N,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30064,-,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30065,terminal,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30066,sequence,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30067,analysis,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30068,of,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30069,the,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30070,14-,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30071,and,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30072,28,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30073,-,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30074,kDa,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30075,pepper,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30076,and,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30077,23,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30078,-,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30079,kDa,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30080,paprika,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30081,allergens,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30082,revealed,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30083,no,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30084,homology,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30085,to,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30086,known,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30087,allergens,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30088,.,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30166,N,O,1021.0,N - terminal amino acid sequence analysis of the main allergens in pepper and paprika indicate a relation to frequently occurring plant proteins .
30167,-,O,1021.0,N - terminal amino acid sequence analysis of the main allergens in pepper and paprika indicate a relation to frequently occurring plant proteins .
30168,terminal,O,1021.0,N - terminal amino acid sequence analysis of the main allergens in pepper and paprika indicate a relation to frequently occurring plant proteins .
30169,amino,O,1021.0,N - terminal amino acid sequence analysis of the main allergens in pepper and paprika indicate a relation to frequently occurring plant proteins .
30170,acid,O,1021.0,N - terminal amino acid sequence analysis of the main allergens in pepper and paprika indicate a relation to frequently occurring plant proteins .
30171,sequence,O,1021.0,N - terminal amino acid sequence analysis of the main allergens in pepper and paprika indicate a relation to frequently occurring plant proteins .
30172,analysis,O,1021.0,N - terminal amino acid sequence analysis of the main allergens in pepper and paprika indicate a relation to frequently occurring plant proteins .
30173,of,O,1021.0,N - terminal amino acid sequence analysis of the main allergens in pepper and paprika indicate a relation to frequently occurring plant proteins .
30174,the,O,1021.0,N - terminal amino acid sequence analysis of the main allergens in pepper and paprika indicate a relation to frequently occurring plant proteins .
30175,main,O,1021.0,N - terminal amino acid sequence analysis of the main allergens in pepper and paprika indicate a relation to frequently occurring plant proteins .
30176,allergens,O,1021.0,N - terminal amino acid sequence analysis of the main allergens in pepper and paprika indicate a relation to frequently occurring plant proteins .
30177,in,O,1021.0,N - terminal amino acid sequence analysis of the main allergens in pepper and paprika indicate a relation to frequently occurring plant proteins .
30178,pepper,B-http://purl.bioontology.org/ontology/SNOMEDCT/227563001,1021.0,N - terminal amino acid sequence analysis of the main allergens in pepper and paprika indicate a relation to frequently occurring plant proteins .
30179,and,O,1021.0,N - terminal amino acid sequence analysis of the main allergens in pepper and paprika indicate a relation to frequently occurring plant proteins .
30180,paprika,B-http://purl.bioontology.org/ontology/SNOMEDCT/227408005,1021.0,N - terminal amino acid sequence analysis of the main allergens in pepper and paprika indicate a relation to frequently occurring plant proteins .
30181,indicate,O,1021.0,N - terminal amino acid sequence analysis of the main allergens in pepper and paprika indicate a relation to frequently occurring plant proteins .
30182,a,O,1021.0,N - terminal amino acid sequence analysis of the main allergens in pepper and paprika indicate a relation to frequently occurring plant proteins .
30183,relation,O,1021.0,N - terminal amino acid sequence analysis of the main allergens in pepper and paprika indicate a relation to frequently occurring plant proteins .
30184,to,O,1021.0,N - terminal amino acid sequence analysis of the main allergens in pepper and paprika indicate a relation to frequently occurring plant proteins .
30185,frequently,O,1021.0,N - terminal amino acid sequence analysis of the main allergens in pepper and paprika indicate a relation to frequently occurring plant proteins .
30186,occurring,O,1021.0,N - terminal amino acid sequence analysis of the main allergens in pepper and paprika indicate a relation to frequently occurring plant proteins .
30187,plant,O,1021.0,N - terminal amino acid sequence analysis of the main allergens in pepper and paprika indicate a relation to frequently occurring plant proteins .
30188,proteins,O,1021.0,N - terminal amino acid sequence analysis of the main allergens in pepper and paprika indicate a relation to frequently occurring plant proteins .
30189,.,O,1021.0,N - terminal amino acid sequence analysis of the main allergens in pepper and paprika indicate a relation to frequently occurring plant proteins .
30713,Mice,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30714,were,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30715,fed,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30716,one,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30717,of,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30718,8,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30719,diets,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30720,:,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30721,a,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30722,control,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30723,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30724,containing,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30725,no,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30726,vegetables,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30727,(,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30728,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30729,1,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30730,),O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30731,;,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30732,a,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30733,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30734,containing,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30735,100,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30736,g,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30737,/,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30738,kg,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30739,(,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30740,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30741,2,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30742,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30743,10,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30744,%,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30745,dose,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30746,),O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30747,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30748,200,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30749,g,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30750,/,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30751,kg,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30752,(,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30753,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30754,3,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30755,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30756,20,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30757,%,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30758,dose,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30759,),O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30760,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30761,or,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30762,400,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30763,g,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30764,/,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30765,kg,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30766,(,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30767,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30768,4,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30769,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30770,40,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30771,%,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30772,dose,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30773,),O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30774,of,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30775,a,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30776,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30777,mixture,I-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30778,;,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30779,or,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30780,a,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30781,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30782,containing,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30783,70,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30784,g,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30785,/,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30786,kg,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30787,of,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30788,cauliflower,B-http://purl.bioontology.org/ontology/SNOMEDCT/735336002,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30789,(,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30790,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30791,5,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30792,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30793,7,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30794,%,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30795,dose,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30796,),O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30797,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30798,73,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30799,g,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30800,/,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30801,kg,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30802,of,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30803,carrots,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30804,(,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30805,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30806,6,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30807,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30808,7.3,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30809,%,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30810,dose,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30811,),O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30812,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30813,226,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30814,g,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30815,/,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30816,kg,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30817,of,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30818,peas,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30819,(,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30820,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30821,7,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30822,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30823,22.6,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30824,%,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30825,dose,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30826,),O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30827,;,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30828,or,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30829,31,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30830,g,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30831,/,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30832,kg,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30833,of,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30834,onions,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30835,(,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30836,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30837,8,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30838,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30839,3.1,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30840,%,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30841,dose,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30842,),O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30843,.,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
31017,These,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31018,genes,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31019,are,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31020,of,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31021,particular,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31022,interest,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31023,because,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31024,they,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31025,were,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31026,consistently,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31027,affected,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31028,and,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31029,could,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31030,be,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31031,involved,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31032,in,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31033,the,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31034,prevention,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31035,of,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31036,CRC,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31037,by,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31038,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31039,consumption,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31040,.,O,1049.0,These genes are of particular interest because they were consistently affected and could be involved in the prevention of CRC by vegetable consumption .
31690,This,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31691,report,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31692,examines,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31693,associations,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31694,of,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31695,various,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31696,food,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31697,groups,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31698,with,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31699,colon,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31700,cancer,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31701,in,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31702,African,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31703,-,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31704,Americans,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31705,and,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31706,Caucasians,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31707,from,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31708,a,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31709,case,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31710,-,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31711,control,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31712,study,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31713,.,O,1075.0,This report examines associations of various food groups with colon cancer in African - Americans and Caucasians from a case - control study .
31754,Diet,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31755,over,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31756,the,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31757,year,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31758,before,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31759,diagnosis,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31760,or,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31761,interview,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31762,date,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31763,was,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31764,assessed,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31765,using,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31766,a,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31767,validated,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31768,food,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31769,frequency,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31770,questionnaire,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31771,adapted,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31772,to,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31773,include,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31774,regional,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31775,foods,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31776,.,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31835,Regardless,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31836,of,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31837,ethnic,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31838,group,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31839,or,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31840,energy,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31841,adjustment,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31842,",",O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31843,high,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31844,and,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31845,frequent,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31846,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31847,consumption,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31848,(,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31849,particularly,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31850,dark,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31851,green,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31852,vegetables,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31853,),O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31854,was,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31855,protective,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31856,",",O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31857,consistent,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31858,with,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31859,20,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31860,-,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31861,50,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31862,%,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31863,reductions,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31864,in,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31865,risk,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31866,.,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
32161,However,O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32162,",",O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32163,despite,O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32164,the,O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32165,growing,O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32166,evidence,O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32167,it,O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32168,remains,O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32169,uncertain,O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32170,whether,O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32171,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32172,",",O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32173,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32174,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32175,and,O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32176,cocoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32177,consumption,O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32178,should,O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32179,be,O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32180,recommended,O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32181,to,O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32182,the,O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32183,general,O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32184,population,O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32185,or,O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32186,to,O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32187,patients,O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32188,as,O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32189,a,O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32190,strategy,O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32191,to,O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32192,reduce,O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32193,the,O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32194,risk,O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32195,of,O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32196,diabetes,O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32197,.,O,1091.0,"However , despite the growing evidence it remains uncertain whether tea , red wine and cocoa consumption should be recommended to the general population or to patients as a strategy to reduce the risk of diabetes ."
32545,The,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32546,authors,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32547,conducted,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32548,a,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32549,case,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32550,-,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32551,control,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32552,study,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32553,in,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32554,Hawaii,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32555,and,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32556,Los,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32557,Angeles,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32558,",",O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32559,California,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32560,",",O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32561,to,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32562,examine,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32563,several,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32564,dietary,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32565,hypotheses,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32566,regarding,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32567,the,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32568,etiology,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32569,of,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32570,ovarian,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32571,cancer,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32572,in,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32573,a,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32574,population,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32575,with,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32576,a,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32577,broad,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32578,range,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32579,of,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32580,dietary,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32581,intakes,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
32582,.,O,1108.0,"The authors conducted a case - control study in Hawaii and Los Angeles , California , to examine several dietary hypotheses regarding the etiology of ovarian cancer in a population with a broad range of dietary intakes ."
33150,Design,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33151,/,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33152,Setting,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33153,In,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33154,the,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33155,absence,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33156,of,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33157,global,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33158,food,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33159,-,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33160,based,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33161,dietary,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33162,guidelines,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33163,",",O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33164,we,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33165,selected,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33166,the,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33167,Dietary,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33168,Approaches,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33169,to,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33170,Stop,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33171,Hypertension,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33172,(,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33173,DASH,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33174,),O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33175,diet,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33176,as,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33177,an,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33178,example,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33179,because,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33180,there,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33181,is,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33182,evidence,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33183,it,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33184,prevents,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33185,diet,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33186,-,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33187,related,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33188,chronic,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33189,disease,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33190,and,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33191,supports,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33192,adequate,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33193,micronutrient,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33194,intakes,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33195,.,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33463,Lastly,O,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33464,",",O,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33465,the,O,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33466,paper,O,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33467,also,O,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33468,reviews,O,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33469,the,O,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33470,utilization,O,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33471,of,O,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33472,medicinal,O,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33473,properties,O,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33474,acquired,O,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33475,by,O,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33476,bamboo,B-http://purl.bioontology.org/ontology/SNOMEDCT/710224000,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33477,shoot,I-http://purl.bioontology.org/ontology/SNOMEDCT/710224000,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33478,.,O,1139.0,"Lastly , the paper also reviews the utilization of medicinal properties acquired by bamboo shoot ."
33800,Differences,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33801,in,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33802,growth,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33803,among,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33804,treatments,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33805,an,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33806,affect,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33807,iron,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33808,bioavailability,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33809,determinations,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33810,when,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33811,change,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33812,in,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33813,hemoglobin,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33814,concentration,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33815,is,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33816,used,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33817,as,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33818,the,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33819,criterion,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
33820,.,O,1154.0,Differences in growth among treatments an affect iron bioavailability determinations when change in hemoglobin concentration is used as the criterion .
34040,Among,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34041,the,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34042,food,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34043,items,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34044,we,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34045,examined,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34046,",",O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34047,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34048,was,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34049,most,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34050,closely,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34051,correlated,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34052,with,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34053,the,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34054,incidence,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34055,of,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34056,testicular,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34057,cancer,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34058,at,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34059,ages,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34060,20,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34061,-,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34062,39,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34063,",",O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34064,followed,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34065,by,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34066,animal,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34067,fats,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34068,and,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34069,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34070,.,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34102,Stepwise,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34103,-,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34104,multiple,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34105,-,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34106,regression,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34107,analysis,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34108,revealed,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34109,that,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34110,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34111,+,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34112,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34113,(,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34114,1961,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34115,-,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34116,65,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34117,),O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34118,made,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34119,a,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34120,significant,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34121,contribution,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34122,to,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34123,the,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34124,incidence,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34125,of,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34126,testicular,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34127,cancer,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34128,(,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34129,standardized,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34130,regression,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34131,coefficient,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34132,[,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34133,R,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34134,],O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34135,=,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34136,0.654,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34137,),O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34138,.,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34251,The,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34252,results,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34253,of,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34254,our,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34255,study,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34256,suggest,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34257,a,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34258,role,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34259,of,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34260,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34261,and,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34262,dairy,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34263,products,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34264,in,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34265,the,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34266,development,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34267,and,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34268,growth,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34269,of,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34270,testicular,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34271,and,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34272,prostatic,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34273,cancers,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34274,.,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34275,The,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34276,close,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34277,correlation,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34278,between,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34279,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34280,and,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34281,testicular,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34282,cancer,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34283,and,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34284,between,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34285,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34286,and,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34287,prostatic,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34288,cancer,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34289,suggests,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34290,that,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34291,further,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34292,mechanistic,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34293,studies,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34294,should,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34295,be,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34296,undertaken,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34297,concerning,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34298,the,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34299,development,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34300,of,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34301,male,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34302,genital,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34303,organ,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34304,cancers,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34305,.,O,1169.0,The close correlation between cheese and testicular cancer and between milk and prostatic cancer suggests that further mechanistic studies should be undertaken concerning the development of male genital organ cancers .
34359,A,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34360,partial,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34361,life,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34362,cycle,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34363,assessment,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34364,detailed,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34365,flows,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34366,of,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34367,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34368,from,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34369,cow,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34370,to,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34371,farm,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34372,gate,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34373,and,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34374,captured,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34375,farm,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34376,inputs,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34377,such,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34378,as,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34379,imported,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34380,feeds,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34381,and,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34382,fertilizers,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34383,.,O,1172.0,A partial life cycle assessment detailed flows of milk from cow to farm gate and captured farm inputs such as imported feeds and fertilizers .
34809,The,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34810,10,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34811,spread,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34812,formulations,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34813,",",O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34814,prepared,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34815,following,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34816,a,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34817,3,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34818,-,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34819,component,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34820,constrained,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34821,simplex,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34822,lattice,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34823,mixture,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34824,design,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34825,",",O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34826,were,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34827,subjected,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34828,to,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34829,a,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34830,consumer,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34831,acceptance,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34832,test,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34833,to,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34834,identify,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34835,sensory,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34836,attributes,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34837,driving,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34838,consumer,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34839,acceptance,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34840,and,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34841,purchase,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34842,intent,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
34843,.,O,1188.0,"The 10 spread formulations , prepared following a 3 - component constrained simplex lattice mixture design , were subjected to a consumer acceptance test to identify sensory attributes driving consumer acceptance and purchase intent ."
35142,An,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35143,ELISA,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35144,was,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35145,developed,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35146,using,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35147,the,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35148,sheep,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35149,antiroasted,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35150,walnut,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35151,serum,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35152,as,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35153,the,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35154,capture,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35155,reagent,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35156,and,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35157,rabbit,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35158,antiroasted,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35159,walnut,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35160,serum,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35161,as,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35162,the,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35163,detector,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35164,reagent,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35165,followed,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35166,by,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35167,addition,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35168,of,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35169,commercial,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35170,goat,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35171,anti,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35172,-,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35173,rabbit,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35174,IgG,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35175,antibody,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35176,labeled,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35177,with,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35178,alkaline,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35179,phosphatase,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35180,and,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35181,subsequent,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35182,substrate,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35183,addition,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35184,.,O,1198.0,An ELISA was developed using the sheep antiroasted walnut serum as the capture reagent and rabbit antiroasted walnut serum as the detector reagent followed by addition of commercial goat anti - rabbit IgG antibody labeled with alkaline phosphatase and subsequent substrate addition .
35559, ,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35560,Using,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35561,the,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35562,case,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35563,control,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35564,data,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35565,",",O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35566,others,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35567,found,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35568,an,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35569,increased,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35570,risk,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35571,for,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35572,total,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35573,lactose,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35574,intake,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35575,in,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35576,women,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35577,who,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35578,never,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35579,used,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35580,oral,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35581,contraceptives,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35582,(,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35583,OCs,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35584,),O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35585,.,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35656, ,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35657,Another,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35658,problem,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35659,is,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35660,that,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35661,the,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35662,subsets,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35663,of,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35664,exposure,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35665,or,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35666,subgroups,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35667,of,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35668,the,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35669,population,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35670,are,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35671,unpredictable,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35672,.,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35707,The,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35708,ingestion,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35709,of,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35710,perchlorate,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35711,is,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35712,of,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35713,concern,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35714,because,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35715,of,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35716,its,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35717,ability,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35718,to,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35719,competitively,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35720,inhibit,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35721,iodide,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35722,uptake,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35723,by,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35724,the,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35725,thyroid,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35726,and,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35727,to,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35728,impair,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35729,synthesis,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35730,of,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35731,thyroid,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35732,hormones,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35733,.,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
36168,The,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36169,vegetable,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36170,fibers,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36171,were,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36172,significantly,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36173,more,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36174,fermentable,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36175,than,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36176,were,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36177,the,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36178,cereal,B-http://purl.bioontology.org/ontology/SNOMEDCT/23182003,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36179,brans,I-http://purl.bioontology.org/ontology/SNOMEDCT/23182003,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36180,",",O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36181,as,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36182,evidenced,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36183,by,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36184,greater,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36185,NDF,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36186,digestibility,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36187,and,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36188,increased,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36189,productions,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36190,of,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36191,SCFA,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36192,",",O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36193,H2,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36194,",",O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36195,and,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36196,CH4,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36197,",",O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36198,despite,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36199,the,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36200,presence,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36201,of,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36202,fermentable,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36203,starch,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36204,and,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36205,protein,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36206,in,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36207,the,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36208,latter,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36209,.,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36405,There,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36406,were,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36407,significant,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36408,reductions,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36409,in,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36410,the,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36411,intake,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36412,of,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36413,table,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36414,fat,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36415,",",O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36416,high,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36417,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36418,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36419,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36420,products,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36421,",",O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36422,pork,B-http://purl.bioontology.org/ontology/SNOMEDCT/226934003,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36423,and,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36424,sausages,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36425,(,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36426,containing,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36427,greater,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36428,than,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36429,11,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36430,%,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36431,fat,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36432,),O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36433,",",O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36434,eggs,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36435,",",O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36436,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36437,",",O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36438,pasta,B-http://purl.bioontology.org/ontology/SNOMEDCT/226740002,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36439,",",O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36440,cakes,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36441,and,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36442,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36443,for,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36444,the,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36445,intervention,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36446,group,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36447,.,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36448,Concurrently,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36449,the,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36450,intake,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36451,of,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36452,vegetables,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36453,",",O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36454,fruits,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36455,",",O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36456,potatoes,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36457,",",O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36458,bread,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36459,",",O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36460,cereals,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36461,",",O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36462,low,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36463,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36464,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36465,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36466,products,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36467,",",O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36468,low,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36469,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36470,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36471,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36472,",",O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36473,sausages,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36474,and,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36475,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36476,increased,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36477,significantly,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36478,.,O,1246.0,"Concurrently the intake of vegetables , fruits , potatoes , bread , cereals , low - fat milk products , low - fat meat , sausages and fish increased significantly ."
36737,Cancer,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36738,protection,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36739,mainly,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36740,derives,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36741,from,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36742,a,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36743,systemic,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36744,metabolic,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36745,environment,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36746,that,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36747,promotes,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36748,healthy,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36749,cell,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36750,replication,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36751,and,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36752,tissue,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36753,integrity,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36754,.,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
37014,Extensive,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37015,evidences,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37016,report,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37017,that,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37018,quercetin,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37019,(,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37020,QE,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37021,),O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37022,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37023,a,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37024,major,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37025,flavonol,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37026,commonly,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37027,found,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37028,in,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37029,apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37030,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37031,berries,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37032,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37033,onion,B-http://purl.bioontology.org/ontology/SNOMEDCT/735047000,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37034,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37035,citrus,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37036,fruits,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37037,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37038,cruciferous,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37039,vegetables,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37040,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37041,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37042,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37043,pepper,B-http://purl.bioontology.org/ontology/SNOMEDCT/227563001,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37044,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37045,tomato,B-http://purl.bioontology.org/ontology/SNOMEDCT/734881000,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37046,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37047,whole,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37048,gain,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37049,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37050,cocoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37051,and,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37052,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37053,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37054,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37055,displays,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37056,a,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37057,wide,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37058,range,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37059,of,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37060,healthy,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37061,properties,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37062,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37063,including,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37064,anti,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37065,-,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37066,oxidative,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37067,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37068,anti,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37069,-,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37070,inflammatory,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37071,",",O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37072,anti,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37073,-,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37074,apoptotic,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37075,and,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37076,hepatoprotective,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37077,activities,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37078,against,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37079,various,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37080,hepatic,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37081,ailments,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37082,.,O,1267.0,"Extensive evidences report that quercetin ( QE ) , a major flavonol commonly found in apple , berries , onion , citrus fruits , cruciferous vegetables , tea , pepper , tomato , whole gain , cocoa and red wine , displays a wide range of healthy properties , including anti - oxidative , anti - inflammatory , anti - apoptotic and hepatoprotective activities against various hepatic ailments ."
37774,Three,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37775,promotion,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37776,studies,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37777,were,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37778,done,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37779,",",O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37780,each,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37781,in,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37782,5,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37783,groups,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37784,of,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37785,10,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37786,rats,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37787,",",O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37788,whose,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37789,diets,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37790,contained,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37791,7,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37792,%,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37793,",",O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37794,14,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37795,%,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37796,",",O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37797,or,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37798,28,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37799,%,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37800,fat,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
37801,.,O,1295.0,"Three promotion studies were done , each in 5 groups of 10 rats , whose diets contained 7 % , 14 % , or 28 % fat ."
38209,A,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38210,possible,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38211,supportive,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38212,action,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38213,may,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38214,be,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38215,the,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38216,modulation,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38217,of,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38218,the,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38219,gut,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38220,microbiota,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38221,by,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38222,non,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38223,-,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38224,digested,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38225,prebiotic,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38226,constituents,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38227,of,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38228,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38229,",",O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38230,but,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38231,the,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38232,available,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38233,data,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38234,are,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38235,still,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38236,scarce,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38237,.,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38679,The,O,1331.0,"The relationship is likely confounded by smoking , complicating the interpretation of previous studies ."
38680,relationship,O,1331.0,"The relationship is likely confounded by smoking , complicating the interpretation of previous studies ."
38681,is,O,1331.0,"The relationship is likely confounded by smoking , complicating the interpretation of previous studies ."
38682,likely,O,1331.0,"The relationship is likely confounded by smoking , complicating the interpretation of previous studies ."
38683,confounded,O,1331.0,"The relationship is likely confounded by smoking , complicating the interpretation of previous studies ."
38684,by,O,1331.0,"The relationship is likely confounded by smoking , complicating the interpretation of previous studies ."
38685,smoking,O,1331.0,"The relationship is likely confounded by smoking , complicating the interpretation of previous studies ."
38686,",",O,1331.0,"The relationship is likely confounded by smoking , complicating the interpretation of previous studies ."
38687,complicating,O,1331.0,"The relationship is likely confounded by smoking , complicating the interpretation of previous studies ."
38688,the,O,1331.0,"The relationship is likely confounded by smoking , complicating the interpretation of previous studies ."
38689,interpretation,O,1331.0,"The relationship is likely confounded by smoking , complicating the interpretation of previous studies ."
38690,of,O,1331.0,"The relationship is likely confounded by smoking , complicating the interpretation of previous studies ."
38691,previous,O,1331.0,"The relationship is likely confounded by smoking , complicating the interpretation of previous studies ."
38692,studies,O,1331.0,"The relationship is likely confounded by smoking , complicating the interpretation of previous studies ."
38693,.,O,1331.0,"The relationship is likely confounded by smoking , complicating the interpretation of previous studies ."
38772,Alcohol,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38773,consumption,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38774,was,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38775,categorized,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38776,into,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38777,amounts,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38778,consumed,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38779,(,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38780,grams,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38781,per,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38782,day,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38783,),O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38784,and,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38785,also,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38786,modelled,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38787,as,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38788,a,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38789,continuous,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38790,variable,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38791,using,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38792,restricted,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38793,cubic,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38794,splines,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38795,for,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38796,potential,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38797,non,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38798,-,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38799,linearity,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38800,.,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38801,Analyses,O,1335.0,Analyses by histologic sub - type were included .
38802,by,O,1335.0,Analyses by histologic sub - type were included .
38803,histologic,O,1335.0,Analyses by histologic sub - type were included .
38804,sub,O,1335.0,Analyses by histologic sub - type were included .
38805,-,O,1335.0,Analyses by histologic sub - type were included .
38806,type,O,1335.0,Analyses by histologic sub - type were included .
38807,were,O,1335.0,Analyses by histologic sub - type were included .
38808,included,O,1335.0,Analyses by histologic sub - type were included .
38809,.,O,1335.0,Analyses by histologic sub - type were included .
38827,Alcohol,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38828,consumption,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38829,was,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38830,inversely,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38831,associated,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38832,with,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38833,lung,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38834,cancer,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38835,risk,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38836,with,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38837,evidence,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38838,most,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38839,strongly,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38840,supporting,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38841,lower,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38842,risk,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38843,for,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38844,light,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38845,and,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38846,moderate,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38847,drinkers,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38848,relative,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38849,to,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38850,non,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38851,-,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38852,drinkers,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38853,(,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38854,>,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38855,0,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38856,-,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38857,4.9,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38858,g,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38859,per,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38860,day,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38861,:,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38862,OR,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38863, ,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38864,=,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38865, ,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38866,0.80,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38867,",",O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38868,95,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38869,%,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38870,CI,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38871, ,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38872,=,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38873, ,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38874,0.70,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38875,-,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38876,0.90,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38877,;,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38878,5,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38879,-,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38880,9.9,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38881,g,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38882,per,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38883,day,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38884,:,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38885,OR,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38886, ,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38887,=,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38888, ,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38889,0.82,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38890,",",O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38891,95,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38892,%,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38893,CI,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38894, ,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38895,=,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38896, ,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38897,0.69,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38898,-,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38899,0.99,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38900,;,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38901,10,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38902,-,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38903,19.9,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38904,g,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38905,per,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38906,day,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38907,:,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38908,OR,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38909, ,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38910,=,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38911, ,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38912,0.79,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38913,",",O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38914,95,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38915,%,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38916,CI,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38917, ,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38918,=,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38919, ,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38920,0.65,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38921,-,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38922,0.96,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38923,),O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
38924,.,O,1337.0,"Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non - drinkers ( > 0 - 4.9 g per day : OR   =   0.80 , 95 % CI   =   0.70 - 0.90 ; 5 - 9.9 g per day : OR   =   0.82 , 95 % CI   =   0.69 - 0.99 ; 10 - 19.9 g per day : OR   =   0.79 , 95 % CI   =   0.65 - 0.96 ) ."
39095,In,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39096,crossed,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39097,immunoelectrophoresis,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39098,(,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39099,CIE,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39100,),O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39101,of,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39102,samples,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39103,of,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39104,apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39105,",",O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39106,carrot,B-http://purl.bioontology.org/ontology/SNOMEDCT/256319004,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39107,or,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39108,celery,B-http://purl.bioontology.org/ontology/SNOMEDCT/256326004,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39109,extracts,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39110,towards,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39111,antibodies,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39112,against,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39113,birch,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39114,pollen,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39115,",",O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39116,grass,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39117,pollen,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39118,or,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39119,mugwort,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39120,pollen,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39121,",",O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39122,four,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39123,to,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39124,14,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39125,distinct,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39126,precipitates,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39127,were,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39128,observed,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39129,and,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39130,shown,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39131,to,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39132,be,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39133,specific,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39134,.,O,1345.0,"In crossed immunoelectrophoresis ( CIE ) of samples of apple , carrot or celery extracts towards antibodies against birch pollen , grass pollen or mugwort pollen , four to 14 distinct precipitates were observed and shown to be specific ."
39135,In,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39136,crossed,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39137,radioimmunoelectrophoresis,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39138,(,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39139,CRIE,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39140,),O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39141,none,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39142,of,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39143,the,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39144,precipitates,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39145,could,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39146,be,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39147,shown,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39148,to,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39149,act,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39150,as,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39151,an,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39152,allergen,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39153,.,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39926,Each,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39927,subject,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39928,consumed,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39929,each,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39930,of,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39931,five,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39932,reduced,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39933,-,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39934,fat,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39935,diets,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39936,[,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39937,30,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39938,energy,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39939,percent,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39940,(,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39941,E%,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39942,),O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39943,fat,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39944,",",O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39945,17,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39946,E%,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39947,protein,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39948,and,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39949,53,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39950,E%,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39951,carbohydrate,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39952,],O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39953,enriched,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39954,in,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39955,beef,B-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39956,tallow,I-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39957,",",O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39958,canola,B-http://purl.bioontology.org/ontology/SNOMEDCT/713648000;http://purl.bioontology.org/ontology/SNOMEDCT/226908006,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39959,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/713648000;http://purl.bioontology.org/ontology/SNOMEDCT/226908006,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39960,",",O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39961,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39962,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39963,",",O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39964,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39965,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39966,or,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39967,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005;http://purl.bioontology.org/ontology/SNOMEDCT/391858005,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39968,bran,I-http://purl.bioontology.org/ontology/SNOMEDCT/67324005;http://purl.bioontology.org/ontology/SNOMEDCT/391858005,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39969,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/67324005;http://purl.bioontology.org/ontology/SNOMEDCT/391858005,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39970,(,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39971,20,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39972,E%,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39973,),O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39974,for,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39975,32,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39976,-,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39977,d,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39978,periods,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39979,.,O,1372.0,"Each subject consumed each of five reduced - fat diets [ 30 energy percent ( E% ) fat , 17 E% protein and 53 E% carbohydrate ] enriched in beef tallow , canola oil , corn oil , olive oil or rice bran oil ( 20 E% ) for 32 - d periods ."
39980,In,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39981,vitro,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39982,oxidation,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39983,of,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39984,LDL,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39985,was,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39986,assessed,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39987,by,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39988,incubating,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39989,LDL,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39990,with,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39991,hemin,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39992,and,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39993,hydrogen,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39994,peroxide,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39995,",",O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39996,and,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39997,measuring,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39998,the,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
39999,time,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
40000,required,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
40001,for,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
40002,the,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
40003,reaction,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
40004,to,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
40005,reach,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
40006,maximum,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
40007,velocity,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
40008,(,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
40009,lag,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
40010,time,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
40011,),O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
40012,.,O,1373.0,"In vitro oxidation of LDL was assessed by incubating LDL with hemin and hydrogen peroxide , and measuring the time required for the reaction to reach maximum velocity ( lag time ) ."
53731,Ketogenic,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53732,diets,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53733,appear,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53734,to,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53735,be,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53736,more,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53737,effective,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53738,than,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53739,low,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53740,-,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53741,fat,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53742,diets,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53743,for,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53744,treatment,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53745,of,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53746,obesity,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53747,and,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53748,diabetes,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53749,.,O,1851.0,Ketogenic diets appear to be more effective than low - fat diets for treatment of obesity and diabetes .
53875,To,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53876,cope,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53877,with,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53878,this,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53879,issue,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53880,",",O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53881,researchers,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53882,in,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53883,the,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53884,agricultural,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53885,sector,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53886,have,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53887,implemented,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53888,deficit,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53889,irrigation,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53890,strategies,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53891,intended,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53892,to,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53893,reduce,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53894,water,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53895,consumption,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53896,by,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53897,increasing,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53898,fruit,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53899,quality,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
53900,.,O,1856.0,"To cope with this issue , researchers in the agricultural sector have implemented deficit irrigation strategies intended to reduce water consumption by increasing fruit quality ."
54160,However,O,1869.0,"However , consumption of butter and yogurt had no associations with the risk ."
54161,",",O,1869.0,"However , consumption of butter and yogurt had no associations with the risk ."
54162,consumption,O,1869.0,"However , consumption of butter and yogurt had no associations with the risk ."
54163,of,O,1869.0,"However , consumption of butter and yogurt had no associations with the risk ."
54164,butter,B-http://purl.bioontology.org/ontology/SNOMEDCT/226888007,1869.0,"However , consumption of butter and yogurt had no associations with the risk ."
54165,and,O,1869.0,"However , consumption of butter and yogurt had no associations with the risk ."
54166,yogurt,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,1869.0,"However , consumption of butter and yogurt had no associations with the risk ."
54167,had,O,1869.0,"However , consumption of butter and yogurt had no associations with the risk ."
54168,no,O,1869.0,"However , consumption of butter and yogurt had no associations with the risk ."
54169,associations,O,1869.0,"However , consumption of butter and yogurt had no associations with the risk ."
54170,with,O,1869.0,"However , consumption of butter and yogurt had no associations with the risk ."
54171,the,O,1869.0,"However , consumption of butter and yogurt had no associations with the risk ."
54172,risk,O,1869.0,"However , consumption of butter and yogurt had no associations with the risk ."
54173,.,O,1869.0,"However , consumption of butter and yogurt had no associations with the risk ."
54200,It,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54201,was,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54202,suggested,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54203,that,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54204,urothelial,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54205,cancer,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54206,death,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54207,could,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54208,be,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54209,potentially,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54210,preventable,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54211,by,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54212,smoking,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54213,cessation,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54214,and,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54215,regular,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54216,intake,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54217,of,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54218,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54219,and,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54220,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54221,.,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54334,Some,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54335,42.3,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54336,%,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54337,had,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54338,family,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54339,history,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54340,of,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54341,atopia,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54342,",",O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54343,lower,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54344,than,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54345,in,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54346,the,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54347,control,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54348,group,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54349,(,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54350,P,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54351,<,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54352,0.05,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54353,),O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54354,",",O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54355,while,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54356,the,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54357,prevalence,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54358,of,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54359,asthma,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54360,and,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54361,urticaria,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54362,was,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54363,significantly,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54364,higher,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54365,(,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54366,P,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54367,<,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54368,0.05,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54369,),O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54370,.,O,1876.0,"Some 42.3 % had family history of atopia , lower than in the control group ( P < 0.05 ) , while the prevalence of asthma and urticaria was significantly higher ( P < 0.05 ) ."
54587,Using,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54588,case,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54589,-,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54590,cohort,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54591,analysis,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54592,",",O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54593,the,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54594,authors,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54595,calculated,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54596,rate,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54597,ratios,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54598,and,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54599,95,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54600,%,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54601,confidence,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54602,intervals,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54603,adjusted,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54604,for,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54605,age,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54606,",",O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54607,alcohol,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54608,intake,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54609,",",O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54610,and,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54611,family,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54612,history,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54613,of,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54614,colorectal,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54615,cancer,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54616,.,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
55081,Myosmine,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55082,is,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55083,easily,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55084,nitrosated,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55085,giving,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55086,rise,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55087,to,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55088,a,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55089,DNA,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55090,adduct,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55091,identical,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55092,to,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55093,the,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55094,esophageal,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55095,tobacco,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55096,carcinogen,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55097,N,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55098,-,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55099,nitrosonornicotine,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55100,.,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55296,The,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55297,usual,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55298,choice,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55299,of,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55300,spread,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55301,used,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55302,on,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55303,bread,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55304,",",O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55305,and,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55306,the,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55307,calculated,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55308,total,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55309,amount,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55310,of,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55311,fat,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55312,spread,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55313,on,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55314,bread,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55315,per,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55316,day,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55317,",",O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55318,were,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55319,related,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55320,to,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55321,socio,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55322,-,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55323,economic,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55324,and,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55325,coronary,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55326,artery,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55327,disease,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55328,risk,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55329,factors,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55330,in,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55331,9003,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55332,respondents,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55333,in,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55334,the,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55335,Health,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55336,and,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55337,Lifestyle,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55338,Survey,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55339,.,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55682,Denaturing,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55683,gradient,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55684,gel,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55685,electrophoresis,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55686,of,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55687,PCR,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55688,-,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55689,amplified,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55690,16S,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55691,rRNA,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55692,gene,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55693,fragments,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55694,showed,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55695,that,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55696,the,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55697,composition,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55698,of,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55699,faecal,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55700,microbiota,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55701,was,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55702,different,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55703,between,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55704,mice,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55705,fed,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55706,Yukihikari,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55707,and,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55708,those,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55709,fed,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55710,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55711,A.,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55712,Analysis,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55713,of,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55714,the,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55715,16S,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55716,rRNA,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55717,clone,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55718,library,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55719,and,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55720,species,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55721,-,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55722,specific,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55723,real,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55724,-,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55725,time,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55726,PCR,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55727,showed,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55728,that,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55729,the,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55730,abundance,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55731,of,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55732,Akkermansia,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55733,muciniphila,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55734,",",O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55735,a,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55736,mucin,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55737,degrader,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55738,",",O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55739,tended,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55740,to,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55741,be,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55742,lower,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55743,in,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55744,mice,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55745,fed,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55746,Yukihikari,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55747,.,O,1926.0,"Denaturing gradient gel electrophoresis of PCR - amplified 16S rRNA gene fragments showed that the composition of faecal microbiota was different between mice fed Yukihikari and those fed rice A. Analysis of the 16S rRNA clone library and species - specific real - time PCR showed that the abundance of Akkermansia muciniphila , a mucin degrader , tended to be lower in mice fed Yukihikari ."
55858,The,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55859,Eastern,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55860,Mediterranean,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55861,Region,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55862,(,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55863,EMR,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55864,),O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55865,has,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55866,witnessed,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55867,significant,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55868,social,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55869,and,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55870,economic,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55871,changes,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55872,that,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55873,may,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55874,have,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55875,influenced,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55876,the,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55877,diet,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55878,of,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55879,children,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55880,and,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55881,adolescents,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55882,",",O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55883,and,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55884,increased,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55885,the,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55886,risk,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55887,for,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55888,obesity,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55889,and,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55890,malnutrition,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55891,in,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55892,this,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55893,age,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55894,group,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55895,.,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
56162,Sixty,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56163,-,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56164,four,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56165,healthy,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56166,postmenopausal,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56167,women,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56168,were,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56169,randomly,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56170,assigned,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56171,to,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56172,drink,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56173,8,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56174,ounces,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56175,of,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56176,either,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56177,100,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56178,%,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56179,commercial,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56180,pomegranate,B-http://purl.bioontology.org/ontology/SNOMEDCT/227441008;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56181,juice,I-http://purl.bioontology.org/ontology/SNOMEDCT/227441008;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56182,(,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56183,intervention,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56184,),O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56185,or,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56186,apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/226491003;http://purl.bioontology.org/ontology/SNOMEDCT/735215001;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56187,juice,I-http://purl.bioontology.org/ontology/SNOMEDCT/226491003;http://purl.bioontology.org/ontology/SNOMEDCT/735215001;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56188,(,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56189,control,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56190,),O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56191,for,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56192,3,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56193,weeks,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56194,.,O,1940.0,Sixty - four healthy postmenopausal women were randomly assigned to drink 8 ounces of either 100 % commercial pomegranate juice ( intervention ) or apple juice ( control ) for 3 weeks .
56495,The,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56496,oxidation,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56497,level,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56498,used,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56499,in,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56500,the,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56501,study,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56502,did,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56503,not,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56504,alter,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56505,the,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56506,gelatinization,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56507,temperature,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56508,of,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56509,most,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56510,starches,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56511,",",O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56512,but,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56513,increased,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56514,the,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56515,peak,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56516,pasting,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56517,viscosity,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56518,of,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56519,both,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56520,types,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56521,of,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56522,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/412357001;http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56523,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/412357001;http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56524,rice,I-http://purl.bioontology.org/ontology/SNOMEDCT/412357001;http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56525,starches,I-http://purl.bioontology.org/ontology/SNOMEDCT/412357001;http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56526,and,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56527,decreased,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56528,that,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56529,of,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56530,tapioca,B-http://purl.bioontology.org/ontology/SNOMEDCT/226733003;http://purl.bioontology.org/ontology/SNOMEDCT/735053000,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56531,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/226733003;http://purl.bioontology.org/ontology/SNOMEDCT/735053000,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56532,potato,I-http://purl.bioontology.org/ontology/SNOMEDCT/226733003;http://purl.bioontology.org/ontology/SNOMEDCT/735053000,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56533,starches,I-http://purl.bioontology.org/ontology/SNOMEDCT/226733003;http://purl.bioontology.org/ontology/SNOMEDCT/735053000,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56534,.,O,1952.0,"The oxidation level used in the study did not alter the gelatinization temperature of most starches , but increased the peak pasting viscosity of both types of corn and rice starches and decreased that of tapioca and potato starches ."
56602,Potatoes,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56603,(,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56604,Solanum,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56605,tuberosum,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56606,),O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56607,are,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56608,an,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56609,important,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56610,global,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56611,crop,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56612,that,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56613,can,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56614,be,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56615,transformed,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56616,into,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56617,many,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56618,products,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56619,impacting,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56620,several,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56621,health,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56622,dimensions,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56623,ranging,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56624,from,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56625,undernutrition,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56626,",",O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56627,food,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56628,security,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56629,and,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56630,disease,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56631,prevention,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56632,to,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56633,issues,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56634,of,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56635,overnutrition,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56636,including,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56637,obesity,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56638,",",O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56639,diabetes,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56640,",",O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56641,heart,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56642,disease,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56643,.,O,1955.0,"Potatoes ( Solanum tuberosum ) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition , food security and disease prevention to issues of overnutrition including obesity , diabetes , heart disease ."
56644,Processed,B-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56645,potato,I-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56646,products,I-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56647,are,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56648,typically,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56649,categorized,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56650,as,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56651,high,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56652,fat,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56653,and,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56654,sodium,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56655,foods,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56656,",",O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56657,as,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56658,well,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56659,as,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56660,being,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56661,classified,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56662,as,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56663,a,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56664,significant,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56665,source,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56666,of,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56667,carbohydrate,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56668,",",O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56669,in,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56670,the,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56671,form,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56672,of,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56673,starch,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56674,.,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56798,Proteins,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56799,play,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56800,a,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56801,crucial,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56802,role,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56803,in,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56804,metabolism,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56805,",",O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56806,in,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56807,maintaining,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56808,fluid,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56809,and,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56810,acid,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56811,-,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56812,base,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56813,balance,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56814,and,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56815,antibody,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56816,synthesis,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
56817,.,O,1960.0,"Proteins play a crucial role in metabolism , in maintaining fluid and acid - base balance and antibody synthesis ."
57018,The,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57019,aim,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57020,of,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57021,this,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57022,expert,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57023,opinion,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57024,recommendation,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57025,was,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57026,to,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57027,elucidate,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57028,the,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57029,different,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57030,impact,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57031,of,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57032,animal,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57033,vs,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57034,vegetable,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57035,protein,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57036,on,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57037,modifying,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57038,cardiometabolic,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57039,risk,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57040,factors,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57041,.,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57147,Specific,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57148,amino,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57149,acids,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57150,have,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57151,favourable,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57152,results,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57153,in,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57154,modifying,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57155,major,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57156,risk,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57157,factors,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57158,for,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57159,CVD,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57160,",",O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57161,such,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57162,as,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57163,hypertension,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57164,.,O,1974.0,"Specific amino acids have favourable results in modifying major risk factors for CVD , such as hypertension ."
57247,Teaching,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57248,teams,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57249,",",O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57250,consisting,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57251,of,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57252,an,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57253,extension,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57254,agent,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57255,and,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57256,a,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57257,registered,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57258,dietitian,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57259,",",O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57260,were,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57261,used,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57262,in,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57263,course,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57264,delivery,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57265,.,O,1978.0,"Teaching teams , consisting of an extension agent and a registered dietitian , were used in course delivery ."
57334,One,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57335,hundred,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57336,forty,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57337,-,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57338,two,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57339,of,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57340,195,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57341,participants,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57342,(,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57343,73,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57344,%,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57345,),O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57346,completed,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57347,the,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57348,course,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57349,and,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57350,the,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57351,evaluation,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57352,.,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57454,Further,O,1986.0,Further study is recommended to determine whether individuals maintain the dietary changes and how those changes affect others in the person 's immediate environment .
57455,study,O,1986.0,Further study is recommended to determine whether individuals maintain the dietary changes and how those changes affect others in the person 's immediate environment .
57456,is,O,1986.0,Further study is recommended to determine whether individuals maintain the dietary changes and how those changes affect others in the person 's immediate environment .
57457,recommended,O,1986.0,Further study is recommended to determine whether individuals maintain the dietary changes and how those changes affect others in the person 's immediate environment .
57458,to,O,1986.0,Further study is recommended to determine whether individuals maintain the dietary changes and how those changes affect others in the person 's immediate environment .
57459,determine,O,1986.0,Further study is recommended to determine whether individuals maintain the dietary changes and how those changes affect others in the person 's immediate environment .
57460,whether,O,1986.0,Further study is recommended to determine whether individuals maintain the dietary changes and how those changes affect others in the person 's immediate environment .
57461,individuals,O,1986.0,Further study is recommended to determine whether individuals maintain the dietary changes and how those changes affect others in the person 's immediate environment .
57462,maintain,O,1986.0,Further study is recommended to determine whether individuals maintain the dietary changes and how those changes affect others in the person 's immediate environment .
57463,the,O,1986.0,Further study is recommended to determine whether individuals maintain the dietary changes and how those changes affect others in the person 's immediate environment .
57464,dietary,O,1986.0,Further study is recommended to determine whether individuals maintain the dietary changes and how those changes affect others in the person 's immediate environment .
57465,changes,O,1986.0,Further study is recommended to determine whether individuals maintain the dietary changes and how those changes affect others in the person 's immediate environment .
57466,and,O,1986.0,Further study is recommended to determine whether individuals maintain the dietary changes and how those changes affect others in the person 's immediate environment .
57467,how,O,1986.0,Further study is recommended to determine whether individuals maintain the dietary changes and how those changes affect others in the person 's immediate environment .
57468,those,O,1986.0,Further study is recommended to determine whether individuals maintain the dietary changes and how those changes affect others in the person 's immediate environment .
57469,changes,O,1986.0,Further study is recommended to determine whether individuals maintain the dietary changes and how those changes affect others in the person 's immediate environment .
57470,affect,O,1986.0,Further study is recommended to determine whether individuals maintain the dietary changes and how those changes affect others in the person 's immediate environment .
57471,others,O,1986.0,Further study is recommended to determine whether individuals maintain the dietary changes and how those changes affect others in the person 's immediate environment .
57472,in,O,1986.0,Further study is recommended to determine whether individuals maintain the dietary changes and how those changes affect others in the person 's immediate environment .
57473,the,O,1986.0,Further study is recommended to determine whether individuals maintain the dietary changes and how those changes affect others in the person 's immediate environment .
57474,person,O,1986.0,Further study is recommended to determine whether individuals maintain the dietary changes and how those changes affect others in the person 's immediate environment .
57475,'s,O,1986.0,Further study is recommended to determine whether individuals maintain the dietary changes and how those changes affect others in the person 's immediate environment .
57476,immediate,O,1986.0,Further study is recommended to determine whether individuals maintain the dietary changes and how those changes affect others in the person 's immediate environment .
57477,environment,O,1986.0,Further study is recommended to determine whether individuals maintain the dietary changes and how those changes affect others in the person 's immediate environment .
57478,.,O,1986.0,Further study is recommended to determine whether individuals maintain the dietary changes and how those changes affect others in the person 's immediate environment .
57499,As,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57500,is,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57501,known,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57502,",",O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57503,diet,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57504,plays,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57505,an,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57506,important,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57507,role,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57508,in,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57509,the,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57510,management,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57511,of,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57512,diabetes,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57513,.,O,1988.0,"As is known , diet plays an important role in the management of diabetes ."
57526,Therefore,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57527,",",O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57528,we,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57529,investigated,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57530,the,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57531,dietary,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57532,habits,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57533,and,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57534,established,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57535,their,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57536,relationship,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57537,with,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57538,the,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57539,nutritional,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57540,status,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57541,and,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57542,glycemic,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57543,profile,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57544,of,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57545,such,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57546,women,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57547,.,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57645,Principal,O,1996.0,"Principal component analysis identified two major dietary patterns , the first one "" healthy "" and the second one "" unhealthy "" ."
57646,component,O,1996.0,"Principal component analysis identified two major dietary patterns , the first one "" healthy "" and the second one "" unhealthy "" ."
57647,analysis,O,1996.0,"Principal component analysis identified two major dietary patterns , the first one "" healthy "" and the second one "" unhealthy "" ."
57648,identified,O,1996.0,"Principal component analysis identified two major dietary patterns , the first one "" healthy "" and the second one "" unhealthy "" ."
57649,two,O,1996.0,"Principal component analysis identified two major dietary patterns , the first one "" healthy "" and the second one "" unhealthy "" ."
57650,major,O,1996.0,"Principal component analysis identified two major dietary patterns , the first one "" healthy "" and the second one "" unhealthy "" ."
57651,dietary,O,1996.0,"Principal component analysis identified two major dietary patterns , the first one "" healthy "" and the second one "" unhealthy "" ."
57652,patterns,O,1996.0,"Principal component analysis identified two major dietary patterns , the first one "" healthy "" and the second one "" unhealthy "" ."
57653,",",O,1996.0,"Principal component analysis identified two major dietary patterns , the first one "" healthy "" and the second one "" unhealthy "" ."
57654,the,O,1996.0,"Principal component analysis identified two major dietary patterns , the first one "" healthy "" and the second one "" unhealthy "" ."
57655,first,O,1996.0,"Principal component analysis identified two major dietary patterns , the first one "" healthy "" and the second one "" unhealthy "" ."
57656,one,O,1996.0,"Principal component analysis identified two major dietary patterns , the first one "" healthy "" and the second one "" unhealthy "" ."
57657,"""",O,1996.0,"Principal component analysis identified two major dietary patterns , the first one "" healthy "" and the second one "" unhealthy "" ."
57658,healthy,O,1996.0,"Principal component analysis identified two major dietary patterns , the first one "" healthy "" and the second one "" unhealthy "" ."
57659,"""",O,1996.0,"Principal component analysis identified two major dietary patterns , the first one "" healthy "" and the second one "" unhealthy "" ."
57660,and,O,1996.0,"Principal component analysis identified two major dietary patterns , the first one "" healthy "" and the second one "" unhealthy "" ."
57661,the,O,1996.0,"Principal component analysis identified two major dietary patterns , the first one "" healthy "" and the second one "" unhealthy "" ."
57662,second,O,1996.0,"Principal component analysis identified two major dietary patterns , the first one "" healthy "" and the second one "" unhealthy "" ."
57663,one,O,1996.0,"Principal component analysis identified two major dietary patterns , the first one "" healthy "" and the second one "" unhealthy "" ."
57664,"""",O,1996.0,"Principal component analysis identified two major dietary patterns , the first one "" healthy "" and the second one "" unhealthy "" ."
57665,unhealthy,O,1996.0,"Principal component analysis identified two major dietary patterns , the first one "" healthy "" and the second one "" unhealthy "" ."
57666,"""",O,1996.0,"Principal component analysis identified two major dietary patterns , the first one "" healthy "" and the second one "" unhealthy "" ."
57667,.,O,1996.0,"Principal component analysis identified two major dietary patterns , the first one "" healthy "" and the second one "" unhealthy "" ."
58237,RWT,O,2008.0,RWT and RWF showed significantly higher glucagon secretion as compared with the control ( P<0·05 ) .
58238,and,O,2008.0,RWT and RWF showed significantly higher glucagon secretion as compared with the control ( P<0·05 ) .
58239,RWF,O,2008.0,RWT and RWF showed significantly higher glucagon secretion as compared with the control ( P<0·05 ) .
58240,showed,O,2008.0,RWT and RWF showed significantly higher glucagon secretion as compared with the control ( P<0·05 ) .
58241,significantly,O,2008.0,RWT and RWF showed significantly higher glucagon secretion as compared with the control ( P<0·05 ) .
58242,higher,O,2008.0,RWT and RWF showed significantly higher glucagon secretion as compared with the control ( P<0·05 ) .
58243,glucagon,O,2008.0,RWT and RWF showed significantly higher glucagon secretion as compared with the control ( P<0·05 ) .
58244,secretion,O,2008.0,RWT and RWF showed significantly higher glucagon secretion as compared with the control ( P<0·05 ) .
58245,as,O,2008.0,RWT and RWF showed significantly higher glucagon secretion as compared with the control ( P<0·05 ) .
58246,compared,O,2008.0,RWT and RWF showed significantly higher glucagon secretion as compared with the control ( P<0·05 ) .
58247,with,O,2008.0,RWT and RWF showed significantly higher glucagon secretion as compared with the control ( P<0·05 ) .
58248,the,O,2008.0,RWT and RWF showed significantly higher glucagon secretion as compared with the control ( P<0·05 ) .
58249,control,O,2008.0,RWT and RWF showed significantly higher glucagon secretion as compared with the control ( P<0·05 ) .
58250,(,O,2008.0,RWT and RWF showed significantly higher glucagon secretion as compared with the control ( P<0·05 ) .
58251,P<0·05,O,2008.0,RWT and RWF showed significantly higher glucagon secretion as compared with the control ( P<0·05 ) .
58252,),O,2008.0,RWT and RWF showed significantly higher glucagon secretion as compared with the control ( P<0·05 ) .
58253,.,O,2008.0,RWT and RWF showed significantly higher glucagon secretion as compared with the control ( P<0·05 ) .
59020,Beer,B-http://purl.bioontology.org/ontology/SNOMEDCT/53410008,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59021,consumption,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59022,contributed,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59023,to,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59024,9·6,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59025,and,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59026,5·3,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59027,%,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59028,inter,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59029,-,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59030,individual,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59031,variation,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59032,in,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59033,GI,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59034,and,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59035,GL,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59036,",",O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59037,respectively,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59038,.,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59517,In,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59518,addition,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59519,",",O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59520,olives,B-http://purl.bioontology.org/ontology/SNOMEDCT/227436000,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59521,(,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59522,Olea,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59523,europaea,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59524,L.,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59525,),O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59526,and,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59527,olive,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59528,oils,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59529,provide,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59530,a,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59531,rich,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59532,source,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59533,of,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59534,natural,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59535,antioxidants,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59536,.,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59581,Uncured,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59582,and,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59583,nitrite,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59584,-,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59585,cured,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59586,chicken,B-http://purl.bioontology.org/ontology/SNOMEDCT/226955001,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59587,",",O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59588,pork,B-http://purl.bioontology.org/ontology/SNOMEDCT/226934003,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59589,",",O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59590,and,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59591,beef,B-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59592,were,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59593,used,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59594,as,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59595,low,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59596,",",O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59597,medium,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59598,",",O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59599,and,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59600,high,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59601,sources,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59602,of,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59603,heme,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59604,-,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59605,Fe,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59606,",",O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59607,respectively,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59608,",",O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59609,and,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59610,exposed,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59611,to,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59612,an,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59613,in,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59614,vitro,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59615,digestion,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59616,model,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59617,simulating,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59618,the,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59619,mouth,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59620,",",O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59621,stomach,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59622,",",O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59623,duodenum,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59624,",",O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59625,and,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59626,colon,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59627,.,O,2063.0,"Uncured and nitrite - cured chicken , pork , and beef were used as low , medium , and high sources of heme - Fe , respectively , and exposed to an in vitro digestion model simulating the mouth , stomach , duodenum , and colon ."
59628,With,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59629,increasing,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59630,content,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59631,of,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59632,iron,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59633,compounds,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59634,",",O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59635,up,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59636,to,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59637,25,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59638,-,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59639,fold,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59640,higher,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59641,concentrations,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59642,of,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59643,the,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59644,toxic,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59645,lipid,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59646,oxidation,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59647,products,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59648,malondialdehyde,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59649,",",O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59650,4,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59651,-,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59652,hydroxy-2,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59653,-,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59654,nonenal,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59655,",",O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59656,and,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59657,other,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59658,volatile,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59659,aldehydes,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59660,were,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59661,formed,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59662,during,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59663,digestion,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59664,",",O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59665,together,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59666,with,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59667,increased,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59668,protein,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59669,carbonyl,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59670,compounds,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59671,as,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59672,measurement,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59673,of,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59674,protein,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59675,oxidation,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59676,.,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59737,This,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59738,study,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59739,confirms,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59740,previously,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59741,reported,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59742,evidence,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59743,that,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59744,heme,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59745,-,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59746,Fe,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59747,is,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59748,involved,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59749,in,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59750,the,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59751,epidemiological,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59752,association,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59753,between,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59754,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59755,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59756,consumption,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59757,and,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59758,colorectal,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59759,cancer,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59760,",",O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59761,but,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59762,questions,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59763,the,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59764,role,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59765,of,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59766,nitrite,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59767,curing,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59768,in,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59769,this,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59770,association,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
59771,.,O,2067.0,"This study confirms previously reported evidence that heme - Fe is involved in the epidemiological association between red meat consumption and colorectal cancer , but questions the role of nitrite curing in this association ."
60084,This,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60085,dietary,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60086,pattern,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60087,also,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60088,promotes,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60089,the,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60090,growth,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60091,of,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60092,unhealthful,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60093,gut,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60094,bacteria,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60095,",",O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60096,fostering,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60097,",",O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60098,among,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60099,other,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60100,things,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60101,",",O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60102,the,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60103,production,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60104,of,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60105,trimethylamine,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60106,N,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60107,-,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60108,oxide,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60109,",",O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60110,a,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60111,proinflammatory,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60112,compound,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60113,associated,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60114,with,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60115,cardiovascular,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60116,and,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60117,neurological,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60118,diseases,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60119,.,O,2080.0,"This dietary pattern also promotes the growth of unhealthful gut bacteria , fostering , among other things , the production of trimethylamine N - oxide , a proinflammatory compound associated with cardiovascular and neurological diseases ."
60517,In,O,2096.0,In general beer has not been portrayed as part of a balanced diet .
60518,general,O,2096.0,In general beer has not been portrayed as part of a balanced diet .
60519,beer,B-http://purl.bioontology.org/ontology/SNOMEDCT/53410008,2096.0,In general beer has not been portrayed as part of a balanced diet .
60520,has,O,2096.0,In general beer has not been portrayed as part of a balanced diet .
60521,not,O,2096.0,In general beer has not been portrayed as part of a balanced diet .
60522,been,O,2096.0,In general beer has not been portrayed as part of a balanced diet .
60523,portrayed,O,2096.0,In general beer has not been portrayed as part of a balanced diet .
60524,as,O,2096.0,In general beer has not been portrayed as part of a balanced diet .
60525,part,O,2096.0,In general beer has not been portrayed as part of a balanced diet .
60526,of,O,2096.0,In general beer has not been portrayed as part of a balanced diet .
60527,a,O,2096.0,In general beer has not been portrayed as part of a balanced diet .
60528,balanced,O,2096.0,In general beer has not been portrayed as part of a balanced diet .
60529,diet,O,2096.0,In general beer has not been portrayed as part of a balanced diet .
60530,.,O,2096.0,In general beer has not been portrayed as part of a balanced diet .
60961,Glucose,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60962,",",O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60963,urea,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60964,",",O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60965,triglycerides,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60966,(,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60967,TG,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60968,),O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60969,",",O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60970,total,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60971,cholesterol,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60972,",",O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60973,beta,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60974,-,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60975,hydroxibutyrate,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60976,(,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60977,BHBA,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60978,),O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60979,",",O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60980,and,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60981,gamma,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60982,-,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60983,glutamyl,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60984,transferase,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60985,(,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60986,GGT,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60987,),O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60988,in,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60989,plasma,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60990,were,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60991,unaffected,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60992,by,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60993,treatment,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60994,.,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
61217,Cocoa,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61218,-,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61219,rich,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61220,diet,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61221,further,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61222,ameliorated,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61223,the,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61224,hepatic,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61225,insulin,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61226,resistance,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61227,by,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61228,abolishing,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61229,the,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61230,increased,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61231,serine,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61232,-,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61233,phosphorylated,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61234,levels,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61235,of,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61236,the,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61237,insulin,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61238,receptor,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61239,substrate,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61240,1,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61241,and,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61242,preventing,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61243,the,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61244,inactivation,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61245,of,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61246,the,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61247,glycogen,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61248,synthase,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61249,kinase,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61250,3,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61251,/,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61252,glycogen,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61253,synthase,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61254,pathway,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61255,in,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61256,the,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61257,liver,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61258,of,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61259,cocoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61260,-,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61261,fed,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61262,ZDF,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61263,rats,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61264,.,O,2125.0,Cocoa - rich diet further ameliorated the hepatic insulin resistance by abolishing the increased serine - phosphorylated levels of the insulin receptor substrate 1 and preventing the inactivation of the glycogen synthase kinase 3 / glycogen synthase pathway in the liver of cocoa - fed ZDF rats .
61603,Ginger,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61604,(,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61605,Zingiber,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61606,officinale,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61607,Roscoe,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61608,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61609,Zingiberacae,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61610,),O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61611,is,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61612,a,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61613,medicinal,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61614,plant,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61615,that,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61616,has,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61617,been,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61618,widely,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61619,used,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61620,in,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61621,Chinese,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61622,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61623,Ayurvedic,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61624,and,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61625,Tibb,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61626,-,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61627,Unani,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61628,herbal,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61629,medicines,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61630,all,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61631,over,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61632,the,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61633,world,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61634,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61635,since,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61636,antiquity,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61637,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61638,for,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61639,a,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61640,wide,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61641,array,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61642,of,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61643,unrelated,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61644,ailments,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61645,that,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61646,include,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61647,arthritis,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61648,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61649,rheumatism,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61650,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61651,sprains,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61652,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61653,muscular,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61654,aches,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61655,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61656,pains,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61657,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61658,sore,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61659,throats,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61660,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61661,cramps,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61662,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61663,constipation,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61664,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61665,indigestion,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61666,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61667,vomiting,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61668,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61669,hypertension,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61670,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61671,dementia,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61672,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61673,fever,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61674,",",O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61675,infectious,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61676,diseases,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61677,and,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61678,helminthiasis,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61679,.,O,2139.0,"Ginger ( Zingiber officinale Roscoe , Zingiberacae ) is a medicinal plant that has been widely used in Chinese , Ayurvedic and Tibb - Unani herbal medicines all over the world , since antiquity , for a wide array of unrelated ailments that include arthritis , rheumatism , sprains , muscular aches , pains , sore throats , cramps , constipation , indigestion , vomiting , hypertension , dementia , fever , infectious diseases and helminthiasis ."
61865,Several,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61866,epidemiological,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61867,studies,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61868,suggested,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61869,the,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61870,inverse,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61871,correlation,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61872,between,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61873,the,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61874,intake,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61875,of,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61876,vegetables,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61877,and,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61878,fruits,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61879,and,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61880,the,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61881,incidence,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61882,of,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61883,breast,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61884,cancer,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61885,.,O,2147.0,Several epidemiological studies suggested the inverse correlation between the intake of vegetables and fruits and the incidence of breast cancer .
61886,Substantial,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61887,experimental,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61888,studies,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61889,indicated,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61890,that,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61891,many,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61892,dietary,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61893,natural,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61894,products,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61895,could,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61896,affect,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61897,the,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61898,development,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61899,and,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61900,progression,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61901,of,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61902,breast,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61903,cancer,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61904,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61905,such,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61906,as,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61907,soy,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61908,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61909,pomegranate,B-http://purl.bioontology.org/ontology/SNOMEDCT/227441008,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61910,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61911,mangosteen,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61912,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61913,citrus,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61914,fruits,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61915,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61916,apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61917,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61918,grape,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61919,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61920,mango,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61921,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61922,cruciferous,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61923,vegetables,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61924,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61925,ginger,B-http://purl.bioontology.org/ontology/SNOMEDCT/227400003,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61926,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61927,garlic,B-http://purl.bioontology.org/ontology/SNOMEDCT/735030001,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61928,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61929,black,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61930,cumin,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61931,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61932,edible,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61933,macro,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61934,-,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61935,fungi,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61936,",",O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61937,and,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61938,cereals,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
61939,.,O,2148.0,"Substantial experimental studies indicated that many dietary natural products could affect the development and progression of breast cancer , such as soy , pomegranate , mangosteen , citrus fruits , apple , grape , mango , cruciferous vegetables , ginger , garlic , black cumin , edible macro - fungi , and cereals ."
63027,Bread,O,2188.0,"Bread parameters evaluated were specific volume and crumb hardness , where the largest specific volume and the lowest value for crumb hardness were considered most desirable ."
63028,parameters,O,2188.0,"Bread parameters evaluated were specific volume and crumb hardness , where the largest specific volume and the lowest value for crumb hardness were considered most desirable ."
63029,evaluated,O,2188.0,"Bread parameters evaluated were specific volume and crumb hardness , where the largest specific volume and the lowest value for crumb hardness were considered most desirable ."
63030,were,O,2188.0,"Bread parameters evaluated were specific volume and crumb hardness , where the largest specific volume and the lowest value for crumb hardness were considered most desirable ."
63031,specific,O,2188.0,"Bread parameters evaluated were specific volume and crumb hardness , where the largest specific volume and the lowest value for crumb hardness were considered most desirable ."
63032,volume,O,2188.0,"Bread parameters evaluated were specific volume and crumb hardness , where the largest specific volume and the lowest value for crumb hardness were considered most desirable ."
63033,and,O,2188.0,"Bread parameters evaluated were specific volume and crumb hardness , where the largest specific volume and the lowest value for crumb hardness were considered most desirable ."
63034,crumb,O,2188.0,"Bread parameters evaluated were specific volume and crumb hardness , where the largest specific volume and the lowest value for crumb hardness were considered most desirable ."
63035,hardness,O,2188.0,"Bread parameters evaluated were specific volume and crumb hardness , where the largest specific volume and the lowest value for crumb hardness were considered most desirable ."
63036,",",O,2188.0,"Bread parameters evaluated were specific volume and crumb hardness , where the largest specific volume and the lowest value for crumb hardness were considered most desirable ."
63037,where,O,2188.0,"Bread parameters evaluated were specific volume and crumb hardness , where the largest specific volume and the lowest value for crumb hardness were considered most desirable ."
63038,the,O,2188.0,"Bread parameters evaluated were specific volume and crumb hardness , where the largest specific volume and the lowest value for crumb hardness were considered most desirable ."
63039,largest,O,2188.0,"Bread parameters evaluated were specific volume and crumb hardness , where the largest specific volume and the lowest value for crumb hardness were considered most desirable ."
63040,specific,O,2188.0,"Bread parameters evaluated were specific volume and crumb hardness , where the largest specific volume and the lowest value for crumb hardness were considered most desirable ."
63041,volume,O,2188.0,"Bread parameters evaluated were specific volume and crumb hardness , where the largest specific volume and the lowest value for crumb hardness were considered most desirable ."
63042,and,O,2188.0,"Bread parameters evaluated were specific volume and crumb hardness , where the largest specific volume and the lowest value for crumb hardness were considered most desirable ."
63043,the,O,2188.0,"Bread parameters evaluated were specific volume and crumb hardness , where the largest specific volume and the lowest value for crumb hardness were considered most desirable ."
63044,lowest,O,2188.0,"Bread parameters evaluated were specific volume and crumb hardness , where the largest specific volume and the lowest value for crumb hardness were considered most desirable ."
63045,value,O,2188.0,"Bread parameters evaluated were specific volume and crumb hardness , where the largest specific volume and the lowest value for crumb hardness were considered most desirable ."
63046,for,O,2188.0,"Bread parameters evaluated were specific volume and crumb hardness , where the largest specific volume and the lowest value for crumb hardness were considered most desirable ."
63047,crumb,O,2188.0,"Bread parameters evaluated were specific volume and crumb hardness , where the largest specific volume and the lowest value for crumb hardness were considered most desirable ."
63048,hardness,O,2188.0,"Bread parameters evaluated were specific volume and crumb hardness , where the largest specific volume and the lowest value for crumb hardness were considered most desirable ."
63049,were,O,2188.0,"Bread parameters evaluated were specific volume and crumb hardness , where the largest specific volume and the lowest value for crumb hardness were considered most desirable ."
63050,considered,O,2188.0,"Bread parameters evaluated were specific volume and crumb hardness , where the largest specific volume and the lowest value for crumb hardness were considered most desirable ."
63051,most,O,2188.0,"Bread parameters evaluated were specific volume and crumb hardness , where the largest specific volume and the lowest value for crumb hardness were considered most desirable ."
63052,desirable,O,2188.0,"Bread parameters evaluated were specific volume and crumb hardness , where the largest specific volume and the lowest value for crumb hardness were considered most desirable ."
63053,.,O,2188.0,"Bread parameters evaluated were specific volume and crumb hardness , where the largest specific volume and the lowest value for crumb hardness were considered most desirable ."
63099,When,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63100,proof,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63101,time,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63102,was,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63103,optimized,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63104,",",O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63105,a,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63106,specific,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63107,volume,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63108,of,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63109,~5.6,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63110,ml,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63111,/,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63112,g,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63113,and,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63114,crumb,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63115,hardness,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63116,value,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63117,of,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63118,~156,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63119,g,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63120,of,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63121,force,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63122,was,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63123,observed,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63124,.,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63285,We,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63286,found,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63287,a,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63288,significant,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63289,inverse,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63290,association,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63291,between,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63292,total,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63293,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/22836000,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63294,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/22836000,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63295,vegetable,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/22836000,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63296,intake,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63297,and,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63298,ESCC,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63299,risk,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63300,(,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63301,HR,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63302,:,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63303,0.78,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63304,",",O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63305,95,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63306,%,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63307,CI,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63308,:,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63309,0.67,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63310,-,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63311,0.91,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63312,),O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63313,",",O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63314,but,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63315,not,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63316,EAC,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63317,risk,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63318,(,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63319,0.98,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63320,",",O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63321,0.90,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63322,-,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63323,1.08,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63324,),O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
63325,.,O,2197.0,"We found a significant inverse association between total fruit and vegetable intake and ESCC risk ( HR : 0.78 , 95 % CI : 0.67 - 0.91 ) , but not EAC risk ( 0.98 , 0.90 - 1.08 ) ."
64057,Pearson,O,2226.0,Pearson 's correlation was > 0.89 ( P < 0.0001 ) .
64058,'s,O,2226.0,Pearson 's correlation was > 0.89 ( P < 0.0001 ) .
64059,correlation,O,2226.0,Pearson 's correlation was > 0.89 ( P < 0.0001 ) .
64060,was,O,2226.0,Pearson 's correlation was > 0.89 ( P < 0.0001 ) .
64061,>,O,2226.0,Pearson 's correlation was > 0.89 ( P < 0.0001 ) .
64062,0.89,O,2226.0,Pearson 's correlation was > 0.89 ( P < 0.0001 ) .
64063,(,O,2226.0,Pearson 's correlation was > 0.89 ( P < 0.0001 ) .
64064,P,O,2226.0,Pearson 's correlation was > 0.89 ( P < 0.0001 ) .
64065,<,O,2226.0,Pearson 's correlation was > 0.89 ( P < 0.0001 ) .
64066,0.0001,O,2226.0,Pearson 's correlation was > 0.89 ( P < 0.0001 ) .
64067,),O,2226.0,Pearson 's correlation was > 0.89 ( P < 0.0001 ) .
64068,.,O,2226.0,Pearson 's correlation was > 0.89 ( P < 0.0001 ) .
64264,The,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64265,evidence,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64266,reviewed,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64267,provides,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64268,additional,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64269,support,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64270,for,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64271,increased,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64272,consumption,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64273,of,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64274,a,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64275,wide,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64276,variety,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64277,of,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64278,vegetables,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64279,",",O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64280,in,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64281,particular,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64282,",",O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64283,dark,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64284,-,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64285,green,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64286,leafy,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64287,",",O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64288,cruciferous,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64289,",",O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64290,and,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64291,deep,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64292,-,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64293,yellow,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64294,-,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64295,orange,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64296,ones,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64297,",",O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64298,and,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64299,a,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64300,wide,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64301,variety,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64302,of,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64303,fruits,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64304,",",O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64305,in,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64306,particular,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64307,",",O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64308,citrus,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64309,and,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64310,deep,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64311,-,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64312,yellow,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64313,-,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64314,orange,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64315,ones,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64316,.,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64360,Milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64361,in,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64362,the,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64363,rumen,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64364,may,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64365,cause,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64366,indigestion,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64367,",",O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64368,diarrhea,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64369,",",O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64370,and,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64371,reduced,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64372,growth,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64373,.,O,2237.0,"Milk in the rumen may cause indigestion , diarrhea , and reduced growth ."
64604,No,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64605,behavioral,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64606,signs,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64607,of,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64608,pain,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64609,or,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64610,discomfort,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64611,were,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64612,observed,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64613,",",O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64614,but,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64615,shivering,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64616,was,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64617,noted,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64618,in,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64619,several,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64620,calves,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64621,drinking,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64622,8,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64623,°,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64624,C,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64625,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64626,.,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64657,In,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64658,this,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64659,study,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64660,",",O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64661,pot,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64662,experiments,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64663,were,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64664,conducted,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64665,to,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64666,determine,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64667,the,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64668,effects,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64669,of,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64670,industrial,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64671,solid,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64672,wastes,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64673,(,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64674,ISWs,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64675,),O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64676,(,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64677,ceramic,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64678,",",O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64679,stone,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64680,",",O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64681,and,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64682,sugar,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64683,factory,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64684,wastes,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64685,),O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64686,and,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64687,organic,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64688,wastes,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64689,(,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64690,rice,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64691,husk,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64692,and,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64693,wheat,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64694,straw,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64695,),O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64696,on,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64697,growth,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64698,and,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64699,heavy,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64700,metals,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64701,uptake,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64702,by,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64703,tomato,B-http://purl.bioontology.org/ontology/SNOMEDCT/734881000,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64704,(,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64705,Lycopersicum,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64706,esculentum,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64707,),O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64708,plants,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64709,.,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64814,In,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64815,control,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64816,and,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64817,ISWs,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64818,-,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64819,treated,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64820,soils,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64821,",",O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64822,dry,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64823,matter,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64824,yield,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64825,of,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64826,tomato,B-http://purl.bioontology.org/ontology/SNOMEDCT/734881000,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64827,grown,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64828,in,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64829,the,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64830,presence,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64831,of,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64832,wheat,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64833,straw,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64834,was,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64835,significantly,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64836,restricted,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64837,",",O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64838,while,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64839,the,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64840,application,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64841,of,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64842,rice,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64843,husk,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64844,increased,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64845,tomato,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64846,shoot,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64847,and,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64848,root,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64849,dry,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64850,weight,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
64851,.,O,2256.0,"In control and ISWs - treated soils , dry matter yield of tomato grown in the presence of wheat straw was significantly restricted , while the application of rice husk increased tomato shoot and root dry weight ."
65187,We,O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65188,explored,O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65189,this,O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65190,paradox,O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65191,by,O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65192,looking,O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65193,at,O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65194,alcohol,O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65195,",",O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65196,diet,O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65197,",",O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65198,and,O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65199,mortality,O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65200,data,O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65201,from,O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65202,21,O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65203,developed,O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65204,",",O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65205,relatively,O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65206,affluent,O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65207,countries,O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65208,in,O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65209,the,O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65210,years,O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65211,1965,O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65212,",",O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65213,1970,O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65214,",",O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65215,1980,O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65216,",",O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65217,and,O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65218,1988,O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65219,.,O,2270.0,"We explored this paradox by looking at alcohol , diet , and mortality data from 21 developed , relatively affluent countries in the years 1965 , 1970 , 1980 , and 1988 ."
65377,Thus,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65378,",",O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65379,while,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65380,the,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65381,risk,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65382,/,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65383,benefit,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65384,ratio,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65385,varies,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65386,for,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65387,individuals,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65388,",",O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65389,the,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65390,use,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65391,of,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65392,alcohol,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65393,for,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65394,cardioprotective,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65395,purposes,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65396,should,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65397,not,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65398,be,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65399,encouraged,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65400,as,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65401,a,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65402,public,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65403,health,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65404,measure,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65405,.,O,2280.0,"Thus , while the risk / benefit ratio varies for individuals , the use of alcohol for cardioprotective purposes should not be encouraged as a public health measure ."
65738,The,O,2292.0,The decreasing trend was significant for beer intake .
65739,decreasing,O,2292.0,The decreasing trend was significant for beer intake .
65740,trend,O,2292.0,The decreasing trend was significant for beer intake .
65741,was,O,2292.0,The decreasing trend was significant for beer intake .
65742,significant,O,2292.0,The decreasing trend was significant for beer intake .
65743,for,O,2292.0,The decreasing trend was significant for beer intake .
65744,beer,B-http://purl.bioontology.org/ontology/SNOMEDCT/53410008,2292.0,The decreasing trend was significant for beer intake .
65745,intake,O,2292.0,The decreasing trend was significant for beer intake .
65746,.,O,2292.0,The decreasing trend was significant for beer intake .
66067,Male,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66068,Sprague,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66069,-,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66070,Dawley,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66071,rats,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66072,were,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66073,divided,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66074,into,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66075,3,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66076,groups,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66077,",",O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66078,an,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66079,ethanol,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66080,(,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66081,13.5,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66082,%,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66083,alcohol,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66084,),O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66085,group,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66086,",",O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66087,a,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66088,red,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66089,wine,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66090,(,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66091,Castle,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66092,Rock,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66093,Pinot,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66094,Noir,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66095,",",O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66096,13.5,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66097,%,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66098,alcohol,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66099,),O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66100,group,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66101,",",O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66102,and,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66103,a,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66104,control,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66105,group,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66106,.,O,2305.0,"Male Sprague - Dawley rats were divided into 3 groups , an ethanol ( 13.5 % alcohol ) group , a red wine ( Castle Rock Pinot Noir , 13.5 % alcohol ) group , and a control group ."
66425,Furthermore,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66426,",",O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66427,strawberry,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66428,extracts,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66429,have,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66430,been,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66431,shown,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66432,to,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66433,inhibit,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66434,COX,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66435,enzymes,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66436,in,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66437,vitro,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66438,",",O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66439,which,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66440,would,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66441,modulate,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66442,the,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66443,inflammatory,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66444,process,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66445,.,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66496,Cancer,O,2322.0,Cancer is one of the leading causes of death worldwide .
66497,is,O,2322.0,Cancer is one of the leading causes of death worldwide .
66498,one,O,2322.0,Cancer is one of the leading causes of death worldwide .
66499,of,O,2322.0,Cancer is one of the leading causes of death worldwide .
66500,the,O,2322.0,Cancer is one of the leading causes of death worldwide .
66501,leading,O,2322.0,Cancer is one of the leading causes of death worldwide .
66502,causes,O,2322.0,Cancer is one of the leading causes of death worldwide .
66503,of,O,2322.0,Cancer is one of the leading causes of death worldwide .
66504,death,O,2322.0,Cancer is one of the leading causes of death worldwide .
66505,worldwide,O,2322.0,Cancer is one of the leading causes of death worldwide .
66506,.,O,2322.0,Cancer is one of the leading causes of death worldwide .
66709,An,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66710,association,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66711,between,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66712,alcohol,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66713,consumption,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66714,and,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66715,prostate,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66716,cancer,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66717,risk,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66718,remains,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66719,uncertain,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66720,.,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66877,White,B-http://purl.bioontology.org/ontology/SNOMEDCT/67990004;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2335.0,White wine consumption was associated with increased risk ( HR for any vs. no white wine consumption = 1.27 ; CI = 1.08 - 1.49 ) .
66878,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/67990004;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2335.0,White wine consumption was associated with increased risk ( HR for any vs. no white wine consumption = 1.27 ; CI = 1.08 - 1.49 ) .
66879,consumption,O,2335.0,White wine consumption was associated with increased risk ( HR for any vs. no white wine consumption = 1.27 ; CI = 1.08 - 1.49 ) .
66880,was,O,2335.0,White wine consumption was associated with increased risk ( HR for any vs. no white wine consumption = 1.27 ; CI = 1.08 - 1.49 ) .
66881,associated,O,2335.0,White wine consumption was associated with increased risk ( HR for any vs. no white wine consumption = 1.27 ; CI = 1.08 - 1.49 ) .
66882,with,O,2335.0,White wine consumption was associated with increased risk ( HR for any vs. no white wine consumption = 1.27 ; CI = 1.08 - 1.49 ) .
66883,increased,O,2335.0,White wine consumption was associated with increased risk ( HR for any vs. no white wine consumption = 1.27 ; CI = 1.08 - 1.49 ) .
66884,risk,O,2335.0,White wine consumption was associated with increased risk ( HR for any vs. no white wine consumption = 1.27 ; CI = 1.08 - 1.49 ) .
66885,(,O,2335.0,White wine consumption was associated with increased risk ( HR for any vs. no white wine consumption = 1.27 ; CI = 1.08 - 1.49 ) .
66886,HR,O,2335.0,White wine consumption was associated with increased risk ( HR for any vs. no white wine consumption = 1.27 ; CI = 1.08 - 1.49 ) .
66887,for,O,2335.0,White wine consumption was associated with increased risk ( HR for any vs. no white wine consumption = 1.27 ; CI = 1.08 - 1.49 ) .
66888,any,O,2335.0,White wine consumption was associated with increased risk ( HR for any vs. no white wine consumption = 1.27 ; CI = 1.08 - 1.49 ) .
66889,vs.,O,2335.0,White wine consumption was associated with increased risk ( HR for any vs. no white wine consumption = 1.27 ; CI = 1.08 - 1.49 ) .
66890,no,O,2335.0,White wine consumption was associated with increased risk ( HR for any vs. no white wine consumption = 1.27 ; CI = 1.08 - 1.49 ) .
66891,white,B-http://purl.bioontology.org/ontology/SNOMEDCT/67990004;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2335.0,White wine consumption was associated with increased risk ( HR for any vs. no white wine consumption = 1.27 ; CI = 1.08 - 1.49 ) .
66892,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/67990004;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2335.0,White wine consumption was associated with increased risk ( HR for any vs. no white wine consumption = 1.27 ; CI = 1.08 - 1.49 ) .
66893,consumption,O,2335.0,White wine consumption was associated with increased risk ( HR for any vs. no white wine consumption = 1.27 ; CI = 1.08 - 1.49 ) .
66894,=,O,2335.0,White wine consumption was associated with increased risk ( HR for any vs. no white wine consumption = 1.27 ; CI = 1.08 - 1.49 ) .
66895,1.27,O,2335.0,White wine consumption was associated with increased risk ( HR for any vs. no white wine consumption = 1.27 ; CI = 1.08 - 1.49 ) .
66896,;,O,2335.0,White wine consumption was associated with increased risk ( HR for any vs. no white wine consumption = 1.27 ; CI = 1.08 - 1.49 ) .
66897,CI,O,2335.0,White wine consumption was associated with increased risk ( HR for any vs. no white wine consumption = 1.27 ; CI = 1.08 - 1.49 ) .
66898,=,O,2335.0,White wine consumption was associated with increased risk ( HR for any vs. no white wine consumption = 1.27 ; CI = 1.08 - 1.49 ) .
66899,1.08,O,2335.0,White wine consumption was associated with increased risk ( HR for any vs. no white wine consumption = 1.27 ; CI = 1.08 - 1.49 ) .
66900,-,O,2335.0,White wine consumption was associated with increased risk ( HR for any vs. no white wine consumption = 1.27 ; CI = 1.08 - 1.49 ) .
66901,1.49,O,2335.0,White wine consumption was associated with increased risk ( HR for any vs. no white wine consumption = 1.27 ; CI = 1.08 - 1.49 ) .
66902,),O,2335.0,White wine consumption was associated with increased risk ( HR for any vs. no white wine consumption = 1.27 ; CI = 1.08 - 1.49 ) .
66903,.,O,2335.0,White wine consumption was associated with increased risk ( HR for any vs. no white wine consumption = 1.27 ; CI = 1.08 - 1.49 ) .
67054,Red,B-http://purl.bioontology.org/ontology/SNOMEDCT/226757003;http://purl.bioontology.org/ontology/SNOMEDCT/67324005,2341.0,Red rice produced a slower digestion rate than white rice .
67055,rice,I-http://purl.bioontology.org/ontology/SNOMEDCT/226757003;http://purl.bioontology.org/ontology/SNOMEDCT/67324005,2341.0,Red rice produced a slower digestion rate than white rice .
67056,produced,O,2341.0,Red rice produced a slower digestion rate than white rice .
67057,a,O,2341.0,Red rice produced a slower digestion rate than white rice .
67058,slower,O,2341.0,Red rice produced a slower digestion rate than white rice .
67059,digestion,O,2341.0,Red rice produced a slower digestion rate than white rice .
67060,rate,O,2341.0,Red rice produced a slower digestion rate than white rice .
67061,than,O,2341.0,Red rice produced a slower digestion rate than white rice .
67062,white,B-http://purl.bioontology.org/ontology/SNOMEDCT/226759000;http://purl.bioontology.org/ontology/SNOMEDCT/67324005,2341.0,Red rice produced a slower digestion rate than white rice .
67063,rice,I-http://purl.bioontology.org/ontology/SNOMEDCT/226759000;http://purl.bioontology.org/ontology/SNOMEDCT/67324005,2341.0,Red rice produced a slower digestion rate than white rice .
67064,.,O,2341.0,Red rice produced a slower digestion rate than white rice .
67272,To,O,2350.0,"To identify reasons for the high incidence rates of stomach cancer in Poland , we conducted a population - based case - control study in Warsaw ."
67273,identify,O,2350.0,"To identify reasons for the high incidence rates of stomach cancer in Poland , we conducted a population - based case - control study in Warsaw ."
67274,reasons,O,2350.0,"To identify reasons for the high incidence rates of stomach cancer in Poland , we conducted a population - based case - control study in Warsaw ."
67275,for,O,2350.0,"To identify reasons for the high incidence rates of stomach cancer in Poland , we conducted a population - based case - control study in Warsaw ."
67276,the,O,2350.0,"To identify reasons for the high incidence rates of stomach cancer in Poland , we conducted a population - based case - control study in Warsaw ."
67277,high,O,2350.0,"To identify reasons for the high incidence rates of stomach cancer in Poland , we conducted a population - based case - control study in Warsaw ."
67278,incidence,O,2350.0,"To identify reasons for the high incidence rates of stomach cancer in Poland , we conducted a population - based case - control study in Warsaw ."
67279,rates,O,2350.0,"To identify reasons for the high incidence rates of stomach cancer in Poland , we conducted a population - based case - control study in Warsaw ."
67280,of,O,2350.0,"To identify reasons for the high incidence rates of stomach cancer in Poland , we conducted a population - based case - control study in Warsaw ."
67281,stomach,O,2350.0,"To identify reasons for the high incidence rates of stomach cancer in Poland , we conducted a population - based case - control study in Warsaw ."
67282,cancer,O,2350.0,"To identify reasons for the high incidence rates of stomach cancer in Poland , we conducted a population - based case - control study in Warsaw ."
67283,in,O,2350.0,"To identify reasons for the high incidence rates of stomach cancer in Poland , we conducted a population - based case - control study in Warsaw ."
67284,Poland,O,2350.0,"To identify reasons for the high incidence rates of stomach cancer in Poland , we conducted a population - based case - control study in Warsaw ."
67285,",",O,2350.0,"To identify reasons for the high incidence rates of stomach cancer in Poland , we conducted a population - based case - control study in Warsaw ."
67286,we,O,2350.0,"To identify reasons for the high incidence rates of stomach cancer in Poland , we conducted a population - based case - control study in Warsaw ."
67287,conducted,O,2350.0,"To identify reasons for the high incidence rates of stomach cancer in Poland , we conducted a population - based case - control study in Warsaw ."
67288,a,O,2350.0,"To identify reasons for the high incidence rates of stomach cancer in Poland , we conducted a population - based case - control study in Warsaw ."
67289,population,O,2350.0,"To identify reasons for the high incidence rates of stomach cancer in Poland , we conducted a population - based case - control study in Warsaw ."
67290,-,O,2350.0,"To identify reasons for the high incidence rates of stomach cancer in Poland , we conducted a population - based case - control study in Warsaw ."
67291,based,O,2350.0,"To identify reasons for the high incidence rates of stomach cancer in Poland , we conducted a population - based case - control study in Warsaw ."
67292,case,O,2350.0,"To identify reasons for the high incidence rates of stomach cancer in Poland , we conducted a population - based case - control study in Warsaw ."
67293,-,O,2350.0,"To identify reasons for the high incidence rates of stomach cancer in Poland , we conducted a population - based case - control study in Warsaw ."
67294,control,O,2350.0,"To identify reasons for the high incidence rates of stomach cancer in Poland , we conducted a population - based case - control study in Warsaw ."
67295,study,O,2350.0,"To identify reasons for the high incidence rates of stomach cancer in Poland , we conducted a population - based case - control study in Warsaw ."
67296,in,O,2350.0,"To identify reasons for the high incidence rates of stomach cancer in Poland , we conducted a population - based case - control study in Warsaw ."
67297,Warsaw,O,2350.0,"To identify reasons for the high incidence rates of stomach cancer in Poland , we conducted a population - based case - control study in Warsaw ."
67298,.,O,2350.0,"To identify reasons for the high incidence rates of stomach cancer in Poland , we conducted a population - based case - control study in Warsaw ."
68125,However,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68126,",",O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68127,there,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68128,has,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68129,been,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68130,increasing,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68131,interest,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68132,in,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68133,wheat,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68134,gluten,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68135,over,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68136,the,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68137,past,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68138,two,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68139,decades,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68140,because,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68141,of,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68142,its,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68143,well,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68144,-,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68145,established,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68146,role,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68147,in,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68148,triggering,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68149,coeliac,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68150,disease,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68151,",",O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68152,and,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68153,its,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68154,perceived,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68155,role,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68156,in,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68157,other,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68158,adverse,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68159,reactions,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68160,to,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68161,wheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/412071004,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68162,.,O,2379.0,"However , there has been increasing interest in wheat gluten over the past two decades because of its well - established role in triggering coeliac disease , and its perceived role in other adverse reactions to wheat ."
68736,Reductions,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68737,in,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68738,the,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68739,different,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68740,types,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68741,of,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68742,discretionary,B-http://purl.bioontology.org/ontology/SNOMEDCT/255620007,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68743,food,I-http://purl.bioontology.org/ontology/SNOMEDCT/255620007,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68744,were,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68745,modelled,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68746,individually,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68747,to,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68748,estimate,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68749,the,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68750,impact,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68751,on,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68752,energy,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68753,consumption,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68754,and,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68755,population,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68756,body,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68757,weight,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68758,by,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68759,5,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68760,-,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68761,year,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68762,age,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68763,and,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68764,sex,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68765,groups,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
68766,.,O,2398.0,Reductions in the different types of discretionary food were modelled individually to estimate the impact on energy consumption and population body weight by 5 - year age and sex groups .
69088,Raw,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69089,materials,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69090,used,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69091,as,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69092,ingredients,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69093,of,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69094,gluten,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69095,-,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69096,free,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69097,products,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69098,were,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69099,limited,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69100,to,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69101,five,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69102,varieties,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69103,:,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69104,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69105,",",O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69106,cassava,B-http://purl.bioontology.org/ontology/SNOMEDCT/227234000,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69107,",",O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69108,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/412357001,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69109,",",O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69110,soy,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69111,",",O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69112,and,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69113,potato,B-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69114,.,O,2407.0,"Raw materials used as ingredients of gluten - free products were limited to five varieties : rice , cassava , corn , soy , and potato ."
69115,Sugar,O,2408.0,Sugar was the most frequently mentioned ingredient on both types of products ' labels .
69116,was,O,2408.0,Sugar was the most frequently mentioned ingredient on both types of products ' labels .
69117,the,O,2408.0,Sugar was the most frequently mentioned ingredient on both types of products ' labels .
69118,most,O,2408.0,Sugar was the most frequently mentioned ingredient on both types of products ' labels .
69119,frequently,O,2408.0,Sugar was the most frequently mentioned ingredient on both types of products ' labels .
69120,mentioned,O,2408.0,Sugar was the most frequently mentioned ingredient on both types of products ' labels .
69121,ingredient,O,2408.0,Sugar was the most frequently mentioned ingredient on both types of products ' labels .
69122,on,O,2408.0,Sugar was the most frequently mentioned ingredient on both types of products ' labels .
69123,both,O,2408.0,Sugar was the most frequently mentioned ingredient on both types of products ' labels .
69124,types,O,2408.0,Sugar was the most frequently mentioned ingredient on both types of products ' labels .
69125,of,O,2408.0,Sugar was the most frequently mentioned ingredient on both types of products ' labels .
69126,products,O,2408.0,Sugar was the most frequently mentioned ingredient on both types of products ' labels .
69127,',O,2408.0,Sugar was the most frequently mentioned ingredient on both types of products ' labels .
69128,labels,O,2408.0,Sugar was the most frequently mentioned ingredient on both types of products ' labels .
69129,.,O,2408.0,Sugar was the most frequently mentioned ingredient on both types of products ' labels .
69391,The,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69392,glycemic,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69393,index,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69394,concept,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69395,remains,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69396,discriminating,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69397,",",O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69398,even,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69399,in,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69400,the,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69401,context,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69402,of,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69403,an,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69404,iso,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69405,-,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69406,glucido,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69407,-,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69408,lipido,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69409,-,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69410,protidic,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69411,meal,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69412,.,O,2418.0,"The glycemic index concept remains discriminating , even in the context of an iso - glucido - lipido - protidic meal ."
69517,In,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69518,Northern,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69519,Nigeria,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69520,(,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69521,where,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69522,the,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69523,Hausas,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69524,and,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69525,Fulanis,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69526,are,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69527,the,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69528,dominant,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69529,ethnic,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69530,groups,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69531,),O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69532,",",O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69533,grains,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69534,such,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69535,as,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69536,sorghum,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69537,",",O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69538,millet,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69539,form,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69540,the,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69541,main,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69542,diet,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69543,;,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69544,these,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69545,are,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69546,served,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69547,with,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69548,palm,B-http://purl.bioontology.org/ontology/SNOMEDCT/226907001;http://purl.bioontology.org/ontology/SNOMEDCT/227566009,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69549,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/226907001;http://purl.bioontology.org/ontology/SNOMEDCT/227566009,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69550,based,I-http://purl.bioontology.org/ontology/SNOMEDCT/226907001;http://purl.bioontology.org/ontology/SNOMEDCT/227566009,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69551,soup,I-http://purl.bioontology.org/ontology/SNOMEDCT/226907001;http://purl.bioontology.org/ontology/SNOMEDCT/227566009,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69552,made,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69553,with,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69554,tomatoes,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69555,and,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69556,okra,B-http://purl.bioontology.org/ontology/SNOMEDCT/227254004,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69557,.,O,2423.0,"In Northern Nigeria ( where the Hausas and Fulanis are the dominant ethnic groups ) , grains such as sorghum , millet form the main diet ; these are served with palm oil based soup made with tomatoes and okra ."
69643,A,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69644,review,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69645,of,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69646,the,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69647,literature,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69648,on,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69649,Nigerian,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69650,cultural,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69651,diets,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69652,identified,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69653,gaps,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69654,in,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69655,knowledge,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69656,with,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69657,respect,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69658,to,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69659,the,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69660,nutritional,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69661,values,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69662,of,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69663,Nigerian,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69664,ethnic,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69665,diets,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
69666,.,O,2428.0,A review of the literature on Nigerian cultural diets identified gaps in knowledge with respect to the nutritional values of Nigerian ethnic diets .
70005,The,O,2439.0,The latter societies have a higher incidence of these cancers than Asians and vegetarians .
70006,latter,O,2439.0,The latter societies have a higher incidence of these cancers than Asians and vegetarians .
70007,societies,O,2439.0,The latter societies have a higher incidence of these cancers than Asians and vegetarians .
70008,have,O,2439.0,The latter societies have a higher incidence of these cancers than Asians and vegetarians .
70009,a,O,2439.0,The latter societies have a higher incidence of these cancers than Asians and vegetarians .
70010,higher,O,2439.0,The latter societies have a higher incidence of these cancers than Asians and vegetarians .
70011,incidence,O,2439.0,The latter societies have a higher incidence of these cancers than Asians and vegetarians .
70012,of,O,2439.0,The latter societies have a higher incidence of these cancers than Asians and vegetarians .
70013,these,O,2439.0,The latter societies have a higher incidence of these cancers than Asians and vegetarians .
70014,cancers,O,2439.0,The latter societies have a higher incidence of these cancers than Asians and vegetarians .
70015,than,O,2439.0,The latter societies have a higher incidence of these cancers than Asians and vegetarians .
70016,Asians,O,2439.0,The latter societies have a higher incidence of these cancers than Asians and vegetarians .
70017,and,O,2439.0,The latter societies have a higher incidence of these cancers than Asians and vegetarians .
70018,vegetarians,O,2439.0,The latter societies have a higher incidence of these cancers than Asians and vegetarians .
70019,.,O,2439.0,The latter societies have a higher incidence of these cancers than Asians and vegetarians .
70455,In,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70456,addition,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70457,",",O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70458,dietary,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70459,EW,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70460,and,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70461,EWH,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70462,decreased,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70463,stearoyl,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70464,-,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70465,CoA,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70466,desaturase,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70467,(,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70468,SCD,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70469,),O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70470,indices,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70471,and,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70472,glucose-6,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70473,-,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70474,phosphate,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70475,dehydrogenase,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70476,activity,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70477,of,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70478,the,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70479,liver,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70480,and,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70481,gastrocnemius,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70482,muscle,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70483,.,O,2455.0,"In addition , dietary EW and EWH decreased stearoyl - CoA desaturase ( SCD ) indices and glucose-6 - phosphate dehydrogenase activity of the liver and gastrocnemius muscle ."
70712,Consumption,O,2464.0,Consumption of reduced - fat milk was associated with reduced relative risk .
70713,of,O,2464.0,Consumption of reduced - fat milk was associated with reduced relative risk .
70714,reduced,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2464.0,Consumption of reduced - fat milk was associated with reduced relative risk .
70715,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2464.0,Consumption of reduced - fat milk was associated with reduced relative risk .
70716,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2464.0,Consumption of reduced - fat milk was associated with reduced relative risk .
70717,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2464.0,Consumption of reduced - fat milk was associated with reduced relative risk .
70718,was,O,2464.0,Consumption of reduced - fat milk was associated with reduced relative risk .
70719,associated,O,2464.0,Consumption of reduced - fat milk was associated with reduced relative risk .
70720,with,O,2464.0,Consumption of reduced - fat milk was associated with reduced relative risk .
70721,reduced,O,2464.0,Consumption of reduced - fat milk was associated with reduced relative risk .
70722,relative,O,2464.0,Consumption of reduced - fat milk was associated with reduced relative risk .
70723,risk,O,2464.0,Consumption of reduced - fat milk was associated with reduced relative risk .
70724,.,O,2464.0,Consumption of reduced - fat milk was associated with reduced relative risk .
71434,In,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71435,this,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71436,specific,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71437,study,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71438,",",O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71439,1182,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71440,adults,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71441,(,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71442,545,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71443,males,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71444,",",O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71445,45·9,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71446,%,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71447,),O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71448,had,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71449,dietary,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71450,data,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71451,collected,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71452,using,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71453,a,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71454,FFQ,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71455,and,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71456,also,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71457,had,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71458,BMD,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71459,measurements,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71460,taken,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71461,using,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71462,dual,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71463,-,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71464,energy,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71465,X,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71466,-,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71467,ray,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71468,absorptiometry,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71469,.,O,2485.0,"In this specific study , 1182 adults ( 545 males , 45·9 % ) had dietary data collected using a FFQ and also had BMD measurements taken using dual - energy X - ray absorptiometry ."
71891,Milk,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71892,fat,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71893,",",O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71894,protein,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71895,",",O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71896,casein,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71897,",",O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71898,and,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71899,somatic,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71900,cell,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71901,count,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71902,concentration,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71903,and,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71904,curd,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71905,-,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71906,firming,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71907,time,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71908,showed,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71909,a,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71910,significant,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71911,interaction,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71912,between,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71913,treatment,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71914,and,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71915,sampling,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71916,date,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71917,.,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
72624,Compared,O,2524.0,"Compared with cabbage , lettuce and spinach , this wild vegetable contained more protein and fat , while the fibre content was less ."
72625,with,O,2524.0,"Compared with cabbage , lettuce and spinach , this wild vegetable contained more protein and fat , while the fibre content was less ."
72626,cabbage,B-http://purl.bioontology.org/ontology/SNOMEDCT/735108004,2524.0,"Compared with cabbage , lettuce and spinach , this wild vegetable contained more protein and fat , while the fibre content was less ."
72627,",",O,2524.0,"Compared with cabbage , lettuce and spinach , this wild vegetable contained more protein and fat , while the fibre content was less ."
72628,lettuce,B-http://purl.bioontology.org/ontology/SNOMEDCT/735042006,2524.0,"Compared with cabbage , lettuce and spinach , this wild vegetable contained more protein and fat , while the fibre content was less ."
72629,and,O,2524.0,"Compared with cabbage , lettuce and spinach , this wild vegetable contained more protein and fat , while the fibre content was less ."
72630,spinach,B-http://purl.bioontology.org/ontology/SNOMEDCT/256329006,2524.0,"Compared with cabbage , lettuce and spinach , this wild vegetable contained more protein and fat , while the fibre content was less ."
72631,",",O,2524.0,"Compared with cabbage , lettuce and spinach , this wild vegetable contained more protein and fat , while the fibre content was less ."
72632,this,O,2524.0,"Compared with cabbage , lettuce and spinach , this wild vegetable contained more protein and fat , while the fibre content was less ."
72633,wild,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,2524.0,"Compared with cabbage , lettuce and spinach , this wild vegetable contained more protein and fat , while the fibre content was less ."
72634,vegetable,I-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,2524.0,"Compared with cabbage , lettuce and spinach , this wild vegetable contained more protein and fat , while the fibre content was less ."
72635,contained,O,2524.0,"Compared with cabbage , lettuce and spinach , this wild vegetable contained more protein and fat , while the fibre content was less ."
72636,more,O,2524.0,"Compared with cabbage , lettuce and spinach , this wild vegetable contained more protein and fat , while the fibre content was less ."
72637,protein,O,2524.0,"Compared with cabbage , lettuce and spinach , this wild vegetable contained more protein and fat , while the fibre content was less ."
72638,and,O,2524.0,"Compared with cabbage , lettuce and spinach , this wild vegetable contained more protein and fat , while the fibre content was less ."
72639,fat,O,2524.0,"Compared with cabbage , lettuce and spinach , this wild vegetable contained more protein and fat , while the fibre content was less ."
72640,",",O,2524.0,"Compared with cabbage , lettuce and spinach , this wild vegetable contained more protein and fat , while the fibre content was less ."
72641,while,O,2524.0,"Compared with cabbage , lettuce and spinach , this wild vegetable contained more protein and fat , while the fibre content was less ."
72642,the,O,2524.0,"Compared with cabbage , lettuce and spinach , this wild vegetable contained more protein and fat , while the fibre content was less ."
72643,fibre,O,2524.0,"Compared with cabbage , lettuce and spinach , this wild vegetable contained more protein and fat , while the fibre content was less ."
72644,content,O,2524.0,"Compared with cabbage , lettuce and spinach , this wild vegetable contained more protein and fat , while the fibre content was less ."
72645,was,O,2524.0,"Compared with cabbage , lettuce and spinach , this wild vegetable contained more protein and fat , while the fibre content was less ."
72646,less,O,2524.0,"Compared with cabbage , lettuce and spinach , this wild vegetable contained more protein and fat , while the fibre content was less ."
72647,.,O,2524.0,"Compared with cabbage , lettuce and spinach , this wild vegetable contained more protein and fat , while the fibre content was less ."
73268,Future,O,2545.0,Future studies with larger samples are needed to further clarify the effects of garlic used at higher but non - toxic doses on specific groups .
73269,studies,O,2545.0,Future studies with larger samples are needed to further clarify the effects of garlic used at higher but non - toxic doses on specific groups .
73270,with,O,2545.0,Future studies with larger samples are needed to further clarify the effects of garlic used at higher but non - toxic doses on specific groups .
73271,larger,O,2545.0,Future studies with larger samples are needed to further clarify the effects of garlic used at higher but non - toxic doses on specific groups .
73272,samples,O,2545.0,Future studies with larger samples are needed to further clarify the effects of garlic used at higher but non - toxic doses on specific groups .
73273,are,O,2545.0,Future studies with larger samples are needed to further clarify the effects of garlic used at higher but non - toxic doses on specific groups .
73274,needed,O,2545.0,Future studies with larger samples are needed to further clarify the effects of garlic used at higher but non - toxic doses on specific groups .
73275,to,O,2545.0,Future studies with larger samples are needed to further clarify the effects of garlic used at higher but non - toxic doses on specific groups .
73276,further,O,2545.0,Future studies with larger samples are needed to further clarify the effects of garlic used at higher but non - toxic doses on specific groups .
73277,clarify,O,2545.0,Future studies with larger samples are needed to further clarify the effects of garlic used at higher but non - toxic doses on specific groups .
73278,the,O,2545.0,Future studies with larger samples are needed to further clarify the effects of garlic used at higher but non - toxic doses on specific groups .
73279,effects,O,2545.0,Future studies with larger samples are needed to further clarify the effects of garlic used at higher but non - toxic doses on specific groups .
73280,of,O,2545.0,Future studies with larger samples are needed to further clarify the effects of garlic used at higher but non - toxic doses on specific groups .
73281,garlic,B-http://purl.bioontology.org/ontology/SNOMEDCT/735030001,2545.0,Future studies with larger samples are needed to further clarify the effects of garlic used at higher but non - toxic doses on specific groups .
73282,used,O,2545.0,Future studies with larger samples are needed to further clarify the effects of garlic used at higher but non - toxic doses on specific groups .
73283,at,O,2545.0,Future studies with larger samples are needed to further clarify the effects of garlic used at higher but non - toxic doses on specific groups .
73284,higher,O,2545.0,Future studies with larger samples are needed to further clarify the effects of garlic used at higher but non - toxic doses on specific groups .
73285,but,O,2545.0,Future studies with larger samples are needed to further clarify the effects of garlic used at higher but non - toxic doses on specific groups .
73286,non,O,2545.0,Future studies with larger samples are needed to further clarify the effects of garlic used at higher but non - toxic doses on specific groups .
73287,-,O,2545.0,Future studies with larger samples are needed to further clarify the effects of garlic used at higher but non - toxic doses on specific groups .
73288,toxic,O,2545.0,Future studies with larger samples are needed to further clarify the effects of garlic used at higher but non - toxic doses on specific groups .
73289,doses,O,2545.0,Future studies with larger samples are needed to further clarify the effects of garlic used at higher but non - toxic doses on specific groups .
73290,on,O,2545.0,Future studies with larger samples are needed to further clarify the effects of garlic used at higher but non - toxic doses on specific groups .
73291,specific,O,2545.0,Future studies with larger samples are needed to further clarify the effects of garlic used at higher but non - toxic doses on specific groups .
73292,groups,O,2545.0,Future studies with larger samples are needed to further clarify the effects of garlic used at higher but non - toxic doses on specific groups .
73293,.,O,2545.0,Future studies with larger samples are needed to further clarify the effects of garlic used at higher but non - toxic doses on specific groups .
73415,The,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73416,medians,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73417,of,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73418,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73419,",",O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73420,yogurt,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73421,and,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73422,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73423,consumption,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73424,were,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73425,293,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73426,(,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73427,interquartile,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73428,range,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73429,(,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73430,IQR,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73431,),O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73432,146,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73433,-,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73434,439,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73435,),O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73436,",",O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73437,35·3,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73438,(,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73439,IQR,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73440,8·8,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73441,-,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73442,71·8,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73443,),O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73444,and,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73445,14·6,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73446,(,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73447,IQR,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73448,4·8,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73449,-,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73450,26·9,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73451,),O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73452,g,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73453,/,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73454,d,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73455,",",O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73456,respectively,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73457,.,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73538,Our,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73539,findings,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73540,suggest,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73541,that,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73542,the,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73543,influence,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73544,of,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73545,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73546,consumption,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73547,on,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73548,lean,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73549,mass,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73550,and,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73551,of,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73552,low,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73553,-,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73554,fat,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73555,dairy,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73556,consumption,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73557,on,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73558,fat,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73559,mass,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73560,distribution,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73561,may,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73562,be,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73563,potential,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73564,pathways,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73565,for,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73566,the,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73567,link,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73568,between,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73569,dairy,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73570,consumption,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73571,and,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73572,metabolic,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73573,risk,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73574,.,O,2555.0,Our findings suggest that the influence of milk consumption on lean mass and of low - fat dairy consumption on fat mass distribution may be potential pathways for the link between dairy consumption and metabolic risk .
73833,These,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73834,results,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73835,indicate,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73836,that,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73837,the,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73838,insulin,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73839,response,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73840,can,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73841,not,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73842,be,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73843,predicted,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73844,by,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73845,the,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73846,glucose,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73847,response,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73848,.,O,2564.0,These results indicate that the insulin response can not be predicted by the glucose response .
73918,Dietary,O,2569.0,Dietary patterns were derived using factor analysis .
73919,patterns,O,2569.0,Dietary patterns were derived using factor analysis .
73920,were,O,2569.0,Dietary patterns were derived using factor analysis .
73921,derived,O,2569.0,Dietary patterns were derived using factor analysis .
73922,using,O,2569.0,Dietary patterns were derived using factor analysis .
73923,factor,O,2569.0,Dietary patterns were derived using factor analysis .
73924,analysis,O,2569.0,Dietary patterns were derived using factor analysis .
73925,.,O,2569.0,Dietary patterns were derived using factor analysis .
74279,An,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74280,association,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74281,between,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74282,allergy,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74283,to,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74284,latex,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74285,and,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74286,allergy,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74287,to,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74288,various,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74289,fruits,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74290,has,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74291,been,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74292,reported,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74293,.,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74445,Of,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74446,326,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74447,atopic,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74448,children,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74449,",",O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74450,10,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74451,(,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74452,3,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74453,%,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74454,),O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74455,presented,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74456,positive,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74457,skin,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74458,test,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74459,to,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74460,latex,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74461,",",O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74462,but,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74463,only,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74464,five,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74465,(,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74466,1.5,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74467,%,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74468,),O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74469,also,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74470,had,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74471,a,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74472,positive,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74473,clinical,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74474,history,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74475,to,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74476,latex,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74477,exposure,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74478,.,O,2585.0,"Of 326 atopic children , 10 ( 3 % ) presented positive skin test to latex , but only five ( 1.5 % ) also had a positive clinical history to latex exposure ."
74586,Apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74587,",",O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74588,kiwi,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74589,",",O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74590,and,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74591,chestnut,B-http://purl.bioontology.org/ontology/SNOMEDCT/260188004,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74592,were,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74593,the,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74594,most,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74595,common,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74596,SPT,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74597,-,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74598,positive,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74599,foods,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74600,.,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74701,To,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74702,date,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74703,",",O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74704,over,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74705,"10,000",O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74706, ,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74707,PAs,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74708,poisoning,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74709,cases,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74710,have,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74711,been,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74712,reported,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74713,worldwide,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74714,.,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74744,This,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74745,review,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74746,summarized,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74747,the,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74748,contamination,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74749,of,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74750,PAs,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74751,in,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74752,foods,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74753,",",O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74754,state,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74755,of,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74756,the,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74757,art,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74758,detection,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74759,methods,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74760,and,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74761,regulations,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74762,by,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74763,different,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74764,countries,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74765,and,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74766,authorities,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74767,",",O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74768,hoping,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74769,to,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74770,propose,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74771,effective,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74772,solutions,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74773,to,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74774,minimize,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74775,the,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74776,consumption,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74777,of,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74778,PAs,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74779,in,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74780,food,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74781,.,O,2598.0,"This review summarized the contamination of PAs in foods , state of the art detection methods and regulations by different countries and authorities , hoping to propose effective solutions to minimize the consumption of PAs in food ."
74990,The,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
74991,intake,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
74992,estimates,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
74993,indicated,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
74994,an,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
74995,increase,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
74996,in,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
74997,mean,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
74998,folic,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
74999,acid,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
75000,intake,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
75001,of,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
75002,159,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
75003, ,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
75004,μg,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
75005,per,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
75006,day,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
75007,for,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
75008,the,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
75009,target,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
75010,group,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
75011,.,O,2606.0,The intake estimates indicated an increase in mean folic acid intake of 159   μg per day for the target group .
75107,Changes,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75108,in,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75109,the,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75110,chemical,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75111,modification,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75112,of,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75113,the,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75114,milk,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75115,protein,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75116,were,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75117,monitored,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75118,by,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75119,measuring,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75120,the,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75121,protein,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75122,-,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75123,bound,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75124,carbonyls,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75125,and,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75126,PAGE,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75127,protein,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75128,profiles,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75129,.,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75335,There,O,2619.0,There is also a likely underrecognized association between poor salt intake and the mentioned electrolyte and acid - base abnormality .
75336,is,O,2619.0,There is also a likely underrecognized association between poor salt intake and the mentioned electrolyte and acid - base abnormality .
75337,also,O,2619.0,There is also a likely underrecognized association between poor salt intake and the mentioned electrolyte and acid - base abnormality .
75338,a,O,2619.0,There is also a likely underrecognized association between poor salt intake and the mentioned electrolyte and acid - base abnormality .
75339,likely,O,2619.0,There is also a likely underrecognized association between poor salt intake and the mentioned electrolyte and acid - base abnormality .
75340,underrecognized,O,2619.0,There is also a likely underrecognized association between poor salt intake and the mentioned electrolyte and acid - base abnormality .
75341,association,O,2619.0,There is also a likely underrecognized association between poor salt intake and the mentioned electrolyte and acid - base abnormality .
75342,between,O,2619.0,There is also a likely underrecognized association between poor salt intake and the mentioned electrolyte and acid - base abnormality .
75343,poor,O,2619.0,There is also a likely underrecognized association between poor salt intake and the mentioned electrolyte and acid - base abnormality .
75344,salt,O,2619.0,There is also a likely underrecognized association between poor salt intake and the mentioned electrolyte and acid - base abnormality .
75345,intake,O,2619.0,There is also a likely underrecognized association between poor salt intake and the mentioned electrolyte and acid - base abnormality .
75346,and,O,2619.0,There is also a likely underrecognized association between poor salt intake and the mentioned electrolyte and acid - base abnormality .
75347,the,O,2619.0,There is also a likely underrecognized association between poor salt intake and the mentioned electrolyte and acid - base abnormality .
75348,mentioned,O,2619.0,There is also a likely underrecognized association between poor salt intake and the mentioned electrolyte and acid - base abnormality .
75349,electrolyte,O,2619.0,There is also a likely underrecognized association between poor salt intake and the mentioned electrolyte and acid - base abnormality .
75350,and,O,2619.0,There is also a likely underrecognized association between poor salt intake and the mentioned electrolyte and acid - base abnormality .
75351,acid,O,2619.0,There is also a likely underrecognized association between poor salt intake and the mentioned electrolyte and acid - base abnormality .
75352,-,O,2619.0,There is also a likely underrecognized association between poor salt intake and the mentioned electrolyte and acid - base abnormality .
75353,base,O,2619.0,There is also a likely underrecognized association between poor salt intake and the mentioned electrolyte and acid - base abnormality .
75354,abnormality,O,2619.0,There is also a likely underrecognized association between poor salt intake and the mentioned electrolyte and acid - base abnormality .
75355,.,O,2619.0,There is also a likely underrecognized association between poor salt intake and the mentioned electrolyte and acid - base abnormality .
75537,Since,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75538,1982,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75539,",",O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75540,13,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75541,further,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75542,publications,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75543,reported,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75544,additional,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75545,cases,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75546,of,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75547,dietary,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75548,chloride,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75549,depletion,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75550,.,O,2626.0,"Since 1982 , 13 further publications reported additional cases of dietary chloride depletion ."
75709,This,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75710,paradoxical,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75711,situation,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75712,can,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75713,be,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75714,explained,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75715,by,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75716,expanded,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75717,access,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75718,to,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75719,clinical,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75720,care,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75721,",",O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75722,increased,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75723,consumption,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75724,of,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75725,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75726,and,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75727,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75728,",",O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75729,improved,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75730,control,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75731,of,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75732,hypertension,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75733,",",O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75734,and,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75735,a,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75736,reduction,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75737,in,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75738,cigarette,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75739,smoking,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75740,.,O,2633.0,"This paradoxical situation can be explained by expanded access to clinical care , increased consumption of fruit and fish , improved control of hypertension , and a reduction in cigarette smoking ."
75881,The,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75882,diet,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75883,is,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75884,characterized,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75885,by,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75886,abundant,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75887,plant,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75888,foods,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75889,(,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75890,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75891,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75892,vegetables,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75893,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75894,breads,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75895,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75896,other,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75897,forms,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75898,of,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75899,cereals,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75900,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75901,potatoes,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75902,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75903,beans,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75904,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75905,nuts,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75906,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75907,and,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75908,seeds,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75909,),O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75910,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75911,fresh,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75912,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75913,as,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75914,the,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75915,typical,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75916,daily,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75917,dessert,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75918,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75919,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75920,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75921,as,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75922,the,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75923,principal,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75924,source,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75925,of,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75926,fat,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75927,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75928,dairy,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75929,products,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75930,(,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75931,principally,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75932,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75933,and,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75934,yogurt,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75935,),O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75936,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75937,and,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75938,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75939,and,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75940,poultry,B-http://purl.bioontology.org/ontology/SNOMEDCT/28230009,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75941,consumed,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75942,in,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75943,low,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75944,to,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75945,moderate,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75946,amounts,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75947,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75948,zero,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75949,to,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75950,four,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75951,eggs,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75952,consumed,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75953,weekly,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75954,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75955,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75956,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75957,consumed,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75958,in,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75959,low,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75960,amounts,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75961,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75962,and,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75963,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75964,consumed,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75965,in,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75966,low,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75967,to,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75968,moderate,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75969,amounts,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75970,",",O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75971,normally,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75972,with,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75973,meals,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
75974,.,O,2639.0,"The diet is characterized by abundant plant foods ( fruit , vegetables , breads , other forms of cereals , potatoes , beans , nuts , and seeds ) , fresh fruit as the typical daily dessert , olive oil as the principal source of fat , dairy products ( principally cheese and yogurt ) , and fish and poultry consumed in low to moderate amounts , zero to four eggs consumed weekly , red meat consumed in low amounts , and wine consumed in low to moderate amounts , normally with meals ."
76012,The,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76013,pyramid,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76014,describes,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76015,a,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76016,dietary,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76017,pattern,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76018,that,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76019,is,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76020,attractive,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76021,for,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76022,its,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76023,famous,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76024,palatability,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76025,as,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76026,well,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76027,as,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76028,for,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76029,its,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76030,health,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76031,benefits,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76032,.,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76033,Consumption,O,2642.0,"Consumption of beef , pork , and lamb has traditionally been low in Mediterranean countries ."
76034,of,O,2642.0,"Consumption of beef , pork , and lamb has traditionally been low in Mediterranean countries ."
76035,beef,B-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,2642.0,"Consumption of beef , pork , and lamb has traditionally been low in Mediterranean countries ."
76036,",",O,2642.0,"Consumption of beef , pork , and lamb has traditionally been low in Mediterranean countries ."
76037,pork,B-http://purl.bioontology.org/ontology/SNOMEDCT/226934003,2642.0,"Consumption of beef , pork , and lamb has traditionally been low in Mediterranean countries ."
76038,",",O,2642.0,"Consumption of beef , pork , and lamb has traditionally been low in Mediterranean countries ."
76039,and,O,2642.0,"Consumption of beef , pork , and lamb has traditionally been low in Mediterranean countries ."
76040,lamb,B-http://purl.bioontology.org/ontology/SNOMEDCT/226942002,2642.0,"Consumption of beef , pork , and lamb has traditionally been low in Mediterranean countries ."
76041,has,O,2642.0,"Consumption of beef , pork , and lamb has traditionally been low in Mediterranean countries ."
76042,traditionally,O,2642.0,"Consumption of beef , pork , and lamb has traditionally been low in Mediterranean countries ."
76043,been,O,2642.0,"Consumption of beef , pork , and lamb has traditionally been low in Mediterranean countries ."
76044,low,O,2642.0,"Consumption of beef , pork , and lamb has traditionally been low in Mediterranean countries ."
76045,in,O,2642.0,"Consumption of beef , pork , and lamb has traditionally been low in Mediterranean countries ."
76046,Mediterranean,O,2642.0,"Consumption of beef , pork , and lamb has traditionally been low in Mediterranean countries ."
76047,countries,O,2642.0,"Consumption of beef , pork , and lamb has traditionally been low in Mediterranean countries ."
76048,.,O,2642.0,"Consumption of beef , pork , and lamb has traditionally been low in Mediterranean countries ."
76289,Nonlinear,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76290,mixed,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76291,-,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76292,effects,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76293,modeling,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76294,(,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76295,NLME,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76296,),O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76297,has,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76298,been,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76299,advocated,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76300,as,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76301,a,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76302,suitable,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76303,pharmaco,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76304,-,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76305,statistical,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76306,method,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76307,for,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76308,the,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76309,study,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76310,of,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76311,drug,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76312,residues,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76313,in,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76314,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76315,.,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76514,Using,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76515,NLME,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76516,and,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76517,PBPK,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76518,models,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76519,",",O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76520,we,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76521,identified,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76522,factors,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76523,associated,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76524,with,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76525,changes,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76526,in,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76527,pirlimycin,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76528,milk,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76529,residues,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76530,that,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76531,may,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76532,affect,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76533,food,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76534,safety,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76535,.,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76822,A,O,2668.0,A dietary survey was carried out in Mazanderan Province of the Caspian Littoral of Iran .
76823,dietary,O,2668.0,A dietary survey was carried out in Mazanderan Province of the Caspian Littoral of Iran .
76824,survey,O,2668.0,A dietary survey was carried out in Mazanderan Province of the Caspian Littoral of Iran .
76825,was,O,2668.0,A dietary survey was carried out in Mazanderan Province of the Caspian Littoral of Iran .
76826,carried,O,2668.0,A dietary survey was carried out in Mazanderan Province of the Caspian Littoral of Iran .
76827,out,O,2668.0,A dietary survey was carried out in Mazanderan Province of the Caspian Littoral of Iran .
76828,in,O,2668.0,A dietary survey was carried out in Mazanderan Province of the Caspian Littoral of Iran .
76829,Mazanderan,O,2668.0,A dietary survey was carried out in Mazanderan Province of the Caspian Littoral of Iran .
76830,Province,O,2668.0,A dietary survey was carried out in Mazanderan Province of the Caspian Littoral of Iran .
76831,of,O,2668.0,A dietary survey was carried out in Mazanderan Province of the Caspian Littoral of Iran .
76832,the,O,2668.0,A dietary survey was carried out in Mazanderan Province of the Caspian Littoral of Iran .
76833,Caspian,O,2668.0,A dietary survey was carried out in Mazanderan Province of the Caspian Littoral of Iran .
76834,Littoral,O,2668.0,A dietary survey was carried out in Mazanderan Province of the Caspian Littoral of Iran .
76835,of,O,2668.0,A dietary survey was carried out in Mazanderan Province of the Caspian Littoral of Iran .
76836,Iran,O,2668.0,A dietary survey was carried out in Mazanderan Province of the Caspian Littoral of Iran .
76837,.,O,2668.0,A dietary survey was carried out in Mazanderan Province of the Caspian Littoral of Iran .
77241,Contraceptive,O,2681.0,Contraceptive and fertility drugs are extensively and effectively used in humans as well as animals for different purposes .
77242,and,O,2681.0,Contraceptive and fertility drugs are extensively and effectively used in humans as well as animals for different purposes .
77243,fertility,O,2681.0,Contraceptive and fertility drugs are extensively and effectively used in humans as well as animals for different purposes .
77244,drugs,O,2681.0,Contraceptive and fertility drugs are extensively and effectively used in humans as well as animals for different purposes .
77245,are,O,2681.0,Contraceptive and fertility drugs are extensively and effectively used in humans as well as animals for different purposes .
77246,extensively,O,2681.0,Contraceptive and fertility drugs are extensively and effectively used in humans as well as animals for different purposes .
77247,and,O,2681.0,Contraceptive and fertility drugs are extensively and effectively used in humans as well as animals for different purposes .
77248,effectively,O,2681.0,Contraceptive and fertility drugs are extensively and effectively used in humans as well as animals for different purposes .
77249,used,O,2681.0,Contraceptive and fertility drugs are extensively and effectively used in humans as well as animals for different purposes .
77250,in,O,2681.0,Contraceptive and fertility drugs are extensively and effectively used in humans as well as animals for different purposes .
77251,humans,O,2681.0,Contraceptive and fertility drugs are extensively and effectively used in humans as well as animals for different purposes .
77252,as,O,2681.0,Contraceptive and fertility drugs are extensively and effectively used in humans as well as animals for different purposes .
77253,well,O,2681.0,Contraceptive and fertility drugs are extensively and effectively used in humans as well as animals for different purposes .
77254,as,O,2681.0,Contraceptive and fertility drugs are extensively and effectively used in humans as well as animals for different purposes .
77255,animals,O,2681.0,Contraceptive and fertility drugs are extensively and effectively used in humans as well as animals for different purposes .
77256,for,O,2681.0,Contraceptive and fertility drugs are extensively and effectively used in humans as well as animals for different purposes .
77257,different,O,2681.0,Contraceptive and fertility drugs are extensively and effectively used in humans as well as animals for different purposes .
77258,purposes,O,2681.0,Contraceptive and fertility drugs are extensively and effectively used in humans as well as animals for different purposes .
77259,.,O,2681.0,Contraceptive and fertility drugs are extensively and effectively used in humans as well as animals for different purposes .
77604,The,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77605,decreasing,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77606,mortality,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77607,rates,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77608,from,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77609,cerebrovascular,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77610,disease,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77611,are,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77612,thought,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77613,to,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77614,reflect,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77615,the,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77616,increases,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77617,in,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77618,animal,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77619,foods,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77620,",",O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77621,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77622,",",O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77623,and,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77624,dairy,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77625,products,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77626,and,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77627,consequently,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77628,in,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77629,saturated,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77630,fatty,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77631,acids,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77632,and,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77633,calcium,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77634,",",O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77635,together,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77636,with,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77637,a,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77638,decrease,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77639,in,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77640,salt,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77641,intake,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77642,which,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77643,may,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77644,have,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77645,led,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77646,to,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77647,a,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77648,decrease,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77649,in,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77650,blood,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77651,pressure,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77652,.,O,2693.0,"The decreasing mortality rates from cerebrovascular disease are thought to reflect the increases in animal foods , milk , and dairy products and consequently in saturated fatty acids and calcium , together with a decrease in salt intake which may have led to a decrease in blood pressure ."
77672,The,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77673,typical,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77674,Japanese,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77675,diet,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77676,as,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77677,characterized,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77678,by,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77679,plant,B-http://purl.bioontology.org/ontology/SNOMEDCT/255620007,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77680,food,I-http://purl.bioontology.org/ontology/SNOMEDCT/255620007,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77681,and,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77682,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77683,as,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77684,well,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77685,as,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77686,modest,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77687,Westernized,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77688,diet,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77689,such,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77690,as,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77691,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77692,",",O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77693,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77694,and,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77695,dairy,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77696,products,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77697,might,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77698,be,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77699,associated,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77700,with,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77701,longevity,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77702,in,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77703,Japan,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77704,.,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
78011,Ovarian,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78012,cancer,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78013,is,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78014,commonly,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78015,a,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78016,fatal,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78017,disease,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78018,and,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78019,",",O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78020,despite,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78021,advances,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78022,in,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78023,screening,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78024,and,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78025,treatment,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78026,",",O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78027,the,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78028,lack,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78029,of,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78030,understanding,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78031,of,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78032,the,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78033,underlying,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78034,etiology,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78035,has,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78036,limited,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78037,prevention,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78038,strategies,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78039,.,O,2706.0,"Ovarian cancer is commonly a fatal disease and , despite advances in screening and treatment , the lack of understanding of the underlying etiology has limited prevention strategies ."
78812,The,O,2733.0,The protective effect may exist aside from the influence of caffeine intake .
78813,protective,O,2733.0,The protective effect may exist aside from the influence of caffeine intake .
78814,effect,O,2733.0,The protective effect may exist aside from the influence of caffeine intake .
78815,may,O,2733.0,The protective effect may exist aside from the influence of caffeine intake .
78816,exist,O,2733.0,The protective effect may exist aside from the influence of caffeine intake .
78817,aside,O,2733.0,The protective effect may exist aside from the influence of caffeine intake .
78818,from,O,2733.0,The protective effect may exist aside from the influence of caffeine intake .
78819,the,O,2733.0,The protective effect may exist aside from the influence of caffeine intake .
78820,influence,O,2733.0,The protective effect may exist aside from the influence of caffeine intake .
78821,of,O,2733.0,The protective effect may exist aside from the influence of caffeine intake .
78822,caffeine,O,2733.0,The protective effect may exist aside from the influence of caffeine intake .
78823,intake,O,2733.0,The protective effect may exist aside from the influence of caffeine intake .
78824,.,O,2733.0,The protective effect may exist aside from the influence of caffeine intake .
78881,Consistent,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78882,positive,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78883,associations,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78884,were,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78885,observed,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78886,with,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78887,more,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78888,frequent,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78889,consumption,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78890,of,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78891,bread,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78892,(,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78893,odds,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78894,ratio,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78895,",",O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78896,OR,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78897,=,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78898,2.1,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78899,for,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78900,colon,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78901,and,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78902,2.2,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78903,for,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78904,rectum,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78905,for,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78906,highest,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78907,vs.,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78908,lowest,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78909,tertile,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78910,),O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78911,",",O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78912,polenta,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78913,(,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78914,OR,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78915,=,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78916,2.1,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78917,for,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78918,colon,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78919,",",O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78920,1.9,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78921,for,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78922,rectum,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78923,),O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78924,",",O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78925,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78926,(,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78927,OR,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78928,=,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78929,1.7,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78930,for,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78931,colon,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78932,",",O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78933,1.8,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78934,for,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78935,rectum,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78936,),O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78937,and,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78938,eggs,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78939,(,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78940,2.5,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78941,for,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78942,colon,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78943,",",O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78944,1.9,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78945,for,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78946,rectum,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78947,),O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78948,",",O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78949,whereas,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78950,reduced,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78951,ORs,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78952,were,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78953,observed,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78954,in,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78955,subjects,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78956,reporting,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78957,more,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78958,frequent,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78959,consumption,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78960,of,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78961,tomatoes,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78962,(,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78963,OR,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78964,=,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78965,0.5,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78966,for,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78967,colon,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78968,and,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78969,0.4,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78970,for,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78971,rectum,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78972,),O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
78973,.,O,2735.0,"Consistent positive associations were observed with more frequent consumption of bread ( odds ratio , OR = 2.1 for colon and 2.2 for rectum for highest vs. lowest tertile ) , polenta ( OR = 2.1 for colon , 1.9 for rectum ) , cheese ( OR = 1.7 for colon , 1.8 for rectum ) and eggs ( 2.5 for colon , 1.9 for rectum ) , whereas reduced ORs were observed in subjects reporting more frequent consumption of tomatoes ( OR = 0.5 for colon and 0.4 for rectum ) ."
79071,Raisins,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79072,are,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79073,dried,B-http://purl.bioontology.org/ontology/SNOMEDCT/256317002,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79074,grapes,I-http://purl.bioontology.org/ontology/SNOMEDCT/256317002,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79075,consumed,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79076,worldwide,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79077,that,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79078,contain,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79079,beneficial,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79080,components,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79081,for,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79082,human,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79083,health,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79084,.,O,2738.0,Raisins are dried grapes consumed worldwide that contain beneficial components for human health .
79930,Red,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79931,foods,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79932,contain,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79933,lycopene,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79934,",",O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79935,the,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79936,pigment,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79937,in,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79938,tomatoes,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79939,",",O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79940,which,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79941,is,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79942,localized,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79943,in,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79944,the,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79945,prostate,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79946,gland,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79947,and,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79948,may,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79949,be,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79950,involved,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79951,in,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79952,maintaining,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79953,prostate,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79954,health,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79955,.,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
80195,Patients,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80196,with,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80197,RA,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80198,frequently,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80199,ask,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80200,their,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80201,doctors,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80202,about,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80203,which,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80204,diets,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80205,to,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80206,follow,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80207,",",O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80208,and,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80209,even,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80210,in,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80211,the,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80212,absence,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80213,of,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80214,advice,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80215,from,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80216,their,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80217,physicians,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80218,",",O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80219,many,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80220,patients,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80221,are,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80222,undertaking,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80223,various,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80224,dietary,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80225,interventions,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80226,.,O,2779.0,"Patients with RA frequently ask their doctors about which diets to follow , and even in the absence of advice from their physicians , many patients are undertaking various dietary interventions ."
80929,However,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80930,",",O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80931,the,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80932,masticated,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80933,and,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80934,digesta,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80935,particle,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80936,sizes,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80937,were,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80938,not,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80939,related,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80940,to,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80941,the,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80942,integrity,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80943,of,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80944,cell,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80945,walls,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80946,or,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80947,lipid,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80948,release,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80949,.,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
81071,The,O,2809.0,The exact nature of the protective effect remains to be established .
81072,exact,O,2809.0,The exact nature of the protective effect remains to be established .
81073,nature,O,2809.0,The exact nature of the protective effect remains to be established .
81074,of,O,2809.0,The exact nature of the protective effect remains to be established .
81075,the,O,2809.0,The exact nature of the protective effect remains to be established .
81076,protective,O,2809.0,The exact nature of the protective effect remains to be established .
81077,effect,O,2809.0,The exact nature of the protective effect remains to be established .
81078,remains,O,2809.0,The exact nature of the protective effect remains to be established .
81079,to,O,2809.0,The exact nature of the protective effect remains to be established .
81080,be,O,2809.0,The exact nature of the protective effect remains to be established .
81081,established,O,2809.0,The exact nature of the protective effect remains to be established .
81082,.,O,2809.0,The exact nature of the protective effect remains to be established .
81751,Measuring,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81752,specific,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81753,serum,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81754,IgE,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81755,levels,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81756,in,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81757,control,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81758,subjects,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81759,tolerant,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81760,to,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81761,egg,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81762,/,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81763,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81764,showed,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81765,that,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81766,false,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81767,positive,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81768,reactions,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81769,occurred,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81770,frequently,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81771,among,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81772,patients,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81773,with,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81774,another,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81775,food,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81776,allergy,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81777,and,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81778,atopic,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81779,dermatitis,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81780,",",O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81781,whereas,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81782,most,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81783,tests,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81784,were,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81785,likely,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81786,to,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81787,be,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81788,negative,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81789,in,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81790,pollen,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81791,-,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81792,allergic,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81793,and,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81794,nonallergic,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81795,volunteers,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
81796,.,O,2834.0,"Measuring specific serum IgE levels in control subjects tolerant to egg / milk showed that false positive reactions occurred frequently among patients with another food allergy and atopic dermatitis , whereas most tests were likely to be negative in pollen - allergic and nonallergic volunteers ."
82132,Furthermore,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82133,",",O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82134,vegetarians,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82135,tend,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82136,to,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82137,have,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82138,a,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82139,lower,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82140,body,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82141,mass,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82142,index,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82143,and,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82144,lower,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82145,overall,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82146,cancer,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82147,rates,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82148,.,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82707,Legumes,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82708,are,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82709,low,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82710,-,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82711,GI,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82712,foods,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82713,(,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82714,<,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82715,55,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82716,),O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82717,",",O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82718,ranging,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82719,from,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82720,6,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82721,(,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82722,chickpeas,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82723,),O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82724,to,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82725,13,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82726,(,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82727,mung,B-http://purl.bioontology.org/ontology/SNOMEDCT/227355001,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82728,beans,I-http://purl.bioontology.org/ontology/SNOMEDCT/227355001,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82729,),O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82730,.,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82766,We,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82767,conclude,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82768,that,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82769,mineral,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82770,availability,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82771,from,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82772,legumes,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82773,differs,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82774,and,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82775,may,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82776,be,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82777,attributed,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82778,to,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82779,their,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82780,mineral,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82781,content,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82782,",",O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82783,mineral,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82784,-,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82785,mineral,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82786,interaction,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82787,and,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82788,from,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82789,their,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82790,phytic,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82791,and,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82792,tannic,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82793,acid,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82794,content,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82795,;,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82796,legumes,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82797,are,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82798,considered,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82799,low,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82800,-,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82801,GI,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82802,foods,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82803,and,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82804,have,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82805,shown,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82806,potential,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82807,hypocholesterolaemic,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82808,effects,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
82809,.,O,2867.0,"We conclude that mineral availability from legumes differs and may be attributed to their mineral content , mineral - mineral interaction and from their phytic and tannic acid content ; legumes are considered low - GI foods and have shown potential hypocholesterolaemic effects ."
83071,Rats,O,2878.0,"Rats fed heme iron had higher Hb , delta Hb and liver Fe when fed high fat than low fat ."
83072,fed,O,2878.0,"Rats fed heme iron had higher Hb , delta Hb and liver Fe when fed high fat than low fat ."
83073,heme,O,2878.0,"Rats fed heme iron had higher Hb , delta Hb and liver Fe when fed high fat than low fat ."
83074,iron,O,2878.0,"Rats fed heme iron had higher Hb , delta Hb and liver Fe when fed high fat than low fat ."
83075,had,O,2878.0,"Rats fed heme iron had higher Hb , delta Hb and liver Fe when fed high fat than low fat ."
83076,higher,O,2878.0,"Rats fed heme iron had higher Hb , delta Hb and liver Fe when fed high fat than low fat ."
83077,Hb,O,2878.0,"Rats fed heme iron had higher Hb , delta Hb and liver Fe when fed high fat than low fat ."
83078,",",O,2878.0,"Rats fed heme iron had higher Hb , delta Hb and liver Fe when fed high fat than low fat ."
83079,delta,O,2878.0,"Rats fed heme iron had higher Hb , delta Hb and liver Fe when fed high fat than low fat ."
83080,Hb,O,2878.0,"Rats fed heme iron had higher Hb , delta Hb and liver Fe when fed high fat than low fat ."
83081,and,O,2878.0,"Rats fed heme iron had higher Hb , delta Hb and liver Fe when fed high fat than low fat ."
83082,liver,O,2878.0,"Rats fed heme iron had higher Hb , delta Hb and liver Fe when fed high fat than low fat ."
83083,Fe,O,2878.0,"Rats fed heme iron had higher Hb , delta Hb and liver Fe when fed high fat than low fat ."
83084,when,O,2878.0,"Rats fed heme iron had higher Hb , delta Hb and liver Fe when fed high fat than low fat ."
83085,fed,O,2878.0,"Rats fed heme iron had higher Hb , delta Hb and liver Fe when fed high fat than low fat ."
83086,high,O,2878.0,"Rats fed heme iron had higher Hb , delta Hb and liver Fe when fed high fat than low fat ."
83087,fat,O,2878.0,"Rats fed heme iron had higher Hb , delta Hb and liver Fe when fed high fat than low fat ."
83088,than,O,2878.0,"Rats fed heme iron had higher Hb , delta Hb and liver Fe when fed high fat than low fat ."
83089,low,O,2878.0,"Rats fed heme iron had higher Hb , delta Hb and liver Fe when fed high fat than low fat ."
83090,fat,O,2878.0,"Rats fed heme iron had higher Hb , delta Hb and liver Fe when fed high fat than low fat ."
83091,.,O,2878.0,"Rats fed heme iron had higher Hb , delta Hb and liver Fe when fed high fat than low fat ."
83342,The,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83343,highest,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83344,values,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83345,above,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83346,the,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83347,50th,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83348,percentile,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83349,of,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83350,these,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83351,minerals,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83352,",",O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83353,especially,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83354,lead,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83355,",",O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83356,were,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83357,observed,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83358,in,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83359,the,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83360,Borgo,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83361,area,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83362,.,O,2888.0,"The highest values above the 50th percentile of these minerals , especially lead , were observed in the Borgo area ."
83962,A,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83963,similar,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83964,effect,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83965,was,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83966,also,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83967,shown,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83968,for,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83969,rennet,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83970,casein,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83971,",",O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83972,whereas,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83973,inulin,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83974,and,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83975,polydextrose,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83976,had,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83977,little,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83978,or,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83979,no,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83980,effect,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83981,on,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83982,these,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83983,rheological,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83984,parameters,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83985,.,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83986,Corn,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83987,dextrin,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83988,had,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83989,no,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83990,effect,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83991,on,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83992,the,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83993,storage,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83994,and,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83995,loss,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83996,moduli,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83997,",",O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83998,but,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83999,affected,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
84000,the,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
84001,gel,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
84002,-,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
84003,sol,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
84004,transition,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
84005,temperature,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
84006,.,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
85175,Cancers,O,2951.0,Cancers of the nasopharynx and colon were significantly correlated with current and past diets .
85176,of,O,2951.0,Cancers of the nasopharynx and colon were significantly correlated with current and past diets .
85177,the,O,2951.0,Cancers of the nasopharynx and colon were significantly correlated with current and past diets .
85178,nasopharynx,O,2951.0,Cancers of the nasopharynx and colon were significantly correlated with current and past diets .
85179,and,O,2951.0,Cancers of the nasopharynx and colon were significantly correlated with current and past diets .
85180,colon,O,2951.0,Cancers of the nasopharynx and colon were significantly correlated with current and past diets .
85181,were,O,2951.0,Cancers of the nasopharynx and colon were significantly correlated with current and past diets .
85182,significantly,O,2951.0,Cancers of the nasopharynx and colon were significantly correlated with current and past diets .
85183,correlated,O,2951.0,Cancers of the nasopharynx and colon were significantly correlated with current and past diets .
85184,with,O,2951.0,Cancers of the nasopharynx and colon were significantly correlated with current and past diets .
85185,current,O,2951.0,Cancers of the nasopharynx and colon were significantly correlated with current and past diets .
85186,and,O,2951.0,Cancers of the nasopharynx and colon were significantly correlated with current and past diets .
85187,past,O,2951.0,Cancers of the nasopharynx and colon were significantly correlated with current and past diets .
85188,diets,O,2951.0,Cancers of the nasopharynx and colon were significantly correlated with current and past diets .
85189,.,O,2951.0,Cancers of the nasopharynx and colon were significantly correlated with current and past diets .
85397,There,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85398,are,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85399,two,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85400,at,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85401,-,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85402,risk,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85403,periods,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85404,in,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85405,the,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85406,lives,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85407,of,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85408,children,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85409,when,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85410,nutritional,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85411,education,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85412,procedures,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85413,as,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85414,well,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85415,as,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85416,diabetes,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85417,care,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85418,in,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85419,general,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85420,are,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85421,less,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85422,likely,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85423,to,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85424,be,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85425,effective,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85426,:,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85427,early,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85428,years,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85429,of,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85430,life,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85431,and,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85432,adolescence,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85433,.,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85520,Appropriate,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85521,nutritional,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85522,education,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85523,helps,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85524,children,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85525,with,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85526,diabetes,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85527,to,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85528,find,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85529,this,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85530,balance,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85531,and,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85532,enjoy,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85533,a,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85534,better,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85535,quality,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85536,of,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85537,life,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85538,.,O,2963.0,Appropriate nutritional education helps children with diabetes to find this balance and enjoy a better quality of life .
85873,The,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85874,Mushroom,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85875,Council,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85876,convened,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85877,the,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85878,Mushrooms,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85879,and,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85880,Health,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85881,Summit,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85882,in,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85883,Washington,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85884,",",O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85885,DC,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85886,",",O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85887,on,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85888,9,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85889,-,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85890,10,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85891,September,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85892,2013,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
85893,.,O,2974.0,"The Mushroom Council convened the Mushrooms and Health Summit in Washington , DC , on 9 - 10 September 2013 ."
86316,Following,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86317,ingestion,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86318,of,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86319,the,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86320,meals,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86321,containing,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86322,protein,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86323,",",O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86324,the,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86325,plasma,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86326,insulin,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86327,concentration,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86328,was,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86329,increased,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86330,further,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86331,and,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86332,remained,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86333,elevated,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86334,longer,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86335,compared,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86336,with,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86337,the,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86338,meal,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86339,containing,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86340,glucose,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86341,alone,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86342,.,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86691,Lowered,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86692,risk,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86693,was,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86694,also,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86695,related,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86696,to,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86697,consumption,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86698,of,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86699,spices,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86700,",",O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86701,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86702,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86703,and,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86704,garlic,B-http://purl.bioontology.org/ontology/SNOMEDCT/735030001,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86705,.,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86993,Treatment,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
86994,with,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
86995,camel,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
86996,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
86997,or,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
86998,bovine,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
86999,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87000,reversed,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87001,these,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87002,abnormalities,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87003,",",O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87004,resulting,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87005,in,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87006,weight,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87007,gain,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87008,",",O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87009,decreased,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87010,blood,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87011,glucose,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87012,levels,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87013,",",O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87014,and,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87015,improved,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87016,glucose,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87017,tolerance,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87018,.,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87048,Long,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87049,-,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87050,term,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87051,administration,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87052,of,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87053,camel,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87054,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87055,or,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87056,bovine,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87057,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87058,counteracted,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87059,streptozotocin,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87060,-,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87061,induced,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87062,metabolic,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87063,manifestations,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87064,in,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87065,rats,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87066,",",O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87067,maintained,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87068,platelet,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87069,function,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87070,",",O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87071,and,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87072,abolished,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87073,coagulopathy,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87074,-,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87075,associated,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87076,fibrinogen,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87077,consumption,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87078,.,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87601,At,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87602,all,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87603,study,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87604,time,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87605,points,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87606,",",O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87607,patients,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87608,categorized,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87609,as,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87610,high,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87611,ONS,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87612,consumers,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87613,(,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87614,>,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87615,15,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87616,%,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87617,of,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87618,total,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87619,daily,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87620,calories,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87621,from,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87622,ONS,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87623,),O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87624,had,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87625,higher,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87626,intakes,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87627,of,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87628,micronutrients,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87629,(,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87630,P,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87631,<,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87632,0.003,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87633,),O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87634,.,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87854,The,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87855,respective,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87856,mean,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87857,IGF,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87858,-,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87859,I,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87860,levels,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87861,were,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87862,213,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87863,",",O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87864,257,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87865,",",O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87866,and,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87867,255,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87868,ng,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87869,/,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87870,ml,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87871,for,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87872,Japanese,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87873,in,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87874,Japan,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87875,",",O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87876,Japanese,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87877,in,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87878,Hawaii,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87879,",",O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87880,and,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87881,Caucasians,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87882,in,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87883,Hawaii,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87884,.,O,3042.0,"The respective mean IGF - I levels were 213 , 257 , and 255 ng / ml for Japanese in Japan , Japanese in Hawaii , and Caucasians in Hawaii ."
87885,Tofu,B-http://purl.bioontology.org/ontology/SNOMEDCT/227365007,3043.0,"Tofu intake was higher in Japan than among Japanese and Caucasians in Hawaii ( 11.0 vs. 9.4 and 4.9 g/1,000 kcal ) ."
87886,intake,O,3043.0,"Tofu intake was higher in Japan than among Japanese and Caucasians in Hawaii ( 11.0 vs. 9.4 and 4.9 g/1,000 kcal ) ."
87887,was,O,3043.0,"Tofu intake was higher in Japan than among Japanese and Caucasians in Hawaii ( 11.0 vs. 9.4 and 4.9 g/1,000 kcal ) ."
87888,higher,O,3043.0,"Tofu intake was higher in Japan than among Japanese and Caucasians in Hawaii ( 11.0 vs. 9.4 and 4.9 g/1,000 kcal ) ."
87889,in,O,3043.0,"Tofu intake was higher in Japan than among Japanese and Caucasians in Hawaii ( 11.0 vs. 9.4 and 4.9 g/1,000 kcal ) ."
87890,Japan,O,3043.0,"Tofu intake was higher in Japan than among Japanese and Caucasians in Hawaii ( 11.0 vs. 9.4 and 4.9 g/1,000 kcal ) ."
87891,than,O,3043.0,"Tofu intake was higher in Japan than among Japanese and Caucasians in Hawaii ( 11.0 vs. 9.4 and 4.9 g/1,000 kcal ) ."
87892,among,O,3043.0,"Tofu intake was higher in Japan than among Japanese and Caucasians in Hawaii ( 11.0 vs. 9.4 and 4.9 g/1,000 kcal ) ."
87893,Japanese,O,3043.0,"Tofu intake was higher in Japan than among Japanese and Caucasians in Hawaii ( 11.0 vs. 9.4 and 4.9 g/1,000 kcal ) ."
87894,and,O,3043.0,"Tofu intake was higher in Japan than among Japanese and Caucasians in Hawaii ( 11.0 vs. 9.4 and 4.9 g/1,000 kcal ) ."
87895,Caucasians,O,3043.0,"Tofu intake was higher in Japan than among Japanese and Caucasians in Hawaii ( 11.0 vs. 9.4 and 4.9 g/1,000 kcal ) ."
87896,in,O,3043.0,"Tofu intake was higher in Japan than among Japanese and Caucasians in Hawaii ( 11.0 vs. 9.4 and 4.9 g/1,000 kcal ) ."
87897,Hawaii,O,3043.0,"Tofu intake was higher in Japan than among Japanese and Caucasians in Hawaii ( 11.0 vs. 9.4 and 4.9 g/1,000 kcal ) ."
87898,(,O,3043.0,"Tofu intake was higher in Japan than among Japanese and Caucasians in Hawaii ( 11.0 vs. 9.4 and 4.9 g/1,000 kcal ) ."
87899,11.0,O,3043.0,"Tofu intake was higher in Japan than among Japanese and Caucasians in Hawaii ( 11.0 vs. 9.4 and 4.9 g/1,000 kcal ) ."
87900,vs.,O,3043.0,"Tofu intake was higher in Japan than among Japanese and Caucasians in Hawaii ( 11.0 vs. 9.4 and 4.9 g/1,000 kcal ) ."
87901,9.4,O,3043.0,"Tofu intake was higher in Japan than among Japanese and Caucasians in Hawaii ( 11.0 vs. 9.4 and 4.9 g/1,000 kcal ) ."
87902,and,O,3043.0,"Tofu intake was higher in Japan than among Japanese and Caucasians in Hawaii ( 11.0 vs. 9.4 and 4.9 g/1,000 kcal ) ."
87903,4.9,O,3043.0,"Tofu intake was higher in Japan than among Japanese and Caucasians in Hawaii ( 11.0 vs. 9.4 and 4.9 g/1,000 kcal ) ."
87904,"g/1,000",O,3043.0,"Tofu intake was higher in Japan than among Japanese and Caucasians in Hawaii ( 11.0 vs. 9.4 and 4.9 g/1,000 kcal ) ."
87905,kcal,O,3043.0,"Tofu intake was higher in Japan than among Japanese and Caucasians in Hawaii ( 11.0 vs. 9.4 and 4.9 g/1,000 kcal ) ."
87906,),O,3043.0,"Tofu intake was higher in Japan than among Japanese and Caucasians in Hawaii ( 11.0 vs. 9.4 and 4.9 g/1,000 kcal ) ."
87907,.,O,3043.0,"Tofu intake was higher in Japan than among Japanese and Caucasians in Hawaii ( 11.0 vs. 9.4 and 4.9 g/1,000 kcal ) ."
88365,However,O,3062.0,"However , both groups were deficient ( less than two - thirds RDA ) in calcium , magnesium , vitamin B6 , vitamin B12 , and thiamin ."
88366,",",O,3062.0,"However , both groups were deficient ( less than two - thirds RDA ) in calcium , magnesium , vitamin B6 , vitamin B12 , and thiamin ."
88367,both,O,3062.0,"However , both groups were deficient ( less than two - thirds RDA ) in calcium , magnesium , vitamin B6 , vitamin B12 , and thiamin ."
88368,groups,O,3062.0,"However , both groups were deficient ( less than two - thirds RDA ) in calcium , magnesium , vitamin B6 , vitamin B12 , and thiamin ."
88369,were,O,3062.0,"However , both groups were deficient ( less than two - thirds RDA ) in calcium , magnesium , vitamin B6 , vitamin B12 , and thiamin ."
88370,deficient,O,3062.0,"However , both groups were deficient ( less than two - thirds RDA ) in calcium , magnesium , vitamin B6 , vitamin B12 , and thiamin ."
88371,(,O,3062.0,"However , both groups were deficient ( less than two - thirds RDA ) in calcium , magnesium , vitamin B6 , vitamin B12 , and thiamin ."
88372,less,O,3062.0,"However , both groups were deficient ( less than two - thirds RDA ) in calcium , magnesium , vitamin B6 , vitamin B12 , and thiamin ."
88373,than,O,3062.0,"However , both groups were deficient ( less than two - thirds RDA ) in calcium , magnesium , vitamin B6 , vitamin B12 , and thiamin ."
88374,two,O,3062.0,"However , both groups were deficient ( less than two - thirds RDA ) in calcium , magnesium , vitamin B6 , vitamin B12 , and thiamin ."
88375,-,O,3062.0,"However , both groups were deficient ( less than two - thirds RDA ) in calcium , magnesium , vitamin B6 , vitamin B12 , and thiamin ."
88376,thirds,O,3062.0,"However , both groups were deficient ( less than two - thirds RDA ) in calcium , magnesium , vitamin B6 , vitamin B12 , and thiamin ."
88377,RDA,O,3062.0,"However , both groups were deficient ( less than two - thirds RDA ) in calcium , magnesium , vitamin B6 , vitamin B12 , and thiamin ."
88378,),O,3062.0,"However , both groups were deficient ( less than two - thirds RDA ) in calcium , magnesium , vitamin B6 , vitamin B12 , and thiamin ."
88379,in,O,3062.0,"However , both groups were deficient ( less than two - thirds RDA ) in calcium , magnesium , vitamin B6 , vitamin B12 , and thiamin ."
88380,calcium,O,3062.0,"However , both groups were deficient ( less than two - thirds RDA ) in calcium , magnesium , vitamin B6 , vitamin B12 , and thiamin ."
88381,",",O,3062.0,"However , both groups were deficient ( less than two - thirds RDA ) in calcium , magnesium , vitamin B6 , vitamin B12 , and thiamin ."
88382,magnesium,O,3062.0,"However , both groups were deficient ( less than two - thirds RDA ) in calcium , magnesium , vitamin B6 , vitamin B12 , and thiamin ."
88383,",",O,3062.0,"However , both groups were deficient ( less than two - thirds RDA ) in calcium , magnesium , vitamin B6 , vitamin B12 , and thiamin ."
88384,vitamin,O,3062.0,"However , both groups were deficient ( less than two - thirds RDA ) in calcium , magnesium , vitamin B6 , vitamin B12 , and thiamin ."
88385,B6,O,3062.0,"However , both groups were deficient ( less than two - thirds RDA ) in calcium , magnesium , vitamin B6 , vitamin B12 , and thiamin ."
88386,",",O,3062.0,"However , both groups were deficient ( less than two - thirds RDA ) in calcium , magnesium , vitamin B6 , vitamin B12 , and thiamin ."
88387,vitamin,O,3062.0,"However , both groups were deficient ( less than two - thirds RDA ) in calcium , magnesium , vitamin B6 , vitamin B12 , and thiamin ."
88388,B12,O,3062.0,"However , both groups were deficient ( less than two - thirds RDA ) in calcium , magnesium , vitamin B6 , vitamin B12 , and thiamin ."
88389,",",O,3062.0,"However , both groups were deficient ( less than two - thirds RDA ) in calcium , magnesium , vitamin B6 , vitamin B12 , and thiamin ."
88390,and,O,3062.0,"However , both groups were deficient ( less than two - thirds RDA ) in calcium , magnesium , vitamin B6 , vitamin B12 , and thiamin ."
88391,thiamin,O,3062.0,"However , both groups were deficient ( less than two - thirds RDA ) in calcium , magnesium , vitamin B6 , vitamin B12 , and thiamin ."
88392,.,O,3062.0,"However , both groups were deficient ( less than two - thirds RDA ) in calcium , magnesium , vitamin B6 , vitamin B12 , and thiamin ."
88561,Six,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88562,multiparous,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88563,Holstein,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88564,cows,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88565,",",O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88566,averaging,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88567,49,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88568,kg,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88569,of,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88570,milk,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88571,/,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88572,d,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88573,",",O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88574,were,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88575,used,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88576,in,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88577,a,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88578,6,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88579,×,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88580,6,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88581,Latin,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88582,square,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88583,design,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88584,with,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88585,14,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88586,-,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88587,d,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88588,periods,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
88589,.,O,3070.0,"Six multiparous Holstein cows , averaging 49 kg of milk / d , were used in a 6 × 6 Latin square design with 14 - d periods ."
89519,Among,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89520,these,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89521,",",O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89522,chlorogenic,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89523,acids,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89524,(,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89525,CGAs,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89526,),O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89527,received,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89528,considerable,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89529,attention,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89530,for,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89531,their,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89532,wide,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89533,distribution,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89534,and,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89535,part,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89536,of,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89537,human,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89538,diet,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89539,with,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89540,potential,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89541,biological,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89542,effects,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89543,.,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89618,The,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89619,traditional,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89620,Chinese,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89621,medicinal,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89622,plants,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89623,such,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89624,as,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89625,flowers,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89626,and,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89627,buds,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89628,of,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89629,Lonicera,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89630,japonica,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89631,Thunb,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89632,and,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89633,the,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89634,leaves,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89635,of,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89636,Eucommia,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89637,ulmodies,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89638,contained,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89639,CGAs,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89640,as,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89641,bioactive,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89642,compound,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89643,.,O,3104.0,The traditional Chinese medicinal plants such as flowers and buds of Lonicera japonica Thunb and the leaves of Eucommia ulmodies contained CGAs as bioactive compound .
89921,Gluten,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89922,-,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89923,free,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89924,bread,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89925,quality,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89926,is,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89927,dependent,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89928,on,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89929,ingredients,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89930,and,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89931,additives,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89932,combination,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89933,",",O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89934,but,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89935,also,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89936,processing,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89937,can,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89938,provide,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89939,a,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89940,way,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89941,to,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89942,improve,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89943,bread,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89944,quality,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89945,.,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
90090,The,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90091,main,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90092,goal,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90093,of,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90094,this,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90095,study,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90096,was,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90097,to,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90098,estimate,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90099,group,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90100,rejection,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90101,thresholds,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90102,for,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90103,bitterness,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90104,in,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90105,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009;http://purl.bioontology.org/ontology/SNOMEDCT/227708009;http://purl.bioontology.org/ontology/SNOMEDCT/255621006,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90106,ice,I-http://purl.bioontology.org/ontology/SNOMEDCT/102262009;http://purl.bioontology.org/ontology/SNOMEDCT/227708009;http://purl.bioontology.org/ontology/SNOMEDCT/255621006,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90107,cream,I-http://purl.bioontology.org/ontology/SNOMEDCT/102262009;http://purl.bioontology.org/ontology/SNOMEDCT/227708009;http://purl.bioontology.org/ontology/SNOMEDCT/255621006,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90108,",",O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90109,and,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90110,to,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90111,see,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90112,if,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90113,solid,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90114,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90115,preferences,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90116,(,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90117,dark,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90118,vs.,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90119,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90120,),O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90121,generalized,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90122,to,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90123,ice,B-http://purl.bioontology.org/ontology/SNOMEDCT/227708009;http://purl.bioontology.org/ontology/SNOMEDCT/255621006,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90124,cream,I-http://purl.bioontology.org/ontology/SNOMEDCT/227708009;http://purl.bioontology.org/ontology/SNOMEDCT/255621006,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90125,.,O,3123.0,"The main goal of this study was to estimate group rejection thresholds for bitterness in chocolate ice cream , and to see if solid chocolate preferences ( dark vs. milk ) generalized to ice cream ."
90391,Based,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90392,on,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90393,available,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90394,data,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90395,",",O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90396,it,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90397,appears,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90398,that,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90399,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90400,",",O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90401,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90402,",",O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90403,and,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90404,yogurt,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90405,are,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90406,inversely,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90407,associated,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90408,with,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90409,cardiovascular,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90410,disease,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90411,risk,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90412,.,O,3132.0,"Based on available data , it appears that milk , cheese , and yogurt are inversely associated with cardiovascular disease risk ."
90511,The,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90512,concentrations,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90513,effects,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90514,of,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90515,sugars,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90516,(,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90517,trehalose,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90518,and,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90519,allose,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90520,),O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90521,and,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90522,oils,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90523,(,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90524,canola,B-http://purl.bioontology.org/ontology/SNOMEDCT/28942008;http://purl.bioontology.org/ontology/SNOMEDCT/735211005,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90525,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/28942008;http://purl.bioontology.org/ontology/SNOMEDCT/735211005,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90526,coconut,I-http://purl.bioontology.org/ontology/SNOMEDCT/28942008;http://purl.bioontology.org/ontology/SNOMEDCT/735211005,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90527,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/28942008;http://purl.bioontology.org/ontology/SNOMEDCT/735211005,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90528,),O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90529,on,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90530,the,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90531,characteristics,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90532,of,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90533,rice,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90534,starch,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90535,suspension,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90536,and,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90537,mechanical,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90538,properties,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90539,of,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90540,rice,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90541,starch,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90542,film,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90543,were,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90544,studied,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
90545,.,O,3136.0,The concentrations effects of sugars ( trehalose and allose ) and oils ( canola and coconut oil ) on the characteristics of rice starch suspension and mechanical properties of rice starch film were studied .
91269,Five,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91270,participants,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91271,ate,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91272,polyunsaturated,B-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91273,beef,I-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91274,and,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91275,dairy,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91276,products,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91277,during,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91278,the,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91279,first,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91280,experimental,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91281,period,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91282,and,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91283,their,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91284,saturated,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91285,counterparts,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91286,in,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91287,the,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91288,second,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91289,;,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91290,six,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91291,participants,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91292,ate,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91293,saturated,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91294,products,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91295,first,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91296,",",O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91297,then,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91298,polyunsaturated,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91299,.,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91621,Intakes,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91622,of,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91623,vitamin,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91624,C,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91625,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91626,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91627,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91628,0.0001,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91629,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91630,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91631,folate,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91632,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91633,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91634,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91635,0.0001,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91636,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91637,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91638,riboflavin,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91639,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91640,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91641,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91642,0.03,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91643,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91644,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91645,thiamine,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91646,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91647,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91648,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91649,0.0001,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91650,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91651,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91652,and,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91653,magnesium,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91654,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91655,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91656,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91657,0.0001,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91658,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91659,per,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91660,megajoule,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91661,increased,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91662,as,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91663,quartile,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91664,of,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91665,total,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91666,fat,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91667,intake,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91668,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91669,as,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91670,a,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91671,%,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91672,of,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91673,total,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91674,energy,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91675,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91676,decreased,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91677,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91678,reflecting,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91679,increased,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91680,intakes,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91681,of,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91682,cereals,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91683,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91684,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91685,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91686,0.002,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91687,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91688,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91689,pasta,B-http://purl.bioontology.org/ontology/SNOMEDCT/226740002,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91690,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91691,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91692,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91693,0.01,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91694,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91695,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91696,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91697,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91698,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91699,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91700,0.0001,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91701,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91702,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91703,pure,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91704,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91705,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91706,not,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91707,minced,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91708,or,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91709,meat,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91710,products,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91711,;,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91712,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91713,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91714,0.047,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91715,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91716,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91717,skim,B-http://purl.bioontology.org/ontology/SNOMEDCT/25743006;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91718,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/25743006;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91719,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91720,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91721,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91722,0.0001,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91723,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91724,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91725,and,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91726,skim,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91727,cheese,I-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91728,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91729,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91730,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91731,0.005,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91732,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91733,.,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
92020,In,O,3189.0,"In this regard , future prospects are to use frequent on - farm measurements of milk constituents for short - term automatic nutritional management ."
92021,this,O,3189.0,"In this regard , future prospects are to use frequent on - farm measurements of milk constituents for short - term automatic nutritional management ."
92022,regard,O,3189.0,"In this regard , future prospects are to use frequent on - farm measurements of milk constituents for short - term automatic nutritional management ."
92023,",",O,3189.0,"In this regard , future prospects are to use frequent on - farm measurements of milk constituents for short - term automatic nutritional management ."
92024,future,O,3189.0,"In this regard , future prospects are to use frequent on - farm measurements of milk constituents for short - term automatic nutritional management ."
92025,prospects,O,3189.0,"In this regard , future prospects are to use frequent on - farm measurements of milk constituents for short - term automatic nutritional management ."
92026,are,O,3189.0,"In this regard , future prospects are to use frequent on - farm measurements of milk constituents for short - term automatic nutritional management ."
92027,to,O,3189.0,"In this regard , future prospects are to use frequent on - farm measurements of milk constituents for short - term automatic nutritional management ."
92028,use,O,3189.0,"In this regard , future prospects are to use frequent on - farm measurements of milk constituents for short - term automatic nutritional management ."
92029,frequent,O,3189.0,"In this regard , future prospects are to use frequent on - farm measurements of milk constituents for short - term automatic nutritional management ."
92030,on,O,3189.0,"In this regard , future prospects are to use frequent on - farm measurements of milk constituents for short - term automatic nutritional management ."
92031,-,O,3189.0,"In this regard , future prospects are to use frequent on - farm measurements of milk constituents for short - term automatic nutritional management ."
92032,farm,O,3189.0,"In this regard , future prospects are to use frequent on - farm measurements of milk constituents for short - term automatic nutritional management ."
92033,measurements,O,3189.0,"In this regard , future prospects are to use frequent on - farm measurements of milk constituents for short - term automatic nutritional management ."
92034,of,O,3189.0,"In this regard , future prospects are to use frequent on - farm measurements of milk constituents for short - term automatic nutritional management ."
92035,milk,O,3189.0,"In this regard , future prospects are to use frequent on - farm measurements of milk constituents for short - term automatic nutritional management ."
92036,constituents,O,3189.0,"In this regard , future prospects are to use frequent on - farm measurements of milk constituents for short - term automatic nutritional management ."
92037,for,O,3189.0,"In this regard , future prospects are to use frequent on - farm measurements of milk constituents for short - term automatic nutritional management ."
92038,short,O,3189.0,"In this regard , future prospects are to use frequent on - farm measurements of milk constituents for short - term automatic nutritional management ."
92039,-,O,3189.0,"In this regard , future prospects are to use frequent on - farm measurements of milk constituents for short - term automatic nutritional management ."
92040,term,O,3189.0,"In this regard , future prospects are to use frequent on - farm measurements of milk constituents for short - term automatic nutritional management ."
92041,automatic,O,3189.0,"In this regard , future prospects are to use frequent on - farm measurements of milk constituents for short - term automatic nutritional management ."
92042,nutritional,O,3189.0,"In this regard , future prospects are to use frequent on - farm measurements of milk constituents for short - term automatic nutritional management ."
92043,management,O,3189.0,"In this regard , future prospects are to use frequent on - farm measurements of milk constituents for short - term automatic nutritional management ."
92044,.,O,3189.0,"In this regard , future prospects are to use frequent on - farm measurements of milk constituents for short - term automatic nutritional management ."
92092,Their,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92093,calibration,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92094,and,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92095,maintenance,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92096,requirements,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92097,have,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92098,to,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92099,be,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92100,checked,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92101,thoroughly,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92102,before,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92103,they,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92104,can,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92105,be,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92106,regularly,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92107,implemented,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92108,on,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92109,dairy,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92110,farms,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92111,.,O,3192.0,Their calibration and maintenance requirements have to be checked thoroughly before they can be regularly implemented on dairy farms .
92681,Osteoporotic,O,3215.0,"Osteoporotic bone fracture rates are highest in countries that consume the most dairy , calcium , and animal protein ."
92682,bone,O,3215.0,"Osteoporotic bone fracture rates are highest in countries that consume the most dairy , calcium , and animal protein ."
92683,fracture,O,3215.0,"Osteoporotic bone fracture rates are highest in countries that consume the most dairy , calcium , and animal protein ."
92684,rates,O,3215.0,"Osteoporotic bone fracture rates are highest in countries that consume the most dairy , calcium , and animal protein ."
92685,are,O,3215.0,"Osteoporotic bone fracture rates are highest in countries that consume the most dairy , calcium , and animal protein ."
92686,highest,O,3215.0,"Osteoporotic bone fracture rates are highest in countries that consume the most dairy , calcium , and animal protein ."
92687,in,O,3215.0,"Osteoporotic bone fracture rates are highest in countries that consume the most dairy , calcium , and animal protein ."
92688,countries,O,3215.0,"Osteoporotic bone fracture rates are highest in countries that consume the most dairy , calcium , and animal protein ."
92689,that,O,3215.0,"Osteoporotic bone fracture rates are highest in countries that consume the most dairy , calcium , and animal protein ."
92690,consume,O,3215.0,"Osteoporotic bone fracture rates are highest in countries that consume the most dairy , calcium , and animal protein ."
92691,the,O,3215.0,"Osteoporotic bone fracture rates are highest in countries that consume the most dairy , calcium , and animal protein ."
92692,most,O,3215.0,"Osteoporotic bone fracture rates are highest in countries that consume the most dairy , calcium , and animal protein ."
92693,dairy,O,3215.0,"Osteoporotic bone fracture rates are highest in countries that consume the most dairy , calcium , and animal protein ."
92694,",",O,3215.0,"Osteoporotic bone fracture rates are highest in countries that consume the most dairy , calcium , and animal protein ."
92695,calcium,O,3215.0,"Osteoporotic bone fracture rates are highest in countries that consume the most dairy , calcium , and animal protein ."
92696,",",O,3215.0,"Osteoporotic bone fracture rates are highest in countries that consume the most dairy , calcium , and animal protein ."
92697,and,O,3215.0,"Osteoporotic bone fracture rates are highest in countries that consume the most dairy , calcium , and animal protein ."
92698,animal,O,3215.0,"Osteoporotic bone fracture rates are highest in countries that consume the most dairy , calcium , and animal protein ."
92699,protein,O,3215.0,"Osteoporotic bone fracture rates are highest in countries that consume the most dairy , calcium , and animal protein ."
92700,.,O,3215.0,"Osteoporotic bone fracture rates are highest in countries that consume the most dairy , calcium , and animal protein ."
93128,A,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93129,dietary,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93130,case,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93131,-,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93132,control,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93133,study,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93134,based,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93135,on,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93136,818,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93137,newly,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93138,diagnosed,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93139,breast,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93140,cancer,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93141,(,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93142,BC,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93143,),O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93144,patients,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93145,was,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93146,conducted,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93147,in,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93148,Israel,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93149,between,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93150,1975,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93151,and,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93152,1978,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93153,.,O,3232.0,A dietary case - control study based on 818 newly diagnosed breast cancer ( BC ) patients was conducted in Israel between 1975 and 1978 .
93293,This,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93294,association,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93295,was,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93296,observed,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93297,in,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93298,all,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93299,3,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93300,ethnic,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93301,subgroups,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93302,studied,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93303,.,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93562,The,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93563,results,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93564,for,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93565,all,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93566,20,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93567,patients,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93568,show,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93569,that,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93570,uric,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93571,acid,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93572,crystallization,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93573,was,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93574,significantly,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93575,lower,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93576,following,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93577,the,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93578,consumption,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93579,of,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93580,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93581,powder,I-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93582,or,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93583,dark,B-http://purl.bioontology.org/ontology/SNOMEDCT/443931000124105;http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93584,chocolate,I-http://purl.bioontology.org/ontology/SNOMEDCT/443931000124105;http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93585,relative,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93586,to,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93587,baseline,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93588,or,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93589,following,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93590,the,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93591,consumption,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93592,of,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93593,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/227610000;http://purl.bioontology.org/ontology/SNOMEDCT/70813002;http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93594,chocolate,I-http://purl.bioontology.org/ontology/SNOMEDCT/227610000;http://purl.bioontology.org/ontology/SNOMEDCT/70813002;http://purl.bioontology.org/ontology/SNOMEDCT/102262009,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93595,.,O,3246.0,The results for all 20 patients show that uric acid crystallization was significantly lower following the consumption of chocolate powder or dark chocolate relative to baseline or following the consumption of milk chocolate .
93655,The,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93656,patient,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93657,had,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93658,had,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93659,anaphylactic,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93660,episodes,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93661,after,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93662,accidental,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93663,ingestion,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93664,of,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93665,raw,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93666,carrots,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93667,",",O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93668,but,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93669,she,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93670,tolerated,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93671,cooked,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93672,carrots,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93673,.,O,3249.0,"The patient had had anaphylactic episodes after accidental ingestion of raw carrots , but she tolerated cooked carrots ."
93884,If,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93885,shown,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93886,to,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93887,be,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93888,effective,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93889,",",O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93890,botanical,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93891,products,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93892,have,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93893,a,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93894,unique,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93895,position,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93896,in,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93897,potentially,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93898,aiding,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93899,the,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93900,general,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93901,public,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93902,in,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93903,regard,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93904,to,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93905,obesity,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93906,and,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93907,diabetes,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93908,.,O,3260.0,"If shown to be effective , botanical products have a unique position in potentially aiding the general public in regard to obesity and diabetes ."
93909,They,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93910,can,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93911,be,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93912,obtained,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93913,"""",O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93914,over,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93915,-,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93916,the,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93917,-,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93918,counter,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93919,"""",O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93920,and,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93921,may,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93922,have,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93923,less,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93924,side,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93925,effects,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93926,compared,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93927,to,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93928,many,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93929,synthetic,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93930,drugs,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
93931,.,O,3261.0,"They can be obtained "" over - the - counter "" and may have less side effects compared to many synthetic drugs ."
95180,This,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95181,review,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95182,is,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95183,intended,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95184,to,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95185,help,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95186,dietetics,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95187,professionals,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95188,alleviate,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95189,clients,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95190,',O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95191,fears,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95192,about,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95193,lactose,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95194,intolerance,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95195,and,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95196,recommend,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95197,dietary,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95198,strategies,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95199,to,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95200,improve,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95201,tolerance,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95202,to,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95203,lactose,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95204,.,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95399,Celery,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95400,-,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95401,birch,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95402,positive,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95403,patients,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95404,(,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95405,n,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95406,=,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95407,13,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95408,),O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95409,showed,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95410,negative,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95411,or,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95412,low,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95413,RASTs,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95414,to,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95415,heated,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95416,celery,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95417,extracts,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95418,and,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95419,to,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95420,stick,B-http://purl.bioontology.org/ontology/SNOMEDCT/256326004,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95421,celery,I-http://purl.bioontology.org/ontology/SNOMEDCT/256326004,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95422,.,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95602,Subjects,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95603,are,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95604,"477,312",O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95605,men,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95606,and,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95607,women,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95608,mostly,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95609,aged,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95610,35,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95611,to,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95612,70,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95613,years,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95614,participating,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95615,in,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95616,the,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95617,EPIC,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95618,cohort,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95619,",",O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95620,including,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95621,683,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95622,gastric,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95623,adenocarcinomas,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95624,with,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95625,11,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95626,years,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95627,of,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95628,follow,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95629,-,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95630,up,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95631,.,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95759,Although,O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95760,calibration,O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95761,revealed,O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95762,somewhat,O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95763,stronger,O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95764,inverse,O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95765,associations,O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95766,",",O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95767,none,O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95768,of,O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95769,the,O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95770,risks,O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95771,reached,O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95772,statistical,O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95773,significance,O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95774,.,O,3317.0,"Although calibration revealed somewhat stronger inverse associations , none of the risks reached statistical significance ."
95775,There,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95776,was,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95777,no,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95778,association,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95779,between,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95780,total,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95781,or,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95782,specific,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95783,vegetables,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95784,intake,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95785,and,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95786,GC,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95787,risk,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
95788,.,O,3318.0,There was no association between total or specific vegetables intake and GC risk .
96029,Prolamin,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96030,fractions,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96031,showed,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96032,higher,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96033,gluten,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96034,recovery,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96035,compared,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96036,to,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96037,their,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96038,respective,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96039,glutelin,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96040,fractions,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96041,.,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96110,The,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96111,knowledge,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96112,of,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96113,uranium,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96114,concentration,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96115,",",O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96116,in,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96117,the,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96118,products,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96119,entering,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96120,the,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96121,human,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96122,diet,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96123,is,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96124,of,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96125,extreme,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96126,importance,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96127,because,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96128,of,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96129,their,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96130,chemical,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96131,hazard,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96132,to,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96133,health,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96134,.,O,3334.0,"The knowledge of uranium concentration , in the products entering the human diet is of extreme importance because of their chemical hazard to health ."
96583,Furthermore,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96584,",",O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96585,fermentation,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96586,and,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96587,fortification,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96588,of,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96589,dairy,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96590,products,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96591,with,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96592,probiotics,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96593,and,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96594,vitamin,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96595,D,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96596,may,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96597,improve,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96598,a,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96599,dairy,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96600,product,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96601,'s,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96602,glucoregulatory,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96603,effects,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96604,.,O,3345.0,"Furthermore , fermentation and fortification of dairy products with probiotics and vitamin D may improve a dairy product 's glucoregulatory effects ."
96646,Researchers,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96647,are,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96648,working,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96649,to,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96650,explain,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96651,this,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96652,observation,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96653,in,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96654,molecular,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96655,and,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96656,nutritional,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96657,terms,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
96658,.,O,3347.0,Researchers are working to explain this observation in molecular and nutritional terms .
97108,Plant,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97109,lectins,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97110,",",O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97111,a,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97112,unique,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97113,group,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97114,of,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97115,proteins,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97116,and,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97117,glycoproteins,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97118,with,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97119,potent,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97120,biological,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97121,activity,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97122,",",O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97123,occur,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97124,in,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97125,foods,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97126,like,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97127,wheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/412071004,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97128,",",O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97129,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/412357001,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97130,",",O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97131,tomato,B-http://purl.bioontology.org/ontology/SNOMEDCT/734881000,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97132,",",O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97133,peanut,B-http://purl.bioontology.org/ontology/SNOMEDCT/762952008,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97134,",",O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97135,kidney,B-http://purl.bioontology.org/ontology/SNOMEDCT/256354006,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97136,bean,I-http://purl.bioontology.org/ontology/SNOMEDCT/256354006,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97137,",",O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97138,banana,B-http://purl.bioontology.org/ontology/SNOMEDCT/256307007,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97139,",",O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97140,pea,B-http://purl.bioontology.org/ontology/SNOMEDCT/260184002,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97141,",",O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97142,lentil,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97143,",",O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97144,soybean,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97145,",",O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97146,mushroom,B-http://purl.bioontology.org/ontology/SNOMEDCT/735045008,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97147,",",O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97148,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97149,",",O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97150,and,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97151,potato,B-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97152,.,O,3364.0,"Plant lectins , a unique group of proteins and glycoproteins with potent biological activity , occur in foods like wheat , corn , tomato , peanut , kidney bean , banana , pea , lentil , soybean , mushroom , rice , and potato ."
97979,The,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97980,higher,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97981,the,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97982,degree,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97983,of,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97984,birch,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97985,pollen,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97986,allergy,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97987,",",O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97988,according,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97989,to,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97990,skin,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97991,test,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97992,",",O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97993,RAST,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97994,or,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97995,provocation,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97996,test,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97997,",",O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97998,the,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
97999,higher,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
98000,the,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
98001,frequency,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
98002,of,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
98003,FS,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
98004,.,O,3396.0,"The higher the degree of birch pollen allergy , according to skin test , RAST or provocation test , the higher the frequency of FS ."
98233,Although,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98234,there,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98235,were,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98236,no,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98237,ethnic,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98238,differences,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98239,in,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98240,overall,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98241,saturated,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98242,fat,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98243,/,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98244,cholesterol,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98245,avoidance,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98246,",",O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98247,more,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98248,non,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98249,-,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98250,Hispanic,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98251,whites,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98252,recognized,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98253,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98254,",",O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98255,eggs,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98256,",",O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98257,and,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98258,visible,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98259,fat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98260,on,I-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98261,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98262,as,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98263,food,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98264,sources,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98265,to,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98266,avoid,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98267,.,O,3404.0,"Although there were no ethnic differences in overall saturated fat / cholesterol avoidance , more non - Hispanic whites recognized milk , eggs , and visible fat on meat as food sources to avoid ."
98549,Similarly,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98550,",",O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98551,the,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98552,association,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98553,of,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98554,green,B-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98555,tea,I-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98556,consumption,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98557,was,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98558,observed,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98559,among,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98560,never,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98561,smokers,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98562,and,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98563,never,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98564,alcohol,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98565,drinkers,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98566,.,O,3416.0,"Similarly , the association of green tea consumption was observed among never smokers and never alcohol drinkers ."
98612,Food,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98613,sources,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98614,of,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98615,nutrients,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98616,in,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98617,Mexican,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98618,children,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98619,are,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98620,not,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98621,well,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98622,known,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98623,.,O,3419.0,Food sources of nutrients in Mexican children are not well known .
98859,In,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98860,veal,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98861,calves,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98862,",",O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98863,the,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98864,major,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98865,portion,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98866,of,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98867,digestible,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98868,energy,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98869,intake,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98870,originates,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98871,from,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98872,milk,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98873,replacer,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98874,(,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98875,MR,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98876,),O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98877,",",O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98878,with,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98879,lactose,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98880,and,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98881,fat,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98882,contributing,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98883,approximately,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98884,45,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98885,and,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98886,35,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98887,%,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98888,",",O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98889,respectively,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98890,.,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
99051,Postprandial,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99052,blood,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99053,samples,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99054,were,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99055,collected,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99056,to,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99057,assess,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99058,glucose,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99059,",",O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99060,insulin,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99061,",",O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99062,and,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99063,triglyceride,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99064,responses,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99065,to,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99066,feeding,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99067,",",O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99068,and,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99069,24,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99070,-,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99071,h,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99072,urine,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99073,was,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99074,collected,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99075,to,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99076,quantify,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99077,urinary,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99078,glucose,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99079,excretion,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99080,.,O,3435.0,"Postprandial blood samples were collected to assess glucose , insulin , and triglyceride responses to feeding , and 24 - h urine was collected to quantify urinary glucose excretion ."
99330,In,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99331,contrast,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99332,",",O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99333,mRNA,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99334,abundances,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99335,of,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99336,a,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99337,total,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99338,of,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99339,3,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99340,genes,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99341,involved,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99342,in,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99343,inflammation,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99344,and,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99345,14,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99346,genes,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99347,involved,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99348,in,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99349,ER,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99350,stress,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99351,response,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99352,",",O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99353,as,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99354,well,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99355,as,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99356,concentrations,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99357,of,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99358,triacylglycerols,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99359,and,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99360,cholesterol,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99361,",",O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99362,in,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99363,liver,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99364,samples,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99365,of,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99366,wk,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99367,1,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99368,and,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99369,3,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99370,postpartum,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99371,did,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99372,not,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99373,differ,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99374,between,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99375,the,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99376,2,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99377,groups,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99378,.,O,3443.0,"In contrast , mRNA abundances of a total of 3 genes involved in inflammation and 14 genes involved in ER stress response , as well as concentrations of triacylglycerols and cholesterol , in liver samples of wk 1 and 3 postpartum did not differ between the 2 groups ."
99476,At,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99477,2,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99478,wk,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99479,before,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99480,anticipated,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99481,calving,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99482,",",O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99483,Holstein,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99484,cows,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99485,were,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99486,fed,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99487,diets,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99488,that,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99489,provided,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99490,0,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99491,(,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99492,16,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99493,cows,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99494,),O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99495,or,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99496,30,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99497,(,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99498,15,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99499,cows,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99500,),O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99501,g,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99502,/,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99503,d,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99504,of,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99505,supplemental,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99506,vitamin,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99507,C,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99508,(,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99509,phosphorylated,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99510,ascorbic,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99511,acid,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99512,),O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99513,.,O,3447.0,"At 2 wk before anticipated calving , Holstein cows were fed diets that provided 0 ( 16 cows ) or 30 ( 15 cows ) g / d of supplemental vitamin C ( phosphorylated ascorbic acid ) ."
99547,Supplementation,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99548,of,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99549,vitamin,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99550,C,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99551,increased,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99552,plasma,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99553,concentrations,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99554,of,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99555,vitamin,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99556,C,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99557,at,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99558,calving,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99559,",",O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99560,but,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99561,no,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99562,differences,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99563,were,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99564,observed,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99565,in,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99566,samples,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99567,taken,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99568,24,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99569,h,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99570,postinfusion,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99571,.,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99659,Supplemental,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99660,vitamin,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99661,C,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99662,had,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99663,no,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99664,effect,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99665,on,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99666,neutrophil,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99667,phagocytosis,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99668,or,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99669,bacterial,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99670,kill,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99671,.,O,3452.0,Supplemental vitamin C had no effect on neutrophil phagocytosis or bacterial kill .
99695,Celiac,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99696,disease,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99697,is,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99698,an,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99699,autoimmune,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99700,disease,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99701,that,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99702,affects,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99703,the,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99704,villi,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99705,of,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99706,the,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99707,small,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99708,intestine,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99709,causing,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99710,abdominal,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99711,pain,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99712,",",O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99713,gas,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99714,",",O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99715,diarrhea,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99716,",",O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99717,or,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99718,bad,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99719,absorption,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99720,due,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99721,to,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99722,gluten,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99723,intolerance,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99724,.,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
100094,Olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100095,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100096,is,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100097,also,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100098,implicated,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100099,in,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100100,preventing,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100101,certain,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100102,cancers,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100103,",",O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100104,with,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100105,the,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100106,most,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100107,promising,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100108,findings,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100109,for,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100110,breast,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100111,and,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100112,digestive,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100113,tract,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100114,cancers,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100115,",",O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100116,although,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100117,the,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100118,data,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100119,are,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100120,still,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100121,not,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100122,entirely,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100123,consistent,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100124,and,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100125,mainly,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100126,from,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100127,case,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100128,-,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100129,control,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100130,studies,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100131,.,O,3467.0,"Olive oil is also implicated in preventing certain cancers , with the most promising findings for breast and digestive tract cancers , although the data are still not entirely consistent and mainly from case - control studies ."
100518,Systematic,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100519,data,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100520,collection,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100521,has,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100522,continued,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100523,(,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100524,2011,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100525,-,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100526,2018,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100527,),O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100528,and,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100529,the,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100530,dataset,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100531,now,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100532,contains,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100533,over,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100534,3400,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100535,data,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100536,points,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100537,.,O,3483.0,Systematic data collection has continued ( 2011 - 2018 ) and the dataset now contains over 3400 data points .
100878,Whole,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100879,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100880,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100881,yogurt,I-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100882,as,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100883,a,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100884,substitution,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100885,for,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100886,any,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100887,other,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100888,subgroup,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100889,was,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100890,associated,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100891,with,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100892,a,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100893,lower,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100894,rate,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100895,of,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100896,ischaemic,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100897,stroke,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100898,(,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100899,HR,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100900,between,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100901,0·33,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100902,and,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100903,0·36,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100904,/,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100905,serving,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100906,per,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100907,d,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100908,),O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100909,.,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100910,We,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100911,did,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100912,not,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100913,observe,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100914,any,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100915,associations,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100916,for,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100917,haemorrhagic,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100918,stroke,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100919,.,O,3500.0,We did not observe any associations for haemorrhagic stroke .
101045,High,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101046,intakes,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101047,of,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101048,potassium,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101049,",",O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101050,polyunsaturated,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101051,fatty,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101052,acids,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101053,",",O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101054,and,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101055,protein,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101056,",",O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101057,along,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101058,with,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101059,exercise,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101060,and,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101061,possibly,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101062,vitamin,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101063,D,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101064,",",O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101065,may,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101066,reduce,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101067,blood,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101068,pressure,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
101069,.,O,3507.0,"High intakes of potassium , polyunsaturated fatty acids , and protein , along with exercise and possibly vitamin D , may reduce blood pressure ."
102449,In,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102450,this,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102451,review,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102452,",",O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102453,we,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102454,analyzed,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102455,the,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102456,effects,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102457,of,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102458,each,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102459,dietary,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102460,factor,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102461,on,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102462,nephrolithiasis,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102463,incidence,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102464,and,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102465,recurrence,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102466,rate,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102467,.,O,3555.0,"In this review , we analyzed the effects of each dietary factor on nephrolithiasis incidence and recurrence rate ."
102638,The,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102639,survey,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102640,included,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102641,588,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102642,participants,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102643,aged,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102644,25,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102645,to,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102646,65,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102647,years,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102648,who,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102649,were,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102650,selected,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102651,using,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102652,convenience,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102653,samples,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102654,in,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102655,the,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102656,urban,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102657,areas,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102658,of,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102659,Benin,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102660,",",O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102661,Guinea,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102662,",",O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102663,Kenya,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102664,",",O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102665,Mozambique,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102666,",",O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102667,and,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102668,Seychelles,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102669,.,O,3562.0,"The survey included 588 participants aged 25 to 65 years who were selected using convenience samples in the urban areas of Benin , Guinea , Kenya , Mozambique , and Seychelles ."
102756,The,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102757,majority,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102758,of,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102759,the,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102760,participants,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102761,knew,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102762,that,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102763,high,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102764,salt,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102765,intake,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102766,can,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102767,cause,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102768,health,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102769,problems,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102770,(,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102771,85,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102772,%,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102773,),O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102774,and,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102775,thought,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102776,that,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102777,it,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102778,is,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102779,important,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102780,to,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102781,limit,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102782,salt,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102783,intake,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102784,(,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102785,91,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102786,%,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102787,),O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
102788,.,O,3567.0,The majority of the participants knew that high salt intake can cause health problems ( 85 % ) and thought that it is important to limit salt intake ( 91 % ) .
103140,Dietary,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103141,intakes,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103142,of,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103143,nutrients,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103144,were,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103145,estimated,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103146,at,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103147,baseline,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103148,(,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103149,1990,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103150,-,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103151,1994,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103152,),O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103153,using,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103154,a,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103155,121,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103156,-,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103157,item,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103158,food,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103159,frequency,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103160,questionnaire,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103161,.,O,3580.0,Dietary intakes of nutrients were estimated at baseline ( 1990 - 1994 ) using a 121 - item food frequency questionnaire .
103533,During,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103534,the,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103535,past,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103536,20,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103537,years,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103538,",",O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103539,many,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103540,studies,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103541,have,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103542,focused,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103543,on,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103544,polyphenol,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103545,compounds,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103546,for,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103547,their,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103548,potential,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103549,beneficial,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103550,health,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103551,effects,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103552,.,O,3593.0,"During the past 20 years , many studies have focused on polyphenol compounds for their potential beneficial health effects ."
103674,),O,3599.0,) are discussed .
103675,are,O,3599.0,) are discussed .
103676,discussed,O,3599.0,) are discussed .
103677,.,O,3599.0,) are discussed .
103742,The,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103743,aim,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103744,of,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103745,this,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103746,paper,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103747,is,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103748,to,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103749,provide,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103750,an,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103751,up,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103752,-,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103753,to,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103754,-,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103755,date,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103756,review,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103757,of,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103758,the,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103759,latest,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103760,studies,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103761,which,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103762,investigated,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103763,the,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103764,health,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103765,-,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103766,promoting,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103767,components,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103768,forming,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103769,upon,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103770,fermentation,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103771,of,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103772,the,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103773,main,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103774,food,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103775,matrices,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103776,",",O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103777,in,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103778,order,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103779,to,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103780,contribute,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103781,to,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103782,understanding,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103783,their,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103784,important,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103785,role,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103786,in,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103787,healthy,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103788,diets,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103789,and,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103790,relevance,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103791,in,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103792,national,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103793,dietary,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103794,recommendations,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103795,worldwide,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
103796,.,O,3602.0,"The aim of this paper is to provide an up - to - date review of the latest studies which investigated the health - promoting components forming upon fermentation of the main food matrices , in order to contribute to understanding their important role in healthy diets and relevance in national dietary recommendations worldwide ."
104050,The,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104051,inhibition,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104052,of,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104053,mammary,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104054,tumours,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104055,in,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104056,rats,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104057,is,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104058,effective,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104059,regardless,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104060,of,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104061,type,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104062,of,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104063,carcinogen,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104064,or,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104065,type,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104066,or,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104067,amount,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104068,of,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104069,dietary,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104070,fat,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104071,.,O,3616.0,The inhibition of mammary tumours in rats is effective regardless of type of carcinogen or type or amount of dietary fat .
104086,When,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104087,young,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104088,animals,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104089,(,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104090,mice,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104091,",",O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104092,pigs,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104093,),O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104094,are,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104095,placed,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104096,on,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104097,CLA,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104098,-,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104099,containing,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104100,diets,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104101,after,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104102,weaning,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104103,they,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104104,accumulate,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104105,more,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104106,body,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104107,protein,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104108,and,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104109,less,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104110,fat,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104111,.,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
105236,Twenty,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105237,-,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105238,four,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105239,-,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105240,hour,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105241,(,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105242,hr,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105243,),O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105244,dietary,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105245,recall,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105246,data,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105247,and,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105248,24,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105249,-,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105250,hr,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105251,urinary,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105252,potassium,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105253,excretion,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105254,data,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105255,from,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105256,Japanese,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105257,participants,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105258,(,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105259,574,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105260,men,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105261,and,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105262,571,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105263,women,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105264,),O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105265,in,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105266,the,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105267,International,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105268,Study,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105269,of,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105270,Macro,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105271,/,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105272,Micronutrients,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105273,and,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105274,Blood,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105275,Pressure,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105276,(,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105277,INTERMAP,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105278,),O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105279,were,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105280,used,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105281,to,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105282,calculate,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105283,food,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105284,sources,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105285,of,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105286,potassium,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105287,and,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105288,compare,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105289,food,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105290,consumption,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105291,patterns,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105292,among,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105293,quartiles,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105294,of,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105295,participants,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105296,categorized,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105297,according,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105298,to,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105299,24,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105300,-,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105301,hr,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105302,urinary,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105303,potassium,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105304,excretion,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105305,per,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105306,unit,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105307,of,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105308,body,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105309,weight,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105310,(,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105311,UK,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105312,/,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105313,BW,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105314,),O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105315,.,O,3662.0,Twenty - four - hour ( hr ) dietary recall data and 24 - hr urinary potassium excretion data from Japanese participants ( 574 men and 571 women ) in the International Study of Macro / Micronutrients and Blood Pressure ( INTERMAP ) were used to calculate food sources of potassium and compare food consumption patterns among quartiles of participants categorized according to 24 - hr urinary potassium excretion per unit of body weight ( UK / BW ) .
105403,Conclusion,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105404,:,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105405,Advice,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105406,to,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105407,increase,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105408,the,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105409,intake,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105410,of,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105411,vegetables,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105412,and,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105413,fruits,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105414,",",O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105415,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105416,",",O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105417,and,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105418,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105419,may,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105420,be,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105421,useful,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105422,to,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105423,increase,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105424,potassium,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105425,intake,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105426,in,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105427,Japan,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105428,.,O,3665.0,"Conclusion : Advice to increase the intake of vegetables and fruits , fish , and milk may be useful to increase potassium intake in Japan ."
105512,Obesity,O,3669.0,Obesity is a metabolic disorder characterized by visceral adiposity .
105513,is,O,3669.0,Obesity is a metabolic disorder characterized by visceral adiposity .
105514,a,O,3669.0,Obesity is a metabolic disorder characterized by visceral adiposity .
105515,metabolic,O,3669.0,Obesity is a metabolic disorder characterized by visceral adiposity .
105516,disorder,O,3669.0,Obesity is a metabolic disorder characterized by visceral adiposity .
105517,characterized,O,3669.0,Obesity is a metabolic disorder characterized by visceral adiposity .
105518,by,O,3669.0,Obesity is a metabolic disorder characterized by visceral adiposity .
105519,visceral,O,3669.0,Obesity is a metabolic disorder characterized by visceral adiposity .
105520,adiposity,O,3669.0,Obesity is a metabolic disorder characterized by visceral adiposity .
105521,.,O,3669.0,Obesity is a metabolic disorder characterized by visceral adiposity .
105615,Based,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105616,on,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105617,the,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105618,key,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105619,constituents,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105620,of,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105621,honey,B-http://purl.bioontology.org/ontology/SNOMEDCT/227598003,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105622,",",O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105623,the,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105624,paper,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105625,also,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105626,highlights,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105627,polyphenols,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105628,to,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105629,be,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105630,potentially,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105631,responsible,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105632,for,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105633,the,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105634,health,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105635,benefits,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105636,of,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105637,honey,B-http://purl.bioontology.org/ontology/SNOMEDCT/227598003,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105638,.,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105639,Further,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105640,well,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105641,-,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105642,designed,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105643,and,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105644,controlled,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105645,studies,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105646,are,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105647,necessary,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105648,to,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105649,validate,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105650,these,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105651,benefits,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105652,in,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105653,humans,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
105654,.,O,3674.0,Further well - designed and controlled studies are necessary to validate these benefits in humans .
106363,Dairy,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106364,and,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106365,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106366,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106367,were,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106368,more,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106369,consumed,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106370,in,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106371,summer,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106372,and,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106373,winter,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106374,",",O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106375,respectively,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106376,.,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106560,Their,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106561,association,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106562,with,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106563,colorectal,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106564,tumors,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106565,was,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106566,investigated,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106567,in,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106568,516,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106569,adenoma,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106570,cases,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106571,(,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106572,175,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106573,high,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106574,-,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106575,risk,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106576,adenomas,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106577,),O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106578,and,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106579,"4,804",O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106580,polyp,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106581,-,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106582,free,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106583,women,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106584,and,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106585,in,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106586,172,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106587,colorectal,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106588,cancer,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106589,cases,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106590,and,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106591,"67,312",O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106592,cancer,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106593,-,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106594,free,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106595,women,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
106596,.,O,3708.0,"Their association with colorectal tumors was investigated in 516 adenoma cases ( 175 high - risk adenomas ) and 4,804 polyp - free women and in 172 colorectal cancer cases and 67,312 cancer - free women ."
107185,Patients,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107186,with,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107187,renal,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107188,impairment,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107189,",",O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107190,including,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107191,the,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107192,elderly,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107193,",",O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107194,should,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107195,limit,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107196,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107197,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107198,and,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107199,avoid,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107200,egg,B-http://purl.bioontology.org/ontology/SNOMEDCT/256442007,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107201,yolk,I-http://purl.bioontology.org/ontology/SNOMEDCT/256442007,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107202,",",O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107203,as,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107204,should,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107205,other,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107206,patients,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107207,at,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107208,high,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107209,risk,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107210,of,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107211,stroke,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107212,.,O,3726.0,"Patients with renal impairment , including the elderly , should limit red meat and avoid egg yolk , as should other patients at high risk of stroke ."
107772,We,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107773,aimed,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107774,to,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107775,quantify,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107776,the,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107777,association,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107778,between,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107779,dietary,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107780,patterns,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107781,and,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107782,gastric,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107783,cancer,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107784,",",O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107785,by,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107786,location,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107787,and,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107788,histological,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107789,type,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107790,",",O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107791,according,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107792,to,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107793,Helicobacter,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107794,pylori,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107795,infection,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107796,status,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
107797,.,O,3746.0,"We aimed to quantify the association between dietary patterns and gastric cancer , by location and histological type , according to Helicobacter pylori infection status ."
108053,Our,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108054,results,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108055,confirm,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108056,the,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108057,protective,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108058,effect,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108059,of,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108060,high,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108061,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108062,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108063,vegetables,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108064,intake,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108065,",",O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108066,and,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108067,show,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108068,a,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108069,differential,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108070,association,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108071,according,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108072,to,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108073,histological,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108074,type,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108075,.,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108504,Animal,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108505,data,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108506,for,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108507,the,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108508,effects,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108509,of,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108510,individual,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108511,fatty,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108512,acids,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108513,on,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108514,plasma,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108515,LDL,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108516,-,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108517,C,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108518,concentrations,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108519,and,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108520,metabolism,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108521,are,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108522,sparse,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108523,.,O,3771.0,Animal data for the effects of individual fatty acids on plasma LDL - C concentrations and metabolism are sparse .
108566,Lauric,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108567,acid,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108568,(,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108569,12:0,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108570,),O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108571,",",O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108572,myristic,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108573,acid,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108574,(,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108575,14:0,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108576,),O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108577,",",O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108578,and,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108579,palmitic,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108580,acid,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108581,(,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108582,16:0,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108583,),O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108584,are,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108585,approximately,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108586,equivalent,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108587,in,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108588,their,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108589,LDL,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108590,-,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108591,C,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108592,-,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108593,raising,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108594,potential,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108595,by,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108596,reducing,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108597,hepatic,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108598,LDL,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108599,receptor,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108600,activity,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108601,and,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108602,increasing,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108603,the,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108604,LDL,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108605,-,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108606,C,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108607,production,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108608,rate,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108609,",",O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108610,apparently,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108611,via,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108612,modulation,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108613,of,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108614,sterol,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108615,O,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108616,-,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108617,acyltransferase,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108618,activity,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108619,.,O,3773.0,"Lauric acid ( 12:0 ) , myristic acid ( 14:0 ) , and palmitic acid ( 16:0 ) are approximately equivalent in their LDL - C - raising potential by reducing hepatic LDL receptor activity and increasing the LDL - C production rate , apparently via modulation of sterol O - acyltransferase activity ."
108752,Hazards,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108753,ratios,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108754,(,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108755,HR,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108756,),O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108757,with,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108758,95,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108759,%,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108760,CI,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108761,for,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108762,the,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108763,incidence,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108764,of,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108765,MI,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108766,were,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108767,calculated,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108768,using,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108769,Cox,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108770,proportional,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108771,hazards,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108772,regression,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
108773,.,O,3781.0,Hazards ratios ( HR ) with 95 % CI for the incidence of MI were calculated using Cox proportional hazards regression .
109134,Milk,O,3800.0,Milk yield is partly influenced by the number of mammary epithelial cells ( MEC ) in the mammary gland .
109135,yield,O,3800.0,Milk yield is partly influenced by the number of mammary epithelial cells ( MEC ) in the mammary gland .
109136,is,O,3800.0,Milk yield is partly influenced by the number of mammary epithelial cells ( MEC ) in the mammary gland .
109137,partly,O,3800.0,Milk yield is partly influenced by the number of mammary epithelial cells ( MEC ) in the mammary gland .
109138,influenced,O,3800.0,Milk yield is partly influenced by the number of mammary epithelial cells ( MEC ) in the mammary gland .
109139,by,O,3800.0,Milk yield is partly influenced by the number of mammary epithelial cells ( MEC ) in the mammary gland .
109140,the,O,3800.0,Milk yield is partly influenced by the number of mammary epithelial cells ( MEC ) in the mammary gland .
109141,number,O,3800.0,Milk yield is partly influenced by the number of mammary epithelial cells ( MEC ) in the mammary gland .
109142,of,O,3800.0,Milk yield is partly influenced by the number of mammary epithelial cells ( MEC ) in the mammary gland .
109143,mammary,O,3800.0,Milk yield is partly influenced by the number of mammary epithelial cells ( MEC ) in the mammary gland .
109144,epithelial,O,3800.0,Milk yield is partly influenced by the number of mammary epithelial cells ( MEC ) in the mammary gland .
109145,cells,O,3800.0,Milk yield is partly influenced by the number of mammary epithelial cells ( MEC ) in the mammary gland .
109146,(,O,3800.0,Milk yield is partly influenced by the number of mammary epithelial cells ( MEC ) in the mammary gland .
109147,MEC,O,3800.0,Milk yield is partly influenced by the number of mammary epithelial cells ( MEC ) in the mammary gland .
109148,),O,3800.0,Milk yield is partly influenced by the number of mammary epithelial cells ( MEC ) in the mammary gland .
109149,in,O,3800.0,Milk yield is partly influenced by the number of mammary epithelial cells ( MEC ) in the mammary gland .
109150,the,O,3800.0,Milk yield is partly influenced by the number of mammary epithelial cells ( MEC ) in the mammary gland .
109151,mammary,O,3800.0,Milk yield is partly influenced by the number of mammary epithelial cells ( MEC ) in the mammary gland .
109152,gland,O,3800.0,Milk yield is partly influenced by the number of mammary epithelial cells ( MEC ) in the mammary gland .
109153,.,O,3800.0,Milk yield is partly influenced by the number of mammary epithelial cells ( MEC ) in the mammary gland .
109724,An,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109725,increased,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109726,risk,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109727,was,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109728,observed,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109729,for,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109730,consumption,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109731,of,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109732,iodized,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109733,salts,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109734,(,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109735,OR,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109736,2.06,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109737,",",O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109738,95,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109739,%,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109740,CI,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109741,1.21,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109742,-,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109743,3.51,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109744,),O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109745,",",O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109746,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109747,(,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109748,OR,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109749, ,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109750,=,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109751, ,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109752,1.42,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109753,",",O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109754,95,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109755,%,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109756,CI,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109757,0.84,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109758,-,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109759,2.41,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109760,),O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109761,and,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109762,coca,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109763,-,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109764,cola,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109765,(,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109766,OR,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109767, ,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109768,=,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109769, ,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109770,3.08,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109771,",",O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109772,95,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109773,%,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109774,CI,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109775,1.53,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109776,-,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109777,6.20,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109778,),O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109779,.,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
110862,Systematic,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110863,examination,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110864,of,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110865,the,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110866,effects,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110867,of,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110868,dietary,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110869,patterns,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110870,that,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110871,include,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110872,regular,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110873,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110874,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110875,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110876,",",O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110877,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110878,and,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110879,yogurt,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110880,on,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110881,human,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110882,health,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110883,is,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110884,warranted,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110885,.,O,3861.0,"Systematic examination of the effects of dietary patterns that include regular - fat milk , cheese and yogurt on human health is warranted ."
110922,Discrepant,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110923,data,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110924,",",O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110925,however,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110926,",",O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110927,have,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110928,been,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110929,reported,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110930,for,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110931,India,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110932,",",O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110933,Japan,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110934,and,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110935,Korea,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
110936,.,O,3864.0,"Discrepant data , however , have been reported for India , Japan and Korea ."
111696,For,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111697,this,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111698,purpose,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111699,",",O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111700,histopathological,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111701,analysis,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111702,and,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111703,immunohistochemistry,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111704,for,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111705,RUNX-2,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111706,and,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111707,RANK,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111708,-,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111709,L,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111710,were,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111711,investigated,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111712,in,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111713,this,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111714,setting,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111715,.,O,3896.0,"For this purpose , histopathological analysis and immunohistochemistry for RUNX-2 and RANK - L were investigated in this setting ."
111778,injection,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111779,of,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111780,cadmium,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111781,chloride,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111782,(,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111783,1.2,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111784, ,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111785,mg,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111786,/,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111787,kg,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111788,body,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111789,weight,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111790,),O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111791,diluted,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111792,in,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111793,water,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111794,.,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
112790,Logistic,O,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112791,regression,O,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112792,analyses,O,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112793,yielded,O,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112794,odds,O,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112795,ratios,O,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112796,adjusted,O,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112797,for,O,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112798,age,O,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112799,",",O,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112800,sex,O,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112801,",",O,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112802,response,O,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112803,status,O,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112804,",",O,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112805,smoking,O,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112806,",",O,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112807,dietary,O,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112808,intake,O,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112809,of,O,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112810,energy,O,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112811,and,O,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112812,vegetables,O,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112813,and,O,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112814,of,O,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112815,alcoholic,O,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112816,or,O,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112817,non,B-http://purl.bioontology.org/ontology/SNOMEDCT/226465004,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112818,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/226465004,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112819,alcoholic,I-http://purl.bioontology.org/ontology/SNOMEDCT/226465004,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112820,drinks,I-http://purl.bioontology.org/ontology/SNOMEDCT/226465004,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112821,.,O,3935.0,"Logistic regression analyses yielded odds ratios adjusted for age , sex , response status , smoking , dietary intake of energy and vegetables and of alcoholic or non - alcoholic drinks ."
112874,The,O,3937.0,"The consumption of white wine was inversely associated with risk ( OR 0.41 , 95 % CI 0.24 - 0.70 ) ."
112875,consumption,O,3937.0,"The consumption of white wine was inversely associated with risk ( OR 0.41 , 95 % CI 0.24 - 0.70 ) ."
112876,of,O,3937.0,"The consumption of white wine was inversely associated with risk ( OR 0.41 , 95 % CI 0.24 - 0.70 ) ."
112877,white,B-http://purl.bioontology.org/ontology/SNOMEDCT/67990004;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,3937.0,"The consumption of white wine was inversely associated with risk ( OR 0.41 , 95 % CI 0.24 - 0.70 ) ."
112878,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/67990004;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,3937.0,"The consumption of white wine was inversely associated with risk ( OR 0.41 , 95 % CI 0.24 - 0.70 ) ."
112879,was,O,3937.0,"The consumption of white wine was inversely associated with risk ( OR 0.41 , 95 % CI 0.24 - 0.70 ) ."
112880,inversely,O,3937.0,"The consumption of white wine was inversely associated with risk ( OR 0.41 , 95 % CI 0.24 - 0.70 ) ."
112881,associated,O,3937.0,"The consumption of white wine was inversely associated with risk ( OR 0.41 , 95 % CI 0.24 - 0.70 ) ."
112882,with,O,3937.0,"The consumption of white wine was inversely associated with risk ( OR 0.41 , 95 % CI 0.24 - 0.70 ) ."
112883,risk,O,3937.0,"The consumption of white wine was inversely associated with risk ( OR 0.41 , 95 % CI 0.24 - 0.70 ) ."
112884,(,O,3937.0,"The consumption of white wine was inversely associated with risk ( OR 0.41 , 95 % CI 0.24 - 0.70 ) ."
112885,OR,O,3937.0,"The consumption of white wine was inversely associated with risk ( OR 0.41 , 95 % CI 0.24 - 0.70 ) ."
112886,0.41,O,3937.0,"The consumption of white wine was inversely associated with risk ( OR 0.41 , 95 % CI 0.24 - 0.70 ) ."
112887,",",O,3937.0,"The consumption of white wine was inversely associated with risk ( OR 0.41 , 95 % CI 0.24 - 0.70 ) ."
112888,95,O,3937.0,"The consumption of white wine was inversely associated with risk ( OR 0.41 , 95 % CI 0.24 - 0.70 ) ."
112889,%,O,3937.0,"The consumption of white wine was inversely associated with risk ( OR 0.41 , 95 % CI 0.24 - 0.70 ) ."
112890,CI,O,3937.0,"The consumption of white wine was inversely associated with risk ( OR 0.41 , 95 % CI 0.24 - 0.70 ) ."
112891,0.24,O,3937.0,"The consumption of white wine was inversely associated with risk ( OR 0.41 , 95 % CI 0.24 - 0.70 ) ."
112892,-,O,3937.0,"The consumption of white wine was inversely associated with risk ( OR 0.41 , 95 % CI 0.24 - 0.70 ) ."
112893,0.70,O,3937.0,"The consumption of white wine was inversely associated with risk ( OR 0.41 , 95 % CI 0.24 - 0.70 ) ."
112894,),O,3937.0,"The consumption of white wine was inversely associated with risk ( OR 0.41 , 95 % CI 0.24 - 0.70 ) ."
112895,.,O,3937.0,"The consumption of white wine was inversely associated with risk ( OR 0.41 , 95 % CI 0.24 - 0.70 ) ."
113957,Individuals,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113958,with,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113959,celiac,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113960,disease,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113961,generally,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113962,are,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113963,advised,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113964,to,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113965,follow,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113966,a,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113967,lifelong,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113968,gluten,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113969,-,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113970,free,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113971,diet,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113972,and,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113973,avoid,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113974,consumption,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113975,of,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113976,the,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113977,prolamins,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113978,gliadin,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113979,(,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113980,wheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/412071004,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113981,),O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113982,",",O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113983,secalin,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113984,(,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113985,rye,B-http://purl.bioontology.org/ontology/SNOMEDCT/412068007,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113986,),O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113987,",",O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113988,and,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113989,hordein,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113990,(,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113991,barley,B-http://purl.bioontology.org/ontology/SNOMEDCT/735124003,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113992,),O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
113993,.,O,3970.0,"Individuals with celiac disease generally are advised to follow a lifelong gluten - free diet and avoid consumption of the prolamins gliadin ( wheat ) , secalin ( rye ) , and hordein ( barley ) ."
114128,Minimal,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114129,research,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114130,has,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114131,been,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114132,conducted,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114133,on,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114134,the,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114135,toxicity,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114136,of,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114137,foods,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114138,rendered,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114139,gluten,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114140,free,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114141,",",O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114142,and,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114143,there,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114144,are,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114145,no,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114146,definitive,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114147,data,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114148,about,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114149,whether,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114150,the,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114151,small,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114152,amount,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114153,of,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114154,prolamin,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114155,found,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114156,in,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114157,these,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114158,products,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114159,is,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114160,safe,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114161,to,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114162,consume,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114163,.,O,3975.0,"Minimal research has been conducted on the toxicity of foods rendered gluten free , and there are no definitive data about whether the small amount of prolamin found in these products is safe to consume ."
114164,Nonetheless,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114165,",",O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114166,the,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114167,Codex,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114168,Alimentarius,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114169,Standard,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114170,for,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114171,gluten,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114172,-,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114173,free,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114174,foods,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114175,allows,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114176,a,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114177,certain,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114178,amount,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114179,of,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114180,prolamin,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114181,in,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114182,foods,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114183,designated,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114184,gluten,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114185,free,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114186,",",O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114187,and,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114188,these,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114189,products,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114190,have,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114191,been,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114192,used,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114193,in,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114194,many,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114195,countries,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114196,for,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114197,several,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114198,decades,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114199,.,O,3976.0,"Nonetheless , the Codex Alimentarius Standard for gluten - free foods allows a certain amount of prolamin in foods designated gluten free , and these products have been used in many countries for several decades ."
114262,Milk,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114263,",",O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114264,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114265,",",O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114266,yogurt,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114267,",",O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114268,and,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114269,other,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114270,dairy,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114271,products,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114272,have,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114273,long,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114274,been,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114275,known,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114276,to,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114277,provide,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114278,good,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114279,nutrition,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114280,.,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114363,New,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114364,research,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114365,on,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114366,dairy,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114367,products,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114368,and,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114369,nutrition,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114370,will,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114371,improve,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114372,our,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114373,understanding,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114374,of,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114375,the,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114376,connections,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114377,between,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114378,these,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114379,products,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114380,",",O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114381,the,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114382,bioactive,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114383,compounds,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114384,in,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114385,them,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114386,",",O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114387,and,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114388,their,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114389,effects,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114390,on,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114391,the,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114392,human,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114393,body,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114394,.,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114588,We,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114589,used,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114590,Cox,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114591,proportional,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114592,hazard,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114593,models,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114594,to,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114595,determine,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114596,the,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114597,association,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114598,between,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114599,Med,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114600,-,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114601,style,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114602,diet,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114603,tertiles,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114604,and,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114605,first,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114606,sepsis,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114607,events,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114608,",",O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114609,adjusting,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114610,for,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114611,socio,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114612,-,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114613,demographics,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114614,",",O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114615,lifestyle,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114616,factors,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114617,",",O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114618,and,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114619,co,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114620,-,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114621,morbidities,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114622,.,O,3991.0,"We used Cox proportional hazard models to determine the association between Med - style diet tertiles and first sepsis events , adjusting for socio - demographics , lifestyle factors , and co - morbidities ."
114623,We,O,3992.0,We included 21 256 participants with complete dietary data .
114624,included,O,3992.0,We included 21 256 participants with complete dietary data .
114625,21,O,3992.0,We included 21 256 participants with complete dietary data .
114626,256,O,3992.0,We included 21 256 participants with complete dietary data .
114627,participants,O,3992.0,We included 21 256 participants with complete dietary data .
114628,with,O,3992.0,We included 21 256 participants with complete dietary data .
114629,complete,O,3992.0,We included 21 256 participants with complete dietary data .
114630,dietary,O,3992.0,We included 21 256 participants with complete dietary data .
114631,data,O,3992.0,We included 21 256 participants with complete dietary data .
114632,.,O,3992.0,We included 21 256 participants with complete dietary data .
114917,',O,4002.0,' Sarcobesity ' and sarcopaenic diabetes are rapidly growing health issues .
114918,Sarcobesity,O,4002.0,' Sarcobesity ' and sarcopaenic diabetes are rapidly growing health issues .
114919,',O,4002.0,' Sarcobesity ' and sarcopaenic diabetes are rapidly growing health issues .
114920,and,O,4002.0,' Sarcobesity ' and sarcopaenic diabetes are rapidly growing health issues .
114921,sarcopaenic,O,4002.0,' Sarcobesity ' and sarcopaenic diabetes are rapidly growing health issues .
114922,diabetes,O,4002.0,' Sarcobesity ' and sarcopaenic diabetes are rapidly growing health issues .
114923,are,O,4002.0,' Sarcobesity ' and sarcopaenic diabetes are rapidly growing health issues .
114924,rapidly,O,4002.0,' Sarcobesity ' and sarcopaenic diabetes are rapidly growing health issues .
114925,growing,O,4002.0,' Sarcobesity ' and sarcopaenic diabetes are rapidly growing health issues .
114926,health,O,4002.0,' Sarcobesity ' and sarcopaenic diabetes are rapidly growing health issues .
114927,issues,O,4002.0,' Sarcobesity ' and sarcopaenic diabetes are rapidly growing health issues .
114928,.,O,4002.0,' Sarcobesity ' and sarcopaenic diabetes are rapidly growing health issues .
115042,It,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115043,has,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115044,been,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115045,postulated,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115046,that,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115047,the,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115048,components,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115049,in,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115050,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115051,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115052,in,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115053,the,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115054,Mediterranean,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115055,diet,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115056,",",O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115057,a,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115058,diet,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115059,which,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115060,is,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115061,largely,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115062,vegetarian,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115063,in,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115064,nature,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115065,",",O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115066,can,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115067,contribute,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115068,to,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115069,the,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115070,lower,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115071,incidence,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115072,of,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115073,coronary,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115074,heart,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115075,disease,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115076,and,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115077,prostate,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115078,and,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115079,colon,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115080,cancers,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115081,.,O,4006.0,"It has been postulated that the components in olive oil in the Mediterranean diet , a diet which is largely vegetarian in nature , can contribute to the lower incidence of coronary heart disease and prostate and colon cancers ."
115095,Olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115096,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115097,is,O,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115098,a,O,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115099,source,O,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115100,of,O,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115101,at,O,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115102,least,O,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115103,30,O,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115104,phenolic,O,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115105,compounds,O,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115106,.,O,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115107,The,O,4009.0,"The major phenolic compounds in olive oil are oleuropein , hydroxytyrosol and tyrosol ."
115108,major,O,4009.0,"The major phenolic compounds in olive oil are oleuropein , hydroxytyrosol and tyrosol ."
115109,phenolic,O,4009.0,"The major phenolic compounds in olive oil are oleuropein , hydroxytyrosol and tyrosol ."
115110,compounds,O,4009.0,"The major phenolic compounds in olive oil are oleuropein , hydroxytyrosol and tyrosol ."
115111,in,O,4009.0,"The major phenolic compounds in olive oil are oleuropein , hydroxytyrosol and tyrosol ."
115112,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,4009.0,"The major phenolic compounds in olive oil are oleuropein , hydroxytyrosol and tyrosol ."
115113,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,4009.0,"The major phenolic compounds in olive oil are oleuropein , hydroxytyrosol and tyrosol ."
115114,are,O,4009.0,"The major phenolic compounds in olive oil are oleuropein , hydroxytyrosol and tyrosol ."
115115,oleuropein,O,4009.0,"The major phenolic compounds in olive oil are oleuropein , hydroxytyrosol and tyrosol ."
115116,",",O,4009.0,"The major phenolic compounds in olive oil are oleuropein , hydroxytyrosol and tyrosol ."
115117,hydroxytyrosol,O,4009.0,"The major phenolic compounds in olive oil are oleuropein , hydroxytyrosol and tyrosol ."
115118,and,O,4009.0,"The major phenolic compounds in olive oil are oleuropein , hydroxytyrosol and tyrosol ."
115119,tyrosol,O,4009.0,"The major phenolic compounds in olive oil are oleuropein , hydroxytyrosol and tyrosol ."
115120,.,O,4009.0,"The major phenolic compounds in olive oil are oleuropein , hydroxytyrosol and tyrosol ."
115153,Olive,O,4012.0,"Olive "" waste water "" also possesses compounds which are strong antioxidant and radical scavengers ."
115154,"""",O,4012.0,"Olive "" waste water "" also possesses compounds which are strong antioxidant and radical scavengers ."
115155,waste,O,4012.0,"Olive "" waste water "" also possesses compounds which are strong antioxidant and radical scavengers ."
115156,water,O,4012.0,"Olive "" waste water "" also possesses compounds which are strong antioxidant and radical scavengers ."
115157,"""",O,4012.0,"Olive "" waste water "" also possesses compounds which are strong antioxidant and radical scavengers ."
115158,also,O,4012.0,"Olive "" waste water "" also possesses compounds which are strong antioxidant and radical scavengers ."
115159,possesses,O,4012.0,"Olive "" waste water "" also possesses compounds which are strong antioxidant and radical scavengers ."
115160,compounds,O,4012.0,"Olive "" waste water "" also possesses compounds which are strong antioxidant and radical scavengers ."
115161,which,O,4012.0,"Olive "" waste water "" also possesses compounds which are strong antioxidant and radical scavengers ."
115162,are,O,4012.0,"Olive "" waste water "" also possesses compounds which are strong antioxidant and radical scavengers ."
115163,strong,O,4012.0,"Olive "" waste water "" also possesses compounds which are strong antioxidant and radical scavengers ."
115164,antioxidant,O,4012.0,"Olive "" waste water "" also possesses compounds which are strong antioxidant and radical scavengers ."
115165,and,O,4012.0,"Olive "" waste water "" also possesses compounds which are strong antioxidant and radical scavengers ."
115166,radical,O,4012.0,"Olive "" waste water "" also possesses compounds which are strong antioxidant and radical scavengers ."
115167,scavengers,O,4012.0,"Olive "" waste water "" also possesses compounds which are strong antioxidant and radical scavengers ."
115168,.,O,4012.0,"Olive "" waste water "" also possesses compounds which are strong antioxidant and radical scavengers ."
115405,However,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115406,",",O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115407,data,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115408,on,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115409,serum,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115410,zinc,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115411,concentrations,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115412,",",O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115413,the,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115414,recommended,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115415,biomarker,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115416,for,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115417,identifying,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115418,population,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115419,groups,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115420,at,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115421,elevated,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115422,risk,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115423,of,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115424,zinc,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115425,deficiency,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115426,",",O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115427,are,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115428,sparse,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115429,and,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115430,difficult,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115431,to,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115432,interpret,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115433,because,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115434,recommended,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115435,collection,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115436,and,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115437,analytic,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115438,procedures,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115439,have,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115440,not,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115441,always,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115442,been,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115443,followed,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115444,.,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115627,Trans,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115628,isomers,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115629,of,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115630,fatty,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115631,acids,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115632,",",O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115633,formed,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115634,by,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115635,the,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115636,partial,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115637,hydrogenation,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115638,of,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115639,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115640,oils,I-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115641,to,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115642,produce,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115643,margarine,B-http://purl.bioontology.org/ontology/SNOMEDCT/226890008,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115644,and,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115645,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115646,shortening,I-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115647,",",O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115648,increase,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115649,the,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115650,ratio,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115651,of,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115652,plasma,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115653,low,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115654,-,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115655,density,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115656,-,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115657,lipoprotein,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115658,to,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115659,high,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115660,-,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115661,density,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115662,-,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115663,lipoprotein,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115664,cholesterol,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115665,",",O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115666,so,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115667,it,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115668,is,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115669,possible,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115670,that,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115671,they,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115672,adversely,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115673,influence,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115674,risk,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115675,of,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115676,coronary,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115677,heart,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115678,disease,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115679,(,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115680,CHD,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115681,),O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
115682,.,O,4029.0,"Trans isomers of fatty acids , formed by the partial hydrogenation of vegetable oils to produce margarine and vegetable shortening , increase the ratio of plasma low - density - lipoprotein to high - density - lipoprotein cholesterol , so it is possible that they adversely influence risk of coronary heart disease ( CHD ) ."
116101,Garlic,O,4046.0,Garlic has been used medicinally since antiquity .
116102,has,O,4046.0,Garlic has been used medicinally since antiquity .
116103,been,O,4046.0,Garlic has been used medicinally since antiquity .
116104,used,O,4046.0,Garlic has been used medicinally since antiquity .
116105,medicinally,O,4046.0,Garlic has been used medicinally since antiquity .
116106,since,O,4046.0,Garlic has been used medicinally since antiquity .
116107,antiquity,O,4046.0,Garlic has been used medicinally since antiquity .
116108,.,O,4046.0,Garlic has been used medicinally since antiquity .
116779,But,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116780,there,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116781,are,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116782,several,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116783,studies,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116784,indicating,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116785,that,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116786,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116787,and,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116788,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116789,products,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116790,may,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116791,not,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116792,affect,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116793,adversely,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116794,blood,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116795,lipids,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116796,as,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116797,would,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116798,be,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116799,predicted,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116800,from,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116801,its,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116802,fat,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116803,content,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116804,and,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116805,fat,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116806,composition,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116807,.,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116808,There,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116809,are,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116810,even,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116811,factors,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116812,in,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116813,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116814,and,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116815,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116816,products,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116817,which,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116818,may,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116819,actively,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116820,protect,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116821,from,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116822,this,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116823,condition,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116824,by,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116825,improving,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116826,several,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116827,risk,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116828,factors,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
116829,.,O,4075.0,There are even factors in milk and milk products which may actively protect from this condition by improving several risk factors .
117078,Contrary,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117079,to,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117080,expectations,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117081,",",O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117082,epidemiologic,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117083,studies,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117084,and,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117085,clinical,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117086,trials,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117087,suggest,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117088,that,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117089,regular,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117090,nut,B-http://purl.bioontology.org/ontology/SNOMEDCT/13577000,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117091,consumption,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117092,is,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117093,unlikely,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117094,to,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117095,contribute,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117096,to,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117097,obesity,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117098,and,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117099,may,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117100,even,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117101,help,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117102,in,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117103,weight,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117104,loss,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117105,.,O,4086.0,"Contrary to expectations , epidemiologic studies and clinical trials suggest that regular nut consumption is unlikely to contribute to obesity and may even help in weight loss ."
117408,Indices,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117409,of,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117410,beta,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117411,-,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117412,carotene,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117413,and,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117414,ascorbate,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117415,intake,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117416,were,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117417,negatively,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117418,and,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117419,strongly,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117420,related,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117421,with,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117422,gastric,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117423,cancer,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117424,risk,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117425,",",O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117426,but,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117427,the,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117428,association,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117429,with,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117430,these,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117431,micronutrients,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117432,was,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117433,no,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117434,longer,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117435,evident,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117436,after,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117437,simultaneous,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117438,allowance,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117439,for,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117440,various,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117441,food,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117442,items,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117443,.,O,4094.0,"Indices of beta - carotene and ascorbate intake were negatively and strongly related with gastric cancer risk , but the association with these micronutrients was no longer evident after simultaneous allowance for various food items ."
117467,This,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117468,paper,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117469,describes,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117470,composition,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117471,of,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117472,dried,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117473,plums,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117474,and,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117475,their,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117476,products,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117477,(,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117478,prune,B-http://purl.bioontology.org/ontology/SNOMEDCT/129559002,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117479,juice,I-http://purl.bioontology.org/ontology/SNOMEDCT/129559002,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117480,and,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117481,dried,B-http://purl.bioontology.org/ontology/SNOMEDCT/735051003,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117482,plum,I-http://purl.bioontology.org/ontology/SNOMEDCT/735051003,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117483,powder,I-http://purl.bioontology.org/ontology/SNOMEDCT/735051003,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117484,),O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117485,with,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117486,special,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117487,attention,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117488,to,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117489,possibly,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117490,bioactive,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117491,compounds,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117492,.,O,4096.0,This paper describes composition of dried plums and their products ( prune juice and dried plum powder ) with special attention to possibly bioactive compounds .
117630,The,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117631,indirect,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117632,salutary,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117633,effects,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117634,on,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117635,bone,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117636,turnover,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117637,are,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117638,supported,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117639,by,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117640,numerous,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117641,laboratory,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117642,studies,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117643,with,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117644,animals,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117645,and,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117646,cell,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117647,cultures,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117648,.,O,4103.0,The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures .
117986,Using,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117987,the,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117988,UBM,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117989,protocol,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117990,(,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117991,unified,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117992,BARGE,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117993,bioaccessibility,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117994,method,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117995,),O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117996,",",O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117997,the,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117998,bioaccessibility,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
117999,of,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118000,Cd,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118001,was,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118002,measured,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118003,in,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118004,raw,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118005,/,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118006,cooked,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118007,vegetables,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118008,.,O,4116.0,"Using the UBM protocol ( unified BARGE bioaccessibility method ) , the bioaccessibility of Cd was measured in raw / cooked vegetables ."
118090,Cooking,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118091,by,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118092,the,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118093,steaming,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118094,process,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118095,generally,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118096,increased,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118097,the,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118098,bioaccessibility,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118099,of,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118100,Cd,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118101,in,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118102,French,B-http://purl.bioontology.org/ontology/SNOMEDCT/256354006,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118103,bean,I-http://purl.bioontology.org/ontology/SNOMEDCT/256354006,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118104,",",O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118105,carrot,B-http://purl.bioontology.org/ontology/SNOMEDCT/256319004,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118106,",",O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118107,and,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118108,leek,B-http://purl.bioontology.org/ontology/SNOMEDCT/726755004,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118109,.,O,4119.0,"Cooking by the steaming process generally increased the bioaccessibility of Cd in French bean , carrot , and leek ."
118265,There,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118266,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118267,it,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118268,suppresses,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118269,the,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118270,proinflammatory,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118271,transcription,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118272,factors,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118273,nuclear,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118274,factor,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118275,-,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118276,kappa,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118277,B,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118278,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118279,signal,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118280,transducer,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118281,and,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118282,activators,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118283,of,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118284,transcription-3,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118285,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118286,and,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118287,Wnt,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118288,/,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118289,beta,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118290,-,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118291,catenin,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118292,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118293,and,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118294,it,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118295,activates,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118296,peroxisome,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118297,proliferator,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118298,-,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118299,activated,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118300,receptor,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118301,-,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118302,gamma,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118303,and,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118304,Nrf2,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118305,cell,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118306,-,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118307,signaling,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118308,pathways,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118309,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118310,thus,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118311,leading,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118312,to,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118313,the,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118314,downregulation,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118315,of,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118316,adipokines,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118317,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118318,including,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118319,tumor,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118320,necrosis,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118321,factor,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118322,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118323,interleukin-6,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118324,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118325,resistin,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118326,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118327,leptin,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118328,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118329,and,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118330,monocyte,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118331,chemotactic,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118332,protein-1,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118333,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118334,and,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118335,the,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118336,upregulation,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118337,of,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118338,adiponectin,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118339,and,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118340,other,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118341,gene,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118342,products,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118343,.,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118636,The,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118637,analysis,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118638,of,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118639,food,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118640,patterns,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118641,can,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118642,contribute,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118643,to,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118644,the,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118645,understanding,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118646,of,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118647,the,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118648,association,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118649,between,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118650,eating,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118651,habits,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118652,and,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118653,anthropometric,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118654,indicators,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118655,.,O,4138.0,The analysis of food patterns can contribute to the understanding of the association between eating habits and anthropometric indicators .
118992,Human,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
118993,randomized,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
118994,controlled,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
118995,studies,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
118996,were,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
118997,selected,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
118998,according,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
118999,to,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
119000,PRISMA,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
119001,guidelines,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
119002,.,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
119081,After,O,4153.0,"After chronic intake of cocoa flavanols in young adults , a better cognitive performance was found together with increased levels of neurotrophins ."
119082,chronic,O,4153.0,"After chronic intake of cocoa flavanols in young adults , a better cognitive performance was found together with increased levels of neurotrophins ."
119083,intake,O,4153.0,"After chronic intake of cocoa flavanols in young adults , a better cognitive performance was found together with increased levels of neurotrophins ."
119084,of,O,4153.0,"After chronic intake of cocoa flavanols in young adults , a better cognitive performance was found together with increased levels of neurotrophins ."
119085,cocoa,O,4153.0,"After chronic intake of cocoa flavanols in young adults , a better cognitive performance was found together with increased levels of neurotrophins ."
119086,flavanols,O,4153.0,"After chronic intake of cocoa flavanols in young adults , a better cognitive performance was found together with increased levels of neurotrophins ."
119087,in,O,4153.0,"After chronic intake of cocoa flavanols in young adults , a better cognitive performance was found together with increased levels of neurotrophins ."
119088,young,O,4153.0,"After chronic intake of cocoa flavanols in young adults , a better cognitive performance was found together with increased levels of neurotrophins ."
119089,adults,O,4153.0,"After chronic intake of cocoa flavanols in young adults , a better cognitive performance was found together with increased levels of neurotrophins ."
119090,",",O,4153.0,"After chronic intake of cocoa flavanols in young adults , a better cognitive performance was found together with increased levels of neurotrophins ."
119091,a,O,4153.0,"After chronic intake of cocoa flavanols in young adults , a better cognitive performance was found together with increased levels of neurotrophins ."
119092,better,O,4153.0,"After chronic intake of cocoa flavanols in young adults , a better cognitive performance was found together with increased levels of neurotrophins ."
119093,cognitive,O,4153.0,"After chronic intake of cocoa flavanols in young adults , a better cognitive performance was found together with increased levels of neurotrophins ."
119094,performance,O,4153.0,"After chronic intake of cocoa flavanols in young adults , a better cognitive performance was found together with increased levels of neurotrophins ."
119095,was,O,4153.0,"After chronic intake of cocoa flavanols in young adults , a better cognitive performance was found together with increased levels of neurotrophins ."
119096,found,O,4153.0,"After chronic intake of cocoa flavanols in young adults , a better cognitive performance was found together with increased levels of neurotrophins ."
119097,together,O,4153.0,"After chronic intake of cocoa flavanols in young adults , a better cognitive performance was found together with increased levels of neurotrophins ."
119098,with,O,4153.0,"After chronic intake of cocoa flavanols in young adults , a better cognitive performance was found together with increased levels of neurotrophins ."
119099,increased,O,4153.0,"After chronic intake of cocoa flavanols in young adults , a better cognitive performance was found together with increased levels of neurotrophins ."
119100,levels,O,4153.0,"After chronic intake of cocoa flavanols in young adults , a better cognitive performance was found together with increased levels of neurotrophins ."
119101,of,O,4153.0,"After chronic intake of cocoa flavanols in young adults , a better cognitive performance was found together with increased levels of neurotrophins ."
119102,neurotrophins,O,4153.0,"After chronic intake of cocoa flavanols in young adults , a better cognitive performance was found together with increased levels of neurotrophins ."
119103,.,O,4153.0,"After chronic intake of cocoa flavanols in young adults , a better cognitive performance was found together with increased levels of neurotrophins ."
119391,The,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119392,inverse,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119393,association,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119394,of,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119395,DED,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119396,with,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119397,age,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119398,group,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119399,was,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119400,explained,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119401,by,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119402,higher,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119403,intakes,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119404,of,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119405,vegetables,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119406,",",O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119407,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119408,",",O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119409,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119410,",",O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119411,potatoes,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119412,",",O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119413,fresh,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119414,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119415,and,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119416,brown,B-http://purl.bioontology.org/ontology/SNOMEDCT/226560007;http://purl.bioontology.org/ontology/SNOMEDCT/226559002,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119417,bread,I-http://purl.bioontology.org/ontology/SNOMEDCT/226560007;http://purl.bioontology.org/ontology/SNOMEDCT/226559002,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119418,and,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119419,lower,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119420,intakes,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119421,of,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119422,SSB,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119423,",",O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119424,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/227608002;http://purl.bioontology.org/ontology/SNOMEDCT/102262009,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119425,confectionery,I-http://purl.bioontology.org/ontology/SNOMEDCT/227608002;http://purl.bioontology.org/ontology/SNOMEDCT/102262009,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119426,",",O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119427,ready,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119428,-,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119429,to,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119430,-,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119431,eat,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119432,breakfast,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119433,cereals,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119434,and,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119435,savoury,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119436,snacks,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119437,in,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119438,older,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119439,age,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119440,groups,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119441,.,O,4162.0,"The inverse association of DED with age group was explained by higher intakes of vegetables , fruit , fish , potatoes , fresh meat and brown bread and lower intakes of SSB , chocolate confectionery , ready - to - eat breakfast cereals and savoury snacks in older age groups ."
119442,Females,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119443,consumed,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119444,",",O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119445,on,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119446,average,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119447,",",O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119448,1·5,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119449,times,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119450,more,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119451,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119452,and,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119453,vegetables,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119454,combined,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119455,when,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119456,compared,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119457,with,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119458,males,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119459,",",O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119460,largely,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119461,explaining,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119462,the,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119463,sex,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119464,differences,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119465,in,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119466,DED,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119467,estimates,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119468,.,O,4163.0,"Females consumed , on average , 1·5 times more fruit and vegetables combined when compared with males , largely explaining the sex differences in DED estimates ."
119765,These,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119766,findings,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119767,do,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119768,not,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119769,support,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119770,the,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119771,view,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119772,that,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119773,replacement,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119774,of,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119775,dietary,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119776,saturated,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119777,fat,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119778,with,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119779,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119780,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119781,has,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119782,a,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119783,major,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119784,impact,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119785,on,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119786,the,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119787,development,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119788,of,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119789,atherosclerosis,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119790,in,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119791,addition,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119792,to,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119793,that,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119794,accounted,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119795,for,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119796,by,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119797,changes,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119798,in,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119799,plasma,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119800,cholesterol,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119801,levels,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119802,.,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
120165,The,O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120166,activity,O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120167,of,O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120168,sage,B-http://purl.bioontology.org/ontology/SNOMEDCT/227411006,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120169,",",O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120170,mushrooms,O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120171,",",O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120172,and,O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120173,brewers,O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120174,'s,O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120175,yeast,O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120176,was,O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120177,not,O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120178,removed,O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120179,by,O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120180,PVP,O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120181,.,O,4186.0,"The activity of sage , mushrooms , and brewers 's yeast was not removed by PVP ."
120340,It,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120341,is,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120342,known,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120343,that,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120344,bioactive,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120345,metabolites,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120346,and,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120347,live,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120348,enzymes,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120349,that,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120350,occur,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120351,by,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120352,fermentation,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120353,and,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120354,digestion,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120355,",",O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120356,affect,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120357,the,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120358,health,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120359,positively,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120360,by,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120361,improving,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120362,gut,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120363,microbiota,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120364,.,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120451,Unlike,O,4197.0,"Unlike milk , increased acidity during the fermentation of yogurt positively affects calcium absorption ."
120452,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4197.0,"Unlike milk , increased acidity during the fermentation of yogurt positively affects calcium absorption ."
120453,",",O,4197.0,"Unlike milk , increased acidity during the fermentation of yogurt positively affects calcium absorption ."
120454,increased,O,4197.0,"Unlike milk , increased acidity during the fermentation of yogurt positively affects calcium absorption ."
120455,acidity,O,4197.0,"Unlike milk , increased acidity during the fermentation of yogurt positively affects calcium absorption ."
120456,during,O,4197.0,"Unlike milk , increased acidity during the fermentation of yogurt positively affects calcium absorption ."
120457,the,O,4197.0,"Unlike milk , increased acidity during the fermentation of yogurt positively affects calcium absorption ."
120458,fermentation,O,4197.0,"Unlike milk , increased acidity during the fermentation of yogurt positively affects calcium absorption ."
120459,of,O,4197.0,"Unlike milk , increased acidity during the fermentation of yogurt positively affects calcium absorption ."
120460,yogurt,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,4197.0,"Unlike milk , increased acidity during the fermentation of yogurt positively affects calcium absorption ."
120461,positively,O,4197.0,"Unlike milk , increased acidity during the fermentation of yogurt positively affects calcium absorption ."
120462,affects,O,4197.0,"Unlike milk , increased acidity during the fermentation of yogurt positively affects calcium absorption ."
120463,calcium,O,4197.0,"Unlike milk , increased acidity during the fermentation of yogurt positively affects calcium absorption ."
120464,absorption,O,4197.0,"Unlike milk , increased acidity during the fermentation of yogurt positively affects calcium absorption ."
120465,.,O,4197.0,"Unlike milk , increased acidity during the fermentation of yogurt positively affects calcium absorption ."
120517,There,O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120518,are,O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120519,many,O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120520,lipid,O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120521,and,O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120522,lipoid,O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120523,nutrients,O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120524,such,O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120525,as,O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120526,saturated,O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120527,fatty,O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120528,acids,O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120529,",",O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120530,phospholipids,O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120531,",",O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120532,sphingolipids,O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120533,",",O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120534,and,O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120535,conjugated,O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120536,linoleic,O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120537,acid,O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120538,that,O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120539,may,O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120540,affect,O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120541,the,O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120542,blood,O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120543,lipid,O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120544,profile,O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120545,in,O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120546,yogurt,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120547,positively,O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120548,or,O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120549,negatively,O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120550,.,O,4200.0,"There are many lipid and lipoid nutrients such as saturated fatty acids , phospholipids , sphingolipids , and conjugated linoleic acid that may affect the blood lipid profile in yogurt positively or negatively ."
120579,In,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120580,this,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120581,review,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120582,",",O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120583,based,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120584,on,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120585,the,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120586,clinical,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120587,studies,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120588,conducted,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120589,to,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120590,date,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120591,",",O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120592,and,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120593,the,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120594,nutrient,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120595,content,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120596,of,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120597,yogurt,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120598,",",O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120599,possible,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120600,mechanisms,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120601,of,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120602,these,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120603,contradictory,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120604,results,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120605,are,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120606,investigated,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120607,.,O,4202.0,"In this review , based on the clinical studies conducted to date , and the nutrient content of yogurt , possible mechanisms of these contradictory results are investigated ."
120796,These,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120797,findings,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120798,were,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120799,in,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120800,accordance,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120801,with,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120802,the,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120803,generally,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120804,held,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120805,view,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120806,in,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120807,Japan,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120808,that,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120809,moderate,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120810,intake,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120811,of,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120812,animal,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120813,protein,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120814,was,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120815,protective,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120816,against,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120817,stroke,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120818,.,O,4210.0,These findings were in accordance with the generally held view in Japan that moderate intake of animal protein was protective against stroke .
120980,There,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120981,was,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120982,a,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120983,positive,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120984,relationship,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120985,between,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120986,gastric,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120987,-,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120988,cancer,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120989,risk,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120990,and,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120991,the,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120992,age,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120993,at,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120994,which,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120995,the,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120996,interviewees,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120997,started,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120998,using,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
120999,refrigerators,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
121000,.,O,4217.0,There was a positive relationship between gastric - cancer risk and the age at which the interviewees started using refrigerators .
121063,Milk,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121064,small,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121065,extracellular,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121066,vesicles,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121067,(,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121068,sEV,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121069,),O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121070,contain,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121071,proteins,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121072,that,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121073,provide,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121074,potential,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121075,information,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121076,of,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121077,host,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121078,physiology,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121079,and,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121080,immunology,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121081,.,O,4219.0,Milk small extracellular vesicles ( sEV ) contain proteins that provide potential information of host physiology and immunology .
121102,In,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121103,this,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121104,study,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121105,",",O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121106,we,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121107,aimed,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121108,to,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121109,explore,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121110,the,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121111,proteomic,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121112,profile,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121113,of,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121114,milk,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121115,sEV,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121116,from,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121117,BLV,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121118,-,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121119,infected,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121120,cattle,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121121,compared,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121122,with,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121123,those,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121124,from,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121125,uninfected,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121126,cattle,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121127,.,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121569,This,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121570,study,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121571,reports,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121572,an,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121573,independent,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121574,inverse,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121575,relationship,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121576,between,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121577,daily,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121578,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121579,consumption,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121580,and,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121581,levels,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121582,of,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121583,insulin,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121584,",",O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121585,HOMA,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121586,-,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121587,IR,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121588,and,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121589,liver,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121590,enzymes,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121591,in,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121592,adults,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121593,",",O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121594,suggesting,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121595,that,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121596,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121597,consumption,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121598,may,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121599,improve,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121600,liver,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121601,enzymes,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121602,and,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121603,protect,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121604,against,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121605,insulin,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121606,resistance,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121607,",",O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121608,a,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121609,well,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121610,-,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121611,established,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121612,risk,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121613,factor,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121614,for,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121615,cardiometabolic,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121616,disorders,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121617,.,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
122186,Aortic,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122187,fatty,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122188,streak,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122189,area,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122190,(,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122191,AFSA,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122192,),O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122193,was,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122194,significantly,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122195,reduced,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122196,in,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122197,the,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122198,groups,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122199,receiving,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122200,PE,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122201,in,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122202,ethanol,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122203,(,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122204,-32,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122205,%,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122206,),O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122207,or,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122208,PE,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122209,in,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122210,water,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122211,(,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122212,-29,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122213,%,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122214,),O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122215,in,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122216,comparison,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122217,with,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122218,their,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122219,respective,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122220,controls,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122221,.,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122550,Furthermore,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122551,",",O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122552,it,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122553,is,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122554,hypothesized,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122555,that,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122556,the,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122557,dietary,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122558,components,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122559,of,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122560,these,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122561,beverages,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122562,may,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122563,be,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122564,related,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122565,to,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122566,the,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122567,development,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122568,of,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122569,bladder,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122570,cancer,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122571,.,O,4270.0,"Furthermore , it is hypothesized that the dietary components of these beverages may be related to the development of bladder cancer ."
122572,Reduced,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122573,rank,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122574,regression,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122575,(,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122576,RRR,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122577,),O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122578,is,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122579,an,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122580,innovative,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122581,technique,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122582,to,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122583,establish,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122584,dietary,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122585,patterns,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122586,related,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122587,to,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122588,biochemical,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122589,risk,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122590,factors,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122591,for,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122592,type,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122593,2,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122594,diabetes,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122595,",",O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122596,but,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122597,has,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122598,not,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122599,been,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122600,applied,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122601,in,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122602,sub,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122603,-,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122604,Saharan,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122605,Africa,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122606,.,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
123129,Recently,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123130,",",O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123131,we,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123132,demonstrated,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123133,that,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123134,dietary,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123135,beef,B-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123136,causes,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123137,greater,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123138,colonic,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123139,DNA,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123140,strand,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123141,breakage,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123142,than,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123143,equivalent,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123144,levels,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123145,of,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123146,chicken,B-http://purl.bioontology.org/ontology/SNOMEDCT/226955001,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123147,in,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123148,rats,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123149,and,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123150,that,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123151,resistant,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123152,starch,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123153,(,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123154,RS,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123155,),O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123156,as,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123157,20,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123158,%,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123159,high,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123160,amylose,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123161,maize,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123162,starch,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123163,(,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123164,HAMS,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123165,),O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123166,attenuated,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123167,the,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123168,damage,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123169,.,O,4290.0,"Recently , we demonstrated that dietary beef causes greater colonic DNA strand breakage than equivalent levels of chicken in rats and that resistant starch ( RS ) as 20 % high amylose maize starch ( HAMS ) attenuated the damage ."
123443,However,O,4303.0,"However , food matrices and processing conditions can affect the detection of protein residues ."
123444,",",O,4303.0,"However , food matrices and processing conditions can affect the detection of protein residues ."
123445,food,O,4303.0,"However , food matrices and processing conditions can affect the detection of protein residues ."
123446,matrices,O,4303.0,"However , food matrices and processing conditions can affect the detection of protein residues ."
123447,and,O,4303.0,"However , food matrices and processing conditions can affect the detection of protein residues ."
123448,processing,O,4303.0,"However , food matrices and processing conditions can affect the detection of protein residues ."
123449,conditions,O,4303.0,"However , food matrices and processing conditions can affect the detection of protein residues ."
123450,can,O,4303.0,"However , food matrices and processing conditions can affect the detection of protein residues ."
123451,affect,O,4303.0,"However , food matrices and processing conditions can affect the detection of protein residues ."
123452,the,O,4303.0,"However , food matrices and processing conditions can affect the detection of protein residues ."
123453,detection,O,4303.0,"However , food matrices and processing conditions can affect the detection of protein residues ."
123454,of,O,4303.0,"However , food matrices and processing conditions can affect the detection of protein residues ."
123455,protein,O,4303.0,"However , food matrices and processing conditions can affect the detection of protein residues ."
123456,residues,O,4303.0,"However , food matrices and processing conditions can affect the detection of protein residues ."
123457,.,O,4303.0,"However , food matrices and processing conditions can affect the detection of protein residues ."
123458,The,O,4304.0,The effects of acidity on the detectability of several allergenic proteins commonly found in salad dressing using ELISAs was investigated .
123459,effects,O,4304.0,The effects of acidity on the detectability of several allergenic proteins commonly found in salad dressing using ELISAs was investigated .
123460,of,O,4304.0,The effects of acidity on the detectability of several allergenic proteins commonly found in salad dressing using ELISAs was investigated .
123461,acidity,O,4304.0,The effects of acidity on the detectability of several allergenic proteins commonly found in salad dressing using ELISAs was investigated .
123462,on,O,4304.0,The effects of acidity on the detectability of several allergenic proteins commonly found in salad dressing using ELISAs was investigated .
123463,the,O,4304.0,The effects of acidity on the detectability of several allergenic proteins commonly found in salad dressing using ELISAs was investigated .
123464,detectability,O,4304.0,The effects of acidity on the detectability of several allergenic proteins commonly found in salad dressing using ELISAs was investigated .
123465,of,O,4304.0,The effects of acidity on the detectability of several allergenic proteins commonly found in salad dressing using ELISAs was investigated .
123466,several,O,4304.0,The effects of acidity on the detectability of several allergenic proteins commonly found in salad dressing using ELISAs was investigated .
123467,allergenic,O,4304.0,The effects of acidity on the detectability of several allergenic proteins commonly found in salad dressing using ELISAs was investigated .
123468,proteins,O,4304.0,The effects of acidity on the detectability of several allergenic proteins commonly found in salad dressing using ELISAs was investigated .
123469,commonly,O,4304.0,The effects of acidity on the detectability of several allergenic proteins commonly found in salad dressing using ELISAs was investigated .
123470,found,O,4304.0,The effects of acidity on the detectability of several allergenic proteins commonly found in salad dressing using ELISAs was investigated .
123471,in,O,4304.0,The effects of acidity on the detectability of several allergenic proteins commonly found in salad dressing using ELISAs was investigated .
123472,salad,B-http://purl.bioontology.org/ontology/SNOMEDCT/227545001;http://purl.bioontology.org/ontology/SNOMEDCT/227927005,4304.0,The effects of acidity on the detectability of several allergenic proteins commonly found in salad dressing using ELISAs was investigated .
123473,dressing,I-http://purl.bioontology.org/ontology/SNOMEDCT/227545001;http://purl.bioontology.org/ontology/SNOMEDCT/227927005,4304.0,The effects of acidity on the detectability of several allergenic proteins commonly found in salad dressing using ELISAs was investigated .
123474,using,O,4304.0,The effects of acidity on the detectability of several allergenic proteins commonly found in salad dressing using ELISAs was investigated .
123475,ELISAs,O,4304.0,The effects of acidity on the detectability of several allergenic proteins commonly found in salad dressing using ELISAs was investigated .
123476,was,O,4304.0,The effects of acidity on the detectability of several allergenic proteins commonly found in salad dressing using ELISAs was investigated .
123477,investigated,O,4304.0,The effects of acidity on the detectability of several allergenic proteins commonly found in salad dressing using ELISAs was investigated .
123478,.,O,4304.0,The effects of acidity on the detectability of several allergenic proteins commonly found in salad dressing using ELISAs was investigated .
123589,Basic,O,4310.0,Basic extraction of mustard proteins from salad dressing did not improve the mustard detection .
123590,extraction,O,4310.0,Basic extraction of mustard proteins from salad dressing did not improve the mustard detection .
123591,of,O,4310.0,Basic extraction of mustard proteins from salad dressing did not improve the mustard detection .
123592,mustard,O,4310.0,Basic extraction of mustard proteins from salad dressing did not improve the mustard detection .
123593,proteins,O,4310.0,Basic extraction of mustard proteins from salad dressing did not improve the mustard detection .
123594,from,O,4310.0,Basic extraction of mustard proteins from salad dressing did not improve the mustard detection .
123595,salad,B-http://purl.bioontology.org/ontology/SNOMEDCT/227545001;http://purl.bioontology.org/ontology/SNOMEDCT/227927005,4310.0,Basic extraction of mustard proteins from salad dressing did not improve the mustard detection .
123596,dressing,I-http://purl.bioontology.org/ontology/SNOMEDCT/227545001;http://purl.bioontology.org/ontology/SNOMEDCT/227927005,4310.0,Basic extraction of mustard proteins from salad dressing did not improve the mustard detection .
123597,did,O,4310.0,Basic extraction of mustard proteins from salad dressing did not improve the mustard detection .
123598,not,O,4310.0,Basic extraction of mustard proteins from salad dressing did not improve the mustard detection .
123599,improve,O,4310.0,Basic extraction of mustard proteins from salad dressing did not improve the mustard detection .
123600,the,O,4310.0,Basic extraction of mustard proteins from salad dressing did not improve the mustard detection .
123601,mustard,B-http://purl.bioontology.org/ontology/SNOMEDCT/51905005,4310.0,Basic extraction of mustard proteins from salad dressing did not improve the mustard detection .
123602,detection,O,4310.0,Basic extraction of mustard proteins from salad dressing did not improve the mustard detection .
123603,.,O,4310.0,Basic extraction of mustard proteins from salad dressing did not improve the mustard detection .
123688,Our,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123689,study,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123690,highlighted,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123691,the,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123692,importance,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123693,of,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123694,evaluating,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123695,the,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123696,utility,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123697,of,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123698,various,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123699,ELISAs,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123700,for,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123701,specific,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123702,food,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123703,matrices,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123704,and,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123705,the,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123706,recovery,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123707,as,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123708,a,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123709,function,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123710,of,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123711,product,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123712,storage,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
123713,.,O,4314.0,Our study highlighted the importance of evaluating the utility of various ELISAs for specific food matrices and the recovery as a function of product storage .
124329,The,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124330,pathogenesis,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124331,-,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124332,related,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124333,proteins,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124334,represent,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124335,the,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124336,main,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124337,proteins,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124338,in,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124339,all,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124340,of,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124341,the,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124342,wines,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124343,",",O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124344,but,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124345,only,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124346,some,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124347,red,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124348,wines,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124349,show,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124350,a,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124351,band,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124352,with,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124353,a,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124354,molecular,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124355,mass,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124356,of,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124357,12,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124358,kDa,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124359,",",O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124360,identified,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124361,as,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124362,a,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124363,lipid,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124364,transfer,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124365,protein,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124366,(,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124367,LTP,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124368,),O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124369,.,O,4335.0,"The pathogenesis - related proteins represent the main proteins in all of the wines , but only some red wines show a band with a molecular mass of 12 kDa , identified as a lipid transfer protein ( LTP ) ."
124402,Olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,4338.0,Olive oil reportedly has cardioprotective effects .
124403,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,4338.0,Olive oil reportedly has cardioprotective effects .
124404,reportedly,O,4338.0,Olive oil reportedly has cardioprotective effects .
124405,has,O,4338.0,Olive oil reportedly has cardioprotective effects .
124406,cardioprotective,O,4338.0,Olive oil reportedly has cardioprotective effects .
124407,effects,O,4338.0,Olive oil reportedly has cardioprotective effects .
124408,.,O,4338.0,Olive oil reportedly has cardioprotective effects .
124963,Inflammation,O,4359.0,Inflammation is a key component in the development of all CLDs .
124964,is,O,4359.0,Inflammation is a key component in the development of all CLDs .
124965,a,O,4359.0,Inflammation is a key component in the development of all CLDs .
124966,key,O,4359.0,Inflammation is a key component in the development of all CLDs .
124967,component,O,4359.0,Inflammation is a key component in the development of all CLDs .
124968,in,O,4359.0,Inflammation is a key component in the development of all CLDs .
124969,the,O,4359.0,Inflammation is a key component in the development of all CLDs .
124970,development,O,4359.0,Inflammation is a key component in the development of all CLDs .
124971,of,O,4359.0,Inflammation is a key component in the development of all CLDs .
124972,all,O,4359.0,Inflammation is a key component in the development of all CLDs .
124973,CLDs,O,4359.0,Inflammation is a key component in the development of all CLDs .
124974,.,O,4359.0,Inflammation is a key component in the development of all CLDs .
125170,During,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125171,a,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125172,median,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125173,follow,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125174,-,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125175,up,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125176,of,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125177,13·6,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125178,years,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125179,",",O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125180,we,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125181,identified,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125182,656,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125183,female,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125184,and,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125185,1694,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125186,male,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125187,cases,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125188,.,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125377,In,O,4375.0,"In some regions , this crop is replacing maize , due to its high yield , resistance to drought and heat ."
125378,some,O,4375.0,"In some regions , this crop is replacing maize , due to its high yield , resistance to drought and heat ."
125379,regions,O,4375.0,"In some regions , this crop is replacing maize , due to its high yield , resistance to drought and heat ."
125380,",",O,4375.0,"In some regions , this crop is replacing maize , due to its high yield , resistance to drought and heat ."
125381,this,O,4375.0,"In some regions , this crop is replacing maize , due to its high yield , resistance to drought and heat ."
125382,crop,O,4375.0,"In some regions , this crop is replacing maize , due to its high yield , resistance to drought and heat ."
125383,is,O,4375.0,"In some regions , this crop is replacing maize , due to its high yield , resistance to drought and heat ."
125384,replacing,O,4375.0,"In some regions , this crop is replacing maize , due to its high yield , resistance to drought and heat ."
125385,maize,O,4375.0,"In some regions , this crop is replacing maize , due to its high yield , resistance to drought and heat ."
125386,",",O,4375.0,"In some regions , this crop is replacing maize , due to its high yield , resistance to drought and heat ."
125387,due,O,4375.0,"In some regions , this crop is replacing maize , due to its high yield , resistance to drought and heat ."
125388,to,O,4375.0,"In some regions , this crop is replacing maize , due to its high yield , resistance to drought and heat ."
125389,its,O,4375.0,"In some regions , this crop is replacing maize , due to its high yield , resistance to drought and heat ."
125390,high,O,4375.0,"In some regions , this crop is replacing maize , due to its high yield , resistance to drought and heat ."
125391,yield,O,4375.0,"In some regions , this crop is replacing maize , due to its high yield , resistance to drought and heat ."
125392,",",O,4375.0,"In some regions , this crop is replacing maize , due to its high yield , resistance to drought and heat ."
125393,resistance,O,4375.0,"In some regions , this crop is replacing maize , due to its high yield , resistance to drought and heat ."
125394,to,O,4375.0,"In some regions , this crop is replacing maize , due to its high yield , resistance to drought and heat ."
125395,drought,O,4375.0,"In some regions , this crop is replacing maize , due to its high yield , resistance to drought and heat ."
125396,and,O,4375.0,"In some regions , this crop is replacing maize , due to its high yield , resistance to drought and heat ."
125397,heat,O,4375.0,"In some regions , this crop is replacing maize , due to its high yield , resistance to drought and heat ."
125398,.,O,4375.0,"In some regions , this crop is replacing maize , due to its high yield , resistance to drought and heat ."
125658,During,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125659,13.4,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125660,years,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125661,of,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125662,follow,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125663,-,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125664,up,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125665,122,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125666,women,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125667,developed,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125668,RCC,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
125669,.,O,4382.0,During 13.4 years of follow - up 122 women developed RCC .
126105,Risk,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126106,of,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126107,rectal,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126108,cancer,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126109,increased,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126110,nonsignificantly,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126111,among,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126112,men,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126113,with,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126114,beer,B-http://purl.bioontology.org/ontology/SNOMEDCT/53410008,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126115,consumption,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126116,",",O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126117,among,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126118,women,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126119,with,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126120,high,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126121,white,B-http://purl.bioontology.org/ontology/SNOMEDCT/67990004;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126122,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/67990004;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126123,use,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126124,",",O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126125,and,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126126,among,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126127,men,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126128,and,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126129,women,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126130,with,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126131,high,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126132,long,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126133,-,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126134,term,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126135,alcohol,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126136,use,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
126137,.,O,4396.0,"Risk of rectal cancer increased nonsignificantly among men with beer consumption , among women with high white wine use , and among men and women with high long - term alcohol use ."
127729,Given,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127730,the,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127731,potential,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127732,of,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127733,NHPs,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127734,to,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127735,additively,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127736,cause,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127737,hypoglycemia,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127738,when,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127739,used,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127740,concurrently,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127741,with,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127742,conventional,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127743,medications,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127744,",",O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127745,pharmacists,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127746,should,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127747,be,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127748,up,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127749,to,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127750,date,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127751,with,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127752,current,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127753,evidence,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127754,around,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127755,NHPs,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127756,that,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127757,may,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127758,affect,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127759,diabetes,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127760,care,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127761,to,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127762,prevent,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127763,adverse,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127764,reactions,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127765,and,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127766,interactions,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
127767,.,O,4447.0,"Given the potential of NHPs to additively cause hypoglycemia when used concurrently with conventional medications , pharmacists should be up to date with current evidence around NHPs that may affect diabetes care to prevent adverse reactions and interactions ."
128499,RAST,O,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128500,for,O,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128501,apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128502,",",O,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128503,peach,B-http://purl.bioontology.org/ontology/SNOMEDCT/735049002,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128504,",",O,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128505,and,O,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128506,hazelnut,B-http://purl.bioontology.org/ontology/SNOMEDCT/256353000,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128507,was,O,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128508,positive,O,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128509,in,O,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128510,53,O,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128511,(,O,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128512,68.8,O,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128513,%,O,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128514,),O,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128515,",",O,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128516,13,O,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128517,(,O,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128518,16.9,O,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128519,%,O,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128520,),O,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128521,",",O,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128522,and,O,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128523,31,O,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128524,(,O,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128525,40.3,O,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128526,%,O,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128527,),O,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128528,patients,O,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128529,",",O,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128530,respectively,O,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128531,.,O,4468.0,"RAST for apple , peach , and hazelnut was positive in 53 ( 68.8 % ) , 13 ( 16.9 % ) , and 31 ( 40.3 % ) patients , respectively ."
128683,However,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128684,",",O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128685,recent,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128686,human,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128687,studies,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128688,have,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128689,proven,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128690,that,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128691,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128692,has,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128693,beneficial,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128694,effects,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128695,on,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128696,some,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128697,pathogenic,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128698,mechanisms,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128699,of,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128700,heart,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128701,disease,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128702,such,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128703,as,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128704,endothelial,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128705,function,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128706,and,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128707,blood,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128708,pressure,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128709,.,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128880,In,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128881,an,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128882,animal,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128883,model,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128884,of,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128885,atherosclerosis,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128886,",",O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128887,cocoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128888,powder,I-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128889,at,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128890,a,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128891,human,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128892,dose,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128893,equivalent,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128894,of,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128895,two,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128896,dark,B-http://purl.bioontology.org/ontology/SNOMEDCT/443931000124105;http://purl.bioontology.org/ontology/SNOMEDCT/102262009,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128897,chocolate,I-http://purl.bioontology.org/ontology/SNOMEDCT/443931000124105;http://purl.bioontology.org/ontology/SNOMEDCT/102262009,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128898,bars,I-http://purl.bioontology.org/ontology/SNOMEDCT/443931000124105;http://purl.bioontology.org/ontology/SNOMEDCT/102262009,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128899,per,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128900,day,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128901,significantly,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128902,inhibited,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128903,atherosclerosis,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128904,",",O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128905,lowered,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128906,cholesterol,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128907,",",O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128908,low,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128909,-,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128910,density,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128911,lipoprotein,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128912,",",O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128913,and,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128914,triglycerides,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128915,",",O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128916,raised,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128917,high,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128918,-,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128919,density,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128920,lipoprotein,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128921,",",O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128922,and,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128923,protected,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128924,the,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128925,lower,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128926,density,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128927,lipoproteins,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128928,from,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128929,oxidation,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128930,.,O,4483.0,"In an animal model of atherosclerosis , cocoa powder at a human dose equivalent of two dark chocolate bars per day significantly inhibited atherosclerosis , lowered cholesterol , low - density lipoprotein , and triglycerides , raised high - density lipoprotein , and protected the lower density lipoproteins from oxidation ."
128992,We,O,4486.0,We know that saturated fatty acids are more closely associated with risk factors for heart disease than are unsaturated fatty acids .
128993,know,O,4486.0,We know that saturated fatty acids are more closely associated with risk factors for heart disease than are unsaturated fatty acids .
128994,that,O,4486.0,We know that saturated fatty acids are more closely associated with risk factors for heart disease than are unsaturated fatty acids .
128995,saturated,O,4486.0,We know that saturated fatty acids are more closely associated with risk factors for heart disease than are unsaturated fatty acids .
128996,fatty,O,4486.0,We know that saturated fatty acids are more closely associated with risk factors for heart disease than are unsaturated fatty acids .
128997,acids,O,4486.0,We know that saturated fatty acids are more closely associated with risk factors for heart disease than are unsaturated fatty acids .
128998,are,O,4486.0,We know that saturated fatty acids are more closely associated with risk factors for heart disease than are unsaturated fatty acids .
128999,more,O,4486.0,We know that saturated fatty acids are more closely associated with risk factors for heart disease than are unsaturated fatty acids .
129000,closely,O,4486.0,We know that saturated fatty acids are more closely associated with risk factors for heart disease than are unsaturated fatty acids .
129001,associated,O,4486.0,We know that saturated fatty acids are more closely associated with risk factors for heart disease than are unsaturated fatty acids .
129002,with,O,4486.0,We know that saturated fatty acids are more closely associated with risk factors for heart disease than are unsaturated fatty acids .
129003,risk,O,4486.0,We know that saturated fatty acids are more closely associated with risk factors for heart disease than are unsaturated fatty acids .
129004,factors,O,4486.0,We know that saturated fatty acids are more closely associated with risk factors for heart disease than are unsaturated fatty acids .
129005,for,O,4486.0,We know that saturated fatty acids are more closely associated with risk factors for heart disease than are unsaturated fatty acids .
129006,heart,O,4486.0,We know that saturated fatty acids are more closely associated with risk factors for heart disease than are unsaturated fatty acids .
129007,disease,O,4486.0,We know that saturated fatty acids are more closely associated with risk factors for heart disease than are unsaturated fatty acids .
129008,than,O,4486.0,We know that saturated fatty acids are more closely associated with risk factors for heart disease than are unsaturated fatty acids .
129009,are,O,4486.0,We know that saturated fatty acids are more closely associated with risk factors for heart disease than are unsaturated fatty acids .
129010,unsaturated,O,4486.0,We know that saturated fatty acids are more closely associated with risk factors for heart disease than are unsaturated fatty acids .
129011,fatty,O,4486.0,We know that saturated fatty acids are more closely associated with risk factors for heart disease than are unsaturated fatty acids .
129012,acids,O,4486.0,We know that saturated fatty acids are more closely associated with risk factors for heart disease than are unsaturated fatty acids .
129013,.,O,4486.0,We know that saturated fatty acids are more closely associated with risk factors for heart disease than are unsaturated fatty acids .
129209,Results,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129210,associating,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129211,diet,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129212,with,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129213,chronic,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129214,disease,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129215,in,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129216,a,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129217,cohort,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129218,of,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129219,34192,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129220,California,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129221,Seventh,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129222,-,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129223,day,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129224,Adventists,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129225,are,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129226,summarized,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129227,.,O,4495.0,Results associating diet with chronic disease in a cohort of 34192 California Seventh - day Adventists are summarized .
129298,Multivariate,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129299,analyses,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129300,showed,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129301,significant,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129302,associations,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129303,between,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129304,beef,B-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129305,consumption,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129306,and,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129307,fatal,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129308,ischemic,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129309,heart,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129310,disease,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129311,(,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129312,IHD,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129313,),O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129314,in,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129315,men,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129316,[,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129317,relative,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129318,risk,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129319,(,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129320,RR,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129321,),O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129322,=,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129323,2.31,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129324,for,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129325,subjects,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129326,who,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129327,ate,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129328,beef,B-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129329,>,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129330,or,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129331,=3,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129332,times,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129333,/,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129334,wk,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129335,compared,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129336,with,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129337,vegetarians,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129338,],O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129339,",",O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129340,significant,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129341,protective,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129342,associations,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129343,between,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129344,nut,B-http://purl.bioontology.org/ontology/SNOMEDCT/13577000,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129345,consumption,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129346,and,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129347,fatal,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129348,and,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129349,nonfatal,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129350,IHD,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129351,in,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129352,both,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129353,sexes,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129354,(,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129355,RR,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129356,approximately,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129357,0.5,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129358,for,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129359,subjects,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129360,who,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129361,ate,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129362,nuts,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129363,>,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129364,or,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129365,=,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129366,5,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129367,times,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129368,/,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129369,wk,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129370,compared,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129371,with,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129372,those,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129373,who,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129374,ate,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129375,nuts,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129376,<,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129377,1,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129378,time,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129379,/,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129380,wk,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129381,),O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129382,",",O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129383,and,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129384,reduced,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129385,risk,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129386,of,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129387,IHD,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129388,in,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129389,subjects,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129390,preferring,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129391,whole,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129392,-,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129393,grain,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129394,to,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129395,white,B-http://purl.bioontology.org/ontology/SNOMEDCT/226590000;http://purl.bioontology.org/ontology/SNOMEDCT/226559002,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129396,bread,I-http://purl.bioontology.org/ontology/SNOMEDCT/226590000;http://purl.bioontology.org/ontology/SNOMEDCT/226559002,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129397,.,O,4498.0,"Multivariate analyses showed significant associations between beef consumption and fatal ischemic heart disease ( IHD ) in men [ relative risk ( RR ) = 2.31 for subjects who ate beef > or =3 times / wk compared with vegetarians ] , significant protective associations between nut consumption and fatal and nonfatal IHD in both sexes ( RR approximately 0.5 for subjects who ate nuts > or = 5 times / wk compared with those who ate nuts < 1 time / wk ) , and reduced risk of IHD in subjects preferring whole - grain to white bread ."
129973,Of,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129974,23,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129975,food,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129976,and,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129977,beverage,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129978,categories,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129979,",",O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129980,only,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129981,candy,B-http://purl.bioontology.org/ontology/SNOMEDCT/227607007;http://purl.bioontology.org/ontology/SNOMEDCT/227722009,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129982,/,I-http://purl.bioontology.org/ontology/SNOMEDCT/227607007;http://purl.bioontology.org/ontology/SNOMEDCT/227722009,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129983,jelly,I-http://purl.bioontology.org/ontology/SNOMEDCT/227607007;http://purl.bioontology.org/ontology/SNOMEDCT/227722009,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129984,/,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129985,soda,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129986,pop,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129987,consumption,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129988,had,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129989,a,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129990,statistically,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129991,significant,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129992,inverse,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129993,trend,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
129994,.,O,4520.0,"Of 23 food and beverage categories , only candy / jelly / soda pop consumption had a statistically significant inverse trend ."
130092,The,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130093,panel,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130094,of,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130095,food,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130096,products,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130097,tested,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130098,included,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130099,fruits,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130100,",",O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130101,vegetables,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130102,",",O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130103,grains,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130104,",",O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130105,herbs,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130106,and,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130107,spices,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130108,",",O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130109,most,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130110,of,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130111,which,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130112,are,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130113,common,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130114,in,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130115,a,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130116,normal,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130117,European,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130118,-,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130119,style,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130120,diet,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130121,.,O,4525.0,"The panel of food products tested included fruits , vegetables , grains , herbs and spices , most of which are common in a normal European - style diet ."
130241,Both,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130242,aqueous,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130243,and,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130244,organic,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130245,extractions,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130246,of,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130247,ginger,B-http://purl.bioontology.org/ontology/SNOMEDCT/227400003,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130248,significantly,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130249,inhibited,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130250,the,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130251,growth,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130252,of,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130253,one,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130254,or,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130255,both,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130256,E.,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130257,coli,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130258,strains,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130259,",",O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130260,respectively,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130261,(,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130262,also,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130263,at,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130264,the,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130265,1:50,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130266,dilution,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130267,),O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130268,.,O,4529.0,"Both aqueous and organic extractions of ginger significantly inhibited the growth of one or both E. coli strains , respectively ( also at the 1:50 dilution ) ."
130383,When,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130384,small,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130385,amounts,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130386,of,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130387,spices,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130388,were,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130389,spread,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130390,on,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130391,the,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130392,oral,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130393,mucosa,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130394,",",O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130395,local,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130396,reactions,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130397,",",O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130398,especially,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130399,in,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130400,the,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130401,mouth,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130402,and,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130403,nasopharynx,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130404,",",O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130405,were,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130406,found,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130407,in,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130408,14,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130409,out,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130410,of,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130411,35,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130412,unselected,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130413,patients,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130414,with,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130415,positive,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130416,skin,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130417,test,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130418,reactions,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130419,.,O,4535.0,"When small amounts of spices were spread on the oral mucosa , local reactions , especially in the mouth and nasopharynx , were found in 14 out of 35 unselected patients with positive skin test reactions ."
130636,Birds,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130637,exposed,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130638,to,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130639,oil,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130640,externally,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130641,consumed,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130642,more,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130643,fish,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130644,than,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130645,control,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130646,birds,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130647,",",O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130648,indicating,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130649,metabolic,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130650,compensation,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130651,for,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130652,thermal,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130653,stress,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130654,.,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130716,Extensive,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130717,research,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130718,has,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130719,identified,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130720,several,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130721,molecular,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130722,targets,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130723,that,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130724,can,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130725,potentially,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130726,be,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130727,used,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130728,for,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130729,the,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130730,prevention,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130731,and/or,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130732,treatment,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130733,of,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130734,cancer,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130735,.,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130959,As,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130960,tomato,B-http://purl.bioontology.org/ontology/SNOMEDCT/734881000,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130961,sauces,I-http://purl.bioontology.org/ontology/SNOMEDCT/734881000,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130962,are,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130963,usually,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130964,cooked,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130965,with,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130966,the,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130967,addition,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130968,of,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130969,oil,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130970,",",O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130971,some,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130972,studies,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130973,have,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130974,pointed,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130975,out,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130976,that,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130977,both,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130978,processes,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130979,may,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130980,increase,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130981,the,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130982,bioavailability,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130983,of,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130984,the,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130985,bioactive,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130986,compounds,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130987,.,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130988,However,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130989,",",O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130990,the,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130991,effect,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130992,of,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130993,consumption,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130994,of,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130995,raw,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130996,tomatoes,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130997,and,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130998,tomato,B-http://purl.bioontology.org/ontology/SNOMEDCT/734881000,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
130999,sauces,I-http://purl.bioontology.org/ontology/SNOMEDCT/734881000,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131000,on,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131001,inflammation,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131002,biomarkers,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131003,and,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131004,adhesion,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131005,molecules,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131006,related,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131007,to,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131008,atherosclerosis,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131009,remains,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131010,unknown,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131011,.,O,4555.0,"However , the effect of consumption of raw tomatoes and tomato sauces on inflammation biomarkers and adhesion molecules related to atherosclerosis remains unknown ."
131417,Natural,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131418,compounds,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131419,of,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131420,plant,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131421,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131422,fungus,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131423,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131424,and,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131425,actinomycetes,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131426,origin,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131427,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131428,such,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131429,as,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131430,phenolics,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131431,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131432,polyketides,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131433,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131434,tetrapeptide,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131435,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131436,terpenoids,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131437,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131438,alkaloids,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131439,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131440,and,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131441,hydoxamic,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131442,acid,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131443,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131444,have,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131445,been,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131446,reported,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131447,to,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131448,show,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131449,potential,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131450,HDAC,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131451,-,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131452,inhibitory,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131453,activity,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131454,.,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131691,The,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131692,bread,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131693,quality,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131694,parameters,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131695,measured,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131696,were,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131697,specific,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131698,volume,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131699,",",O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131700,dry,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131701,matter,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131702,of,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131703,bread,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131704,",",O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131705,crust,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131706,color,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131707,",",O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131708,crumb,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131709,hardness,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131710,",",O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131711,and,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131712,gas,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131713,cell,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131714,size,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131715,distribution,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131716,.,O,4576.0,"The bread quality parameters measured were specific volume , dry matter of bread , crust color , crumb hardness , and gas cell size distribution ."
131806,Bread,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131807,with,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131808,1.9,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131809,%,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131810,guar,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131811,gum,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131812,(,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131813,w,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131814,/,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131815,w,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131816,",",O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131817,total,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131818,flour,B-http://purl.bioontology.org/ontology/SNOMEDCT/63766005,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131819,basis,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131820,),O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131821,and,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131822,5,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131823,%,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131824,buckwheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/226723006;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131825,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/226723006;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131826,(,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131827,of,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131828,all,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131829,flours,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131830,and,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131831,substitutes,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131832,),O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131833,mimicked,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131834,French,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131835,bread,I-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131836,quality,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131837,attributes,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131838,.,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131839,The,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131840,present,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131841,study,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131842,demonstrated,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131843,that,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131844,the,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131845,zinc,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131846,concentration,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131847,in,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131848,bovine,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131849,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131850,and,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131851,blood,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131852,plasma,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131853,is,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131854,significantly,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131855,affected,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131856,by,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131857,the,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131858,intake,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131859,of,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131860,saturated,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131861,fat,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131862,supplements,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
131863,.,O,4583.0,The present study demonstrated that the zinc concentration in bovine milk and blood plasma is significantly affected by the intake of saturated fat supplements .
